STUDYID|DOMAIN|USUBJID|PPSEQ|PPGRPID|PPTESTCD|PPTEST|PPCAT|PPSCAT|PPORRES|PPORRESU|PPSTRESC|PPSTRESN|PPSTRESU|PPSTAT|PPREASND|PPSPEC|PPANMETH|TAETORD|EPOCH|PPDTC|PPDY|PPRFTDTC|PPSTINT|PPENINT
TRIAL STUDY 134XCP|PP|28FBEC95-59B8-4821-BD7A-125E2C87D71C|1||V0S|VOL DIST INITIAL NORM BY SA||||||||NOT DONE||BREAST MILK|||TREATMENT|1971-01-24||1961-04-02|1963-09-25|1973-04-18
TRIAL STUDY 134XCP|PP|312DF5BA-05C3-49B4-AEDF-DC5F794D12C1|2||AUCTAUDW|AUCTAU NORM BY DOSE/WT||||||||NOT DONE||CERVICOVAGINAL SECRETION|||LONG-TERM FOLLOW-UP|1973-08-02||1972-07-28|1969-08-13|1969-07-21
TRIAL STUDY 134XCP|PP|1117C221-3530-45CB-82B2-B831C4DAD86B|3||RCPCINTS|PCT REC FROM T1 TO T2 NORM BY SA||||||||NOT DONE||VENOUS BLOOD|||TREATMENT|1970-03-08||1967-11-09|1960-11-10|1968-09-27
TRIAL STUDY 134XCP|PP|3ACFF838-5B16-4898-9640-A60C85096F64|4||R2|R SQUARED||||||||NOT DONE||LOCHIA|||RUN-IN|1966-01-01||1964-03-26|1967-06-15|1971-01-16
TRIAL STUDY 134XCP|PP|308F422A-B02B-4C76-86E7-834AAC127FE3|5||RCAMTAUS|AMT REC OVER DOSING INTERVAL NORM BY SA||||||||NOT DONE||EPIDERMAL TISSUE|||SCREENING|1962-05-20||1962-11-04|1967-09-24|1968-05-16
TRIAL STUDY 134XCP|PP|34A3AA01-3595-42C2-95C3-44E3AF77B28D|6||CAVGS|AVERAGE CONC NORM BY SA||||||||NOT DONE||PLASMA|||WASHOUT|1965-08-28||1964-12-18|1967-04-07|1970-01-11
TRIAL STUDY 134XCP|PP|05A82CB3-4A6B-42B9-9B5F-7D48C263EC70|7||ARCTROUG|ACCUMULATION RATIO CTROUGH||||||||NOT DONE||EXUDATE|||BASELINE|1964-08-10||1960-04-28|1972-04-22|1962-11-23
TRIAL STUDY 134XCP|PP|85B73C68-6C9D-4E57-A8E1-E2221AE61E30|8||RENALCL|RENAL CL||||||||NOT DONE||DISCHARGE|||OPEN LABEL TREATMENT|1961-01-15||1972-06-23|1970-04-02|1964-05-14
TRIAL STUDY 134XCP|PP|ECA054C6-EA0F-4D7B-905C-849EA4592624|9||ERINT|EXCRET RATE FROM T1 TO T2||||||||NOT DONE||PUS|||BLINDED TREATMENT|1972-02-15||1970-05-16|1966-11-22|1961-04-01
TRIAL STUDY 134XCP|PP|83823CA3-1C1D-455E-BE49-DC5E3651A939|10||VZOUB|VZ OBS FOR UB||||||||NOT DONE||LUNG SURFACTANT|||WASHOUT|1966-09-12||1961-12-30|1961-06-18|1967-09-03
TRIAL STUDY 134XCP|PP|C04E8E9E-71C7-4595-AD9D-01A86B1AC5BB|11||LAMZUTAU|LAMBDA Z UPPER LIMIT TAU||||||||NOT DONE||PLASMA|||SCREENING|1972-07-11||1967-10-24|1965-03-15|1968-05-14
TRIAL STUDY 134XCP|PP|9C24F018-315A-4B9C-B89B-F54CA26452E7|12||CLSTD|LAST NONZERO CONC NORM BY DOSE||||||||NOT DONE||CARDIAC MUSCLE TISSUE|||RUN-IN|1961-11-22||1969-01-07|1960-01-08|1965-07-20
TRIAL STUDY 134XCP|PP|AA9CE1A1-EAEF-4C04-A6BC-B56469AA236A|13||CLOD|TOTAL CL OBS NORM BY DOSE||||||||NOT DONE||BILE|||SCREENING|1960-09-15||1970-10-10|1963-06-07|1967-08-22
TRIAL STUDY 134XCP|PP|8D48F229-F38B-4335-B8A7-0AA24C928707|14||AUCINTS|AUC FROM T1 TO T2 NORM BY SA||||||||NOT DONE||LOCHIA|||OBSERVATION|1965-05-07||1964-10-03|1963-10-29|1968-07-05
TRIAL STUDY 134XCP|PP|F89F5FD5-AF3D-435F-9ABC-58BCB89FC3C6|15||CONCB|CONC BY BMI||||||||NOT DONE||ISOLATE|||LONG-TERM FOLLOW-UP|1960-02-07||1970-05-28|1963-02-18|1960-08-20
TRIAL STUDY 134XCP|PP|C882CB1F-C0DE-4BE5-B762-611333949C74|16||LAMZNPT|NUMBER OF POINTS FOR LAMBDA Z||||||||NOT DONE||CERVICOVAGINAL SECRETION|||BLINDED TREATMENT|1961-05-07||1965-07-08|1971-05-05|1972-09-26
TRIAL STUDY 134XCP|PP|7F3C3801-607B-4141-AA83-383FDFFD7152|17||CMIND|MIN CONC NORM BY DOSE||||||||NOT DONE||ERYTHROCYTES|||SCREENING|1964-06-19||1971-07-26|1969-07-01|1970-04-25
TRIAL STUDY 134XCP|PP|0DD4FBE8-5D91-4E48-AD35-06597F95E5BB|18||AUCIFPDW|AUCIFPDW NORM BY DOSE/WT||||||||NOT DONE||SERUM OR PLASMA|||OPEN LABEL TREATMENT|1961-02-15||1964-11-15|1971-04-28|1970-08-26
TRIAL STUDY 134XCP|PP|67025219-DBC0-4222-9D04-7F23EE3D5806|19||VSSOB|VOL DIST STEADY STATE OBS NORM BY BMI||||||||NOT DONE||CELL PELLET|||SCREENING|1961-05-19||1971-01-10|1966-09-19|1967-05-12
TRIAL STUDY 134XCP|PP|A865B860-E5F2-423D-8110-58EBF7E470F3|20||ARCMAX|ACCUMULATION RATIO CMAX||||||||NOT DONE||PLATELET|||OPEN LABEL TREATMENT|1968-09-14||1966-09-23|1960-05-19|1966-03-27
TRIAL STUDY 134XCP|PP|E78B2C0E-81D6-4898-B78A-FE136029AEA4|21||ERLSTW|LAST MEAS EXCRETION RATE NORM BY WT||||||||NOT DONE||INFRANATANT, PLASMA|||OBSERVATION|1968-08-16||1966-04-29|1961-01-18|1967-02-21
TRIAL STUDY 134XCP|PP|512B0190-2ABD-4477-BBAA-B5C8A57B1D53|22||AUCINTDW|AUCINT NORM BY DOSE/WT||||||||NOT DONE||EMESIS|||RUN-IN|1968-05-25||1972-09-14|1960-12-01|1969-10-16
TRIAL STUDY 134XCP|PP|C0642FE2-8A9A-4CFA-80C1-71B884E4D8BF|23||AUCIFPDW|AUCIFPDW NORM BY DOSE/WT||||||||NOT DONE||CEREBROSPINAL FLUID|||TREATMENT|1969-09-16||1972-05-08|1961-07-08|1965-03-20
TRIAL STUDY 134XCP|PP|55210E20-F6B9-446F-994D-2D9149E33BAF|24||CLSTB|LAST NONZERO CONC NORM BY BMI||||||||NOT DONE||CAPILLARY BLOOD|||OBSERVATION|1972-08-17||1960-11-17|1966-04-16|1960-07-21
TRIAL STUDY 134XCP|PP|1BE8ACB9-BEE8-4AFD-B384-D4C860B12450|25||CAVGINTW|AVERAGE CONC FROM T1 TO T2 NORM BY WT||||||||NOT DONE||EPIDERMAL TISSUE|||TREATMENT|1961-03-07||1961-08-06|1962-03-06|1968-06-14
TRIAL STUDY 134XCP|PP|68F4DB07-31EC-4ECA-92BF-7D6986E4B33A|26||CLFOB|TOTAL CL OBS BY F NORM BY BMI||||||||NOT DONE||SERUM OR PLASMA OR BLOOD|||CONTINUATION TREATMENT|1963-06-19||1961-08-13|1973-05-22|1961-09-20
TRIAL STUDY 134XCP|PP|C46B45B7-0CC3-4997-A6B9-DAA58B8D33D7|27||VZTAUW|VZ FOR DOSE INT NORM BY WT||||||||NOT DONE||ADIPOSE TISSUE|||FOLLOW-UP|1969-02-06||1965-01-22|1967-02-04|1970-12-11
TRIAL STUDY 134XCP|PP|1616C5D6-32D7-4A5D-A025-59DE09E55B0D|28||ERINTS|EXCRET RATE FROM T1 TO T2 NORM BY SA||||||||NOT DONE||BLOOD|||BLINDED TREATMENT|1968-08-01||1960-03-09|1961-09-05|1972-08-04
TRIAL STUDY 134XCP|PP|CAD0ED37-954A-4935-8A7E-589EC108E141|29||AUCTAUB|AUC OVER DOSING INTERVAL NORM BY BMI||||||||NOT DONE||BUFFY COAT|||FOLLOW-UP|1963-10-22||1968-01-30|1969-10-22|1969-08-24
TRIAL STUDY 134XCP|PP|BC9A31E2-100C-4AC3-8910-A04309854590|30||RARECINT|RATIO AMT REC FROM T1 TO T2||||||||NOT DONE||VITREOUS HUMOR|||WASHOUT|1971-10-02||1970-08-26|1971-06-06|1971-08-07
TRIAL STUDY 134XCP|PP|13A424BB-CC85-41EC-BDED-165A29532DFF|31||RCPCIFP|PCT REC INFINITY PRED||||||||NOT DONE||BONE MARROW MONONUCLEAR CELL|||LONG-TERM FOLLOW-UP|1962-08-06||1967-04-09|1960-03-06|1969-08-05
TRIAL STUDY 134XCP|PP|154D9D23-8ABD-4B69-90A1-A3D96F4743F3|32||RCAMIFPW|AMT REC INFINITY PRED NORM BY WT||||||||NOT DONE||SMEGMA|||RUN-IN|1966-10-03||1971-05-29|1962-10-02|1962-07-11
TRIAL STUDY 134XCP|PP|059FE504-DEE4-4E24-AA80-3C64264636BF|33||AURCINTS|AURC FROM T1 TO T2 NORM BY SA||||||||NOT DONE||EXUDATE|||FOLLOW-UP|1967-02-23||1971-08-31|1970-10-06|1970-10-02
TRIAL STUDY 134XCP|PP|3F806ADA-68C3-42AD-9DB7-2CA8E3A9F236|34||V0S|VOL DIST INITIAL NORM BY SA||||||||NOT DONE||INTERSTITIAL FLUID|||TREATMENT|1970-04-07||1971-08-07|1972-07-29|1972-07-04
TRIAL STUDY 134XCP|PP|69BCF810-6748-43AA-BDFC-64EE1536CB47|35||RENCLTAU|RENAL CL FOR DOSE INT||||||||NOT DONE||ATHEROSCLEROTIC PLAQUE|||WASHOUT|1971-07-23||1968-03-22|1971-05-10|1963-12-09
TRIAL STUDY 134XCP|PP|DCE71DE9-8DFB-4796-BC41-21930EC21925|36||AURCIFPS|AURC INFINITY PRED NORM BY SA||||||||NOT DONE||ARTERIALIZED CAPILLARY BLOOD|||FOLLOW-UP|1968-06-27||1966-11-28|1966-05-05|1971-03-17
TRIAL STUDY 134XCP|PP|9EE46F65-A7A1-4D18-A685-BC2EF905CC19|37||RNCLTAUB|RENAL CL FOR DOSE INT NORM BY BMI||||||||NOT DONE||DERMAL TISSUE|||SCREENING|1967-04-17||1965-09-09|1962-04-17|1967-01-14
TRIAL STUDY 134XCP|PP|97D06076-FE6B-4C77-BD5C-2E665F707C7A|38||TLAG|TIME UNTIL FIRST NONZERO CONC||||||||NOT DONE||CORD BLOOD|||BASELINE|1967-11-07||1963-01-24|1970-04-17|1965-02-08
TRIAL STUDY 134XCP|PP|E9E6E2D8-33F9-4769-B5F3-06ADB2926A9F|39||ARCTROUD|ACCUM RATIO CTROUGH NORM BY DOSE||||||||NOT DONE||BUFFY COAT|||CONTINUATION TREATMENT|1961-05-21||1962-12-24|1960-12-08|1973-03-25
TRIAL STUDY 134XCP|PP|D5A1EB38-77EA-49A5-84CA-740A83D258AF|40||MRCMAX|METABOLITE RATIO FOR MAX CONC||||||||NOT DONE||AMNIOTIC FLUID|||OPEN LABEL TREATMENT|1962-08-25||1971-03-06|1970-01-14|1969-09-10
TRIAL STUDY 134XCP|PP|5255639E-AC65-4DA8-85EF-4ABD53BAAED5|41||AUCALLB|AUC ALL NORM BY BMI||||||||NOT DONE||CARDIAC MUSCLE TISSUE|||CONTINUATION TREATMENT|1966-04-21||1972-09-27|1967-10-10|1969-11-25
TRIAL STUDY 134XCP|PP|99F8DAA7-F186-487C-9E5D-43E9DBFB48C6|42||CLP|TOTAL CL PRED||||||||NOT DONE||CIRCULATING TUMOR CELL|||BLINDED TREATMENT|1964-10-19||1961-06-30|1969-09-28|1973-04-03
TRIAL STUDY 134XCP|PP|88A1099B-F69D-4B6F-90CE-DAAE629CEACE|43||HDER|HEMODIALYSIS EXTRACTION RATIO||||||||NOT DONE||URINE SEDIMENT|||LONG-TERM FOLLOW-UP|1964-08-18||1970-12-27|1970-08-15|1966-04-27
TRIAL STUDY 134XCP|PP|640DDEF5-748A-4F92-A13D-15D1C7CE0800|44||RCPCIFOB|PCT REC INFINITY OBS NORM BY BMI||||||||NOT DONE||MIXED VENOUS BLOOD|||SCREENING|1973-02-11||1963-08-17|1967-07-21|1961-01-17
TRIAL STUDY 134XCP|PP|FB4290D9-A5F8-472C-8AAC-28D8A59D8FED|45||RCAMINTB|AMT REC FROM T1 TO T2 NORM BY BMI||||||||NOT DONE||VENOUS BLOOD|||RUN-IN|1968-12-12||1972-01-22|1973-01-18|1963-07-27
TRIAL STUDY 134XCP|PP|EBC7BF7B-18C6-463C-8500-027B2A6966DB|46||RACMIN|RATIO MIN CONC||||||||NOT DONE||HAIR|||INDUCTION TREATMENT|1966-02-25||1968-05-16|1972-04-05|1969-09-04
TRIAL STUDY 134XCP|PP|3167BE9B-E72D-4011-BD2C-CB4F9F27FE2C|47||PTROUGHR|PEAK TROUGH RATIO||||||||NOT DONE||TRANSUDATE|||TREATMENT|1966-12-28||1963-02-28|1964-12-03|1969-02-12
TRIAL STUDY 134XCP|PP|61A831EB-7AFF-47B7-A0D5-9727CC6EB9CD|48||ARAUCIFO|ACCUM RATIO AUC INFINITY OBS||||||||NOT DONE||LYMPH|||INDUCTION TREATMENT|1963-01-06||1970-02-14|1968-01-14|1967-03-06
TRIAL STUDY 134XCP|PP|74741526-F925-4AA5-9BE3-F3B3884BEE68|49||CONCD|CONC BY DOSE||||||||NOT DONE||CARDIAC MUSCLE TISSUE|||BLINDED TREATMENT|1968-11-08||1960-02-17|1970-10-06|1965-08-26
TRIAL STUDY 134XCP|PP|25088C28-0FA3-4005-90C3-CCF9C6FF5851|50||AURCIFP|AURC INFINITY PRED||||||||NOT DONE||GASTRIC CONTENTS|||LONG-TERM FOLLOW-UP|1963-01-25||1967-10-08|1972-10-01|1973-03-05
TRIAL STUDY 134XCP|PP|9BF13738-0A50-46E6-A3DA-AC956A361B97|51||RCPCIFPS|PCT REC INFINITY PRED NORM BY SA||||||||NOT DONE||DIALYSIS FLUID|||CONTINUATION TREATMENT|1966-05-20||1962-04-24|1964-04-08|1972-03-10
TRIAL STUDY 134XCP|PP|C7432A9E-BB47-46D1-92F6-FED7FBC627A0|52||CLFTAU|TOTAL CL BY F FOR DOSE INT||||||||NOT DONE||PERIPHERAL BLOOD MONONUCLEAR CELL|||CONTINUATION TREATMENT|1966-07-03||1967-03-18|1968-10-05|1973-03-29
TRIAL STUDY 134XCP|PP|F6EBFB06-3EEF-4621-BDA3-36FD6D4799BF|53||ERMAX|MAX EXCRETION RATE||||||||NOT DONE||DISCHARGE|||BLINDED TREATMENT|1963-06-07||1960-03-09|1965-04-28|1964-11-19
TRIAL STUDY 134XCP|PP|5AEA7EE9-1095-4967-B833-7665B6A71B31|54||KDIST|K SLOPE OF DISTRIBUTION||||||||NOT DONE||CORD BLOOD|||TREATMENT|1973-05-26||1971-05-08|1971-02-21|1966-06-28
TRIAL STUDY 134XCP|PP|241CD521-D0BD-40BB-ABA2-B8C8E500B491|55||SRAUC|STATIONARITY RATIO AUC||||||||NOT DONE||CORD SERUM|||FOLLOW-UP|1971-07-09||1961-01-31|1968-09-01|1964-01-29
TRIAL STUDY 134XCP|PP|D37D2206-A2C1-4AC2-93B2-EDB213AF852F|56||MRTIVIFO|MRT INTRAVASC INFINITY OBS||||||||NOT DONE||TISSUE|||OPEN LABEL TREATMENT|1960-06-25||1964-03-29|1967-03-18|1967-03-22
TRIAL STUDY 134XCP|PP|FAC78D40-3CBA-4D35-8911-64C0D25C3AE8|57||RNCLTAUD|RENAL CL FOR DOSE INT NORM BY DOSE||||||||NOT DONE||BREAST MILK|||CONTINUATION TREATMENT|1971-02-24||1970-01-24|1967-01-03|1963-07-09
TRIAL STUDY 134XCP|PP|FD609B1C-D1E7-4349-B036-DF0126D96A52|58||ARCMAX|ACCUMULATION RATIO CMAX||||||||NOT DONE||PERSPIRATION|||BLINDED TREATMENT|1967-08-04||1967-09-12|1973-04-25|1965-12-24
TRIAL STUDY 134XCP|PP|DEB0593B-E3FD-471C-A800-43058AC5FD86|59||SRAUC|STATIONARITY RATIO AUC||||||||NOT DONE||VITREOUS HUMOR|||WASHOUT|1969-12-27||1970-12-20|1968-07-24|1964-03-13
TRIAL STUDY 134XCP|PP|596BD728-2487-44E4-AFB1-8A4331EEDDF6|60||TMIN|TIME OF CMIN OBSERVATION||||||||NOT DONE||EXHALED BREATH CONDENSATE|||TREATMENT|1969-08-18||1961-07-03|1961-11-25|1971-10-24
TRIAL STUDY 134XCP|PP|CAF30D22-3C56-48D4-AB55-46C09A21FDBF|61||CLFP|TOTAL CL PRED BY F||||||||NOT DONE||CIRCULATING TUMOR CELL|||SCREENING|1971-08-19||1962-10-26|1961-02-10|1973-06-10
TRIAL STUDY 134XCP|PP|0365EB5F-7364-4B1F-8919-543D8D21B045|62||CLTAUS|TOTAL CL FOR DOSE INT NORM BY SA||||||||NOT DONE||BONE|||BLINDED TREATMENT|1962-01-28||1960-03-08|1960-05-29|1960-09-09
TRIAL STUDY 134XCP|PP|364277A8-875C-4A6F-93C3-C913BB3C97CA|63||VZFPB|VZ PRED BY F NORM BY BMI||||||||NOT DONE||VENOUS PLASMA|||BLINDED TREATMENT|1960-04-07||1962-07-23|1971-07-15|1962-04-15
TRIAL STUDY 134XCP|PP|B824951F-58EE-4003-A2AD-A91AADBBAC0D|64||AURCALLB|AURC ALL NORM BY BMI||||||||NOT DONE||INFRANATANT, SERUM|||WASHOUT|1970-01-11||1970-12-04|1971-06-09|1961-08-10
TRIAL STUDY 134XCP|PP|CEB92F29-B105-4F82-B0AC-CDDA2C7D3EE0|65||VZFTAUS|VZ FOR DOSE INT BY F NORM BY SA||||||||NOT DONE||PLATELET|||SCREENING|1966-02-03||1963-06-15|1963-06-15|1966-09-22
TRIAL STUDY 134XCP|PP|A108F408-906C-4320-965A-D5D295BC5C31|66||RCPCINTS|PCT REC FROM T1 TO T2 NORM BY SA||||||||NOT DONE||MIXED VENOUS BLOOD|||OPEN LABEL TREATMENT|1973-05-17||1969-11-14|1963-05-21|1971-04-25
TRIAL STUDY 134XCP|PP|8E627D27-4855-4E1B-B823-1E14368973AF|67||RENCLTAU|RENAL CL FOR DOSE INT||||||||NOT DONE||BONE|||WASHOUT|1970-02-18||1971-09-01|1963-02-24|1969-12-18
TRIAL STUDY 134XCP|PP|9D1D7F4D-D1F6-4EC8-A3FB-59BB1F596ED2|68||CLPB|TOTAL CL PRED NORM BY BMI||||||||NOT DONE||CIRCULATING TUMOR CELL|||LONG-TERM FOLLOW-UP|1962-07-17||1961-02-21|1968-11-24|1971-03-07
TRIAL STUDY 134XCP|PP|483D89E1-45FD-41D4-B9E0-22FFB41D323A|69||AURCALLD|AURC ALL NORM BY DOSE||||||||NOT DONE||PUS|||INDUCTION TREATMENT|1961-06-29||1969-03-10|1971-04-21|1972-03-07
TRIAL STUDY 134XCP|PP|2CCBED9D-5F24-4ED8-B575-8523C820A227|70||MRTEVLST|MRT EXTRAVASC TO LAST NONZERO CONC||||||||NOT DONE||KERATINOCYTE|||BASELINE|1973-06-05||1973-08-22|1960-11-01|1962-08-20
TRIAL STUDY 134XCP|PP|F4D6A28D-569F-4639-ACE2-10EB517128B2|71||RNCLUB|RENAL CL FOR UNBOUND DRUG||||||||NOT DONE||INFRANATANT, PLEURAL FLUID|||OPEN LABEL TREATMENT|1964-05-18||1964-10-07|1968-04-10|1967-09-14
TRIAL STUDY 134XCP|PP|7ABB925B-2CB5-498A-9E20-E1A2BE4E50DA|72||FU|FRACTION UNBOUND||||||||NOT DONE||CARDIAC MUSCLE TISSUE|||WASHOUT|1961-10-31||1968-04-08|1972-10-17|1967-10-07
TRIAL STUDY 134XCP|PP|415EF35E-6D99-48F8-80A1-89A4CDC621B8|73||AUCIFOLN|AUC INFINITY OBS LN TRANSFORMED||||||||NOT DONE||CORD BLOOD|||LONG-TERM FOLLOW-UP|1965-04-22||1967-02-26|1970-04-16|1968-05-30
TRIAL STUDY 134XCP|PP|AA0F6192-A377-43C6-8203-BDF7553AEA88|74||RCAMLST|AMT REC TO LAST NONZERO CONC||||||||NOT DONE||EXUDATE|||SCREENING|1966-03-31||1962-06-25|1971-07-22|1965-11-18
TRIAL STUDY 134XCP|PP|99DEAF5F-4F2A-4BFC-ABE7-E947C8FB8162|75||VZFPB|VZ PRED BY F NORM BY BMI||||||||NOT DONE||MENSTRUAL BLOOD|||CONTINUATION TREATMENT|1960-05-19||1966-03-12|1968-07-31|1965-07-13
TRIAL STUDY 134XCP|PP|A848B1B5-679F-4C45-AD73-6506604C835E|76||RAAUCTAU|RATIO AUC OVER DOSING INTERVAL||||||||NOT DONE||SERUM OR PLASMA OR BLOOD|||FOLLOW-UP|1961-04-01||1960-02-07|1972-01-25|1963-02-13
TRIAL STUDY 134XCP|PP|0C1AA66D-A2FC-4F68-B9B6-89F270FD4D47|77||CTROUGHW|CONC TROUGH BY WT||||||||NOT DONE||SUPERNATANT, SERUM|||OPEN LABEL TREATMENT|1965-11-11||1968-06-15|1964-04-28|1972-06-13
TRIAL STUDY 134XCP|PP|ABA9682E-D373-48DA-A7BD-68AB1563CFD6|78||RNCLINTW|RENAL CL FROM T1 TO T2 NORM BY WT||||||||NOT DONE||BLOOD|||INDUCTION TREATMENT|1963-06-30||1969-04-13|1966-08-29|1968-01-31
TRIAL STUDY 134XCP|PP|FC155F37-522F-4620-BBFF-4999D37C1379|79||RACONC|RATIO CONCENTRATION||||||||NOT DONE||ARTERIALIZED CAPILLARY BLOOD|||LONG-TERM FOLLOW-UP|1963-06-04||1967-09-01|1972-08-02|1965-02-17
TRIAL STUDY 134XCP|PP|20F817BC-4C89-4F6C-AA45-36CE786A73A8|80||ARCMIND|ACCUM RATIO CMIN NORM BY DOSE||||||||NOT DONE||LEUKOCYTE|||LONG-TERM FOLLOW-UP|1967-05-14||1970-01-09|1962-05-24|1968-10-03
TRIAL STUDY 134XCP|PP|99058E64-9873-4CD5-BB31-28C08758A1B5|81||ARCTROUD|ACCUM RATIO CTROUGH NORM BY DOSE||||||||NOT DONE||EPIDERMAL TISSUE|||BASELINE|1968-09-30||1961-03-08|1972-04-12|1962-07-30
TRIAL STUDY 134XCP|PP|656B6693-1C1C-433B-84E3-77E89F0B543E|82||CLFPD|TOTAL CL PRED BY F NORM BY DOSE||||||||NOT DONE||VENOUS PLASMA|||FOLLOW-UP|1968-11-18||1973-04-20|1966-09-01|1971-12-10
TRIAL STUDY 134XCP|PP|43C443F9-AB0F-44BE-B28B-63A60EE09205|83||CAVGD|AVERAGE CONC NORM BY DOSE||||||||NOT DONE||LUNG SURFACTANT|||LONG-TERM FOLLOW-UP|1964-02-14||1962-05-12|1965-11-15|1964-10-13
TRIAL STUDY 134XCP|PP|37FF91B1-CE3C-4587-85CE-F76B880D40E7|84||CLO|TOTAL CL OBS||||||||NOT DONE||ERYTHROCYTES|||BLINDED TREATMENT|1969-08-29||1963-06-08|1966-10-21|1969-01-20
TRIAL STUDY 134XCP|PP|9C25B17D-2E57-4EBD-93AF-F4439EB77B03|85||NRENALCL|NONRENAL CL||||||||NOT DONE||SPERMATOZOON|||OBSERVATION|1963-09-30||1963-02-05|1966-01-17|1965-02-27
TRIAL STUDY 134XCP|PP|49017491-2C28-4F86-BF72-CF83651052F6|86||CLFTAUD|TOTAL CL BY F FOR DOSE INT NORM BY DOSE||||||||NOT DONE||SERUM OR PLASMA OR BLOOD|||BLINDED TREATMENT|1961-12-24||1962-07-18|1962-05-19|1969-04-14
TRIAL STUDY 134XCP|PP|DAA65EE6-66ED-4354-935B-1347E1B572A5|87||VSSOB|VOL DIST STEADY STATE OBS NORM BY BMI||||||||NOT DONE||ARTERIALIZED CAPILLARY BLOOD|||TREATMENT|1961-02-28||1968-04-13|1961-07-15|1971-12-06
TRIAL STUDY 134XCP|PP|A440A3E5-F87D-4306-9195-3A842F0DDE33|88||AUCPEO|AUC %EXTRAPOLATION OBS||||||||NOT DONE||LYMPH|||RUN-IN|1960-08-28||1963-04-08|1971-05-08|1961-03-12
TRIAL STUDY 134XCP|PP|48BBE085-BD68-451A-9700-6A1AB18D84EE|89||VZOW|VZ OBS NORM BY WT||||||||NOT DONE||EPIDERMAL TISSUE|||FOLLOW-UP|1973-05-17||1960-06-25|1971-12-28|1962-12-10
TRIAL STUDY 134XCP|PP|F38055A2-11E2-437B-BD6A-662D81521F1D|90||VZFPD|VZ PRED BY F NORM BY DOSE||||||||NOT DONE||LOCHIA|||LONG-TERM FOLLOW-UP|1967-09-08||1971-10-10|1969-04-07|1960-06-15
TRIAL STUDY 134XCP|PP|96CB86AC-5041-4FA3-8CD2-6D390B3269DC|91||AUCALLD|AUC ALL NORM BY DOSE||||||||NOT DONE||SMEGMA|||OBSERVATION|1971-05-05||1969-10-24|1970-07-25|1965-03-31
TRIAL STUDY 134XCP|PP|22B0F097-D571-4E65-9B58-BEF2C3482F05|92||CTROUGHS|CONC TROUGH BY SA||||||||NOT DONE||SERUM|||TREATMENT|1962-08-12||1972-06-27|1960-08-03|1969-05-04
TRIAL STUDY 134XCP|PP|F56B6C70-0513-4032-A0BE-B961F6F2EF30|93||AURCPEP|AURC % EXTRAPOLATION PRED||||||||NOT DONE||SEBUM|||TREATMENT|1968-05-14||1961-05-08|1966-11-06|1969-07-07
TRIAL STUDY 134XCP|PP|8E385A66-25C9-417E-9298-FB87A73B661F|94||RARECINT|RATIO AMT REC FROM T1 TO T2||||||||NOT DONE||PLEURAL TISSUE|||TREATMENT|1964-11-02||1960-09-06|1969-02-28|1968-10-02
TRIAL STUDY 134XCP|PP|0471CF8F-4CA2-422C-94F5-7E8A4A5838F3|95||VZFPUB|VZ PRED BY F FOR UB||||||||NOT DONE||PLEURAL TISSUE|||WASHOUT|1964-06-14||1969-12-16|1962-11-01|1967-09-05
TRIAL STUDY 134XCP|PP|D0AE2069-B430-4771-9A8C-0F5442DFCECE|96||AUCIFPB|AUC INFINITY PRED NORM BY BMI||||||||NOT DONE||EPITHELIAL CELL|||CONTINUATION TREATMENT|1967-03-07||1960-05-25|1970-01-03|1968-04-21
TRIAL STUDY 134XCP|PP|CF214007-AC24-4760-AEDE-F78CDE3D9351|97||CAVGINTW|AVERAGE CONC FROM T1 TO T2 NORM BY WT||||||||NOT DONE||MECONIUM|||FOLLOW-UP|1961-07-03||1960-01-28|1969-10-26|1964-03-24
TRIAL STUDY 134XCP|PP|E996BE19-2824-49D3-944F-B777F3D8E746|98||MRAUCIFO|METABOLITE RATIO FOR AUC INFINITY OBS||||||||NOT DONE||VENOUS BLOOD|||WASHOUT|1963-09-02||1967-07-04|1972-07-26|1964-06-04
TRIAL STUDY 134XCP|PP|B2A31803-615A-4B78-9DFD-CD6EB8ABF5AC|99||CAVGINTB|AVERAGE CONC FROM T1 TO T2 NORM BY BMI||||||||NOT DONE||COLOSTRUM|||BLINDED TREATMENT|1964-07-09||1960-12-20|1966-11-26|1962-06-05
TRIAL STUDY 134XCP|PP|21BA7C51-E98D-4C0F-A437-8B4E05E6D6AE|100||CLOW|TOTAL CL OBS NORM BY WT||||||||NOT DONE||CERUMEN|||INDUCTION TREATMENT|1962-04-25||1973-01-18|1973-02-17|1964-05-17
TRIAL STUDY 134XCP|PP|3AD9D7F8-CD2F-4B45-AA83-20E7DBE60EA5|101||CMIN|MIN CONC||||||||NOT DONE||COLOSTRUM|||INDUCTION TREATMENT|1970-03-06||1963-07-07|1967-09-03|1968-06-02
TRIAL STUDY 134XCP|PP|1F75D53C-E8AA-45DA-8410-F00266080E80|102||LAMZHL|HALF-LIFE LAMBDA Z||||||||NOT DONE||ARTERIAL BLOOD|||WASHOUT|1964-08-05||1965-10-09|1963-07-26|1960-04-28
TRIAL STUDY 134XCP|PP|9CEC9DDD-6ECE-46CB-9C66-C42B46245666|103||V0B|VOL DIST INITIAL NORM BY BMI||||||||NOT DONE||VITREOUS HUMOR|||RUN-IN|1963-02-22||1961-06-26|1968-02-23|1964-07-06
TRIAL STUDY 134XCP|PP|EE14E53E-19A8-4441-BF82-31444CBC8B49|104||MRTIVIFP|MRT INTRAVASC INFINITY PRED||||||||NOT DONE||SUPERNATANT, SERUM|||OBSERVATION|1966-12-01||1970-05-04|1969-02-16|1960-07-28
TRIAL STUDY 134XCP|PP|DAF741EF-DCCF-4E18-844B-05640A94C181|105||ARAUCLST|ACCUM RATIO AUC TO LAST NONZERO CONC||||||||NOT DONE||HAIR|||RUN-IN|1966-01-14||1969-12-07|1970-02-19|1964-12-09
TRIAL STUDY 134XCP|PP|EBABAEE6-8EBE-4E92-9CBA-0AAE56BEAE54|106||AURCLSTW|AURC DOSING TO LAST CONC NORM BY WT||||||||NOT DONE||BREAST MILK|||OPEN LABEL TREATMENT|1967-05-21||1960-01-18|1973-02-25|1971-06-30
TRIAL STUDY 134XCP|PP|9B1490FA-9D19-4E9E-96D6-FA159E2D2B4D|107||ARAUCIND|ACCUM RATIO AUC T1 TO T2 NORM BY DOSE||||||||NOT DONE||ATHEROSCLEROTIC PLAQUE|||INDUCTION TREATMENT|1965-10-24||1966-10-19|1973-03-29|1961-02-15
TRIAL STUDY 134XCP|PP|CF3E1636-762F-4821-A44E-455F33F5E4CC|108||VZFPW|VZ PRED BY F NORM BY WT||||||||NOT DONE||SUPERNATANT, PLEURAL FLUID|||LONG-TERM FOLLOW-UP|1967-02-01||1965-02-15|1968-03-15|1968-12-07
TRIAL STUDY 134XCP|PP|3846A0A8-2D38-44C9-A579-84C66315C436|109||ERLSTW|LAST MEAS EXCRETION RATE NORM BY WT||||||||NOT DONE||BREAST MILK|||SCREENING|1971-08-12||1967-10-05|1968-09-26|1962-01-13
TRIAL STUDY 134XCP|PP|75B429C2-E173-4F72-8D4A-76F62C97F006|110||ARCMIND|ACCUM RATIO CMIN NORM BY DOSE||||||||NOT DONE||DERMAL TISSUE|||WASHOUT|1960-08-16||1965-05-29|1970-12-02|1967-04-28
TRIAL STUDY 134XCP|PP|D0196B36-EE56-4B5E-A60C-5C6E6EAFF381|111||CLPUB|TOTAL CL PRED FOR UNBOUND DRUG||||||||NOT DONE||HAIR FOLLICLE|||WASHOUT|1973-05-04||1962-08-02|1969-12-03|1970-04-18
TRIAL STUDY 134XCP|PP|8065F0B9-9183-43E4-998A-D2F096D87998|112||CLTAU|TOTAL CL FOR DOSE INT||||||||NOT DONE||VITREOUS HUMOR|||INDUCTION TREATMENT|1967-04-28||1964-12-01|1970-11-08|1964-07-29
TRIAL STUDY 134XCP|PP|697EB3B7-5AD1-4D1D-BB53-BB0556915957|113||RAAUCALL|RATIO AUC ALL||||||||NOT DONE||SERUM OR PLASMA OR BLOOD|||OPEN LABEL TREATMENT|1964-12-18||1963-03-21|1973-07-17|1966-02-13
TRIAL STUDY 134XCP|PP|3DC3F05B-BA68-42F0-BC91-003D9FB00A91|114||CLPB|TOTAL CL PRED NORM BY BMI||||||||NOT DONE||BASAL TEAR|||INDUCTION TREATMENT|1961-02-18||1962-11-15|1966-12-12|1960-10-18
TRIAL STUDY 134XCP|PP|469A321E-3F7B-4C3E-B5CE-A6A02B8D8A94|115||AURCLSTD|AURC DOSING TO LAST CONC NORM BY DOSE||||||||NOT DONE||SALIVA|||SCREENING|1971-06-02||1970-05-11|1968-11-15|1970-07-06
TRIAL STUDY 134XCP|PP|52EC57AA-56E4-47A8-AADA-36F62653B423|116||AUMCIFPB|AUMC INFINITY PRED NORM BY BMI||||||||NOT DONE||SWABBED MATERIAL|||TREATMENT|1972-02-27||1968-02-26|1962-01-17|1966-03-17
TRIAL STUDY 134XCP|PP|F09C04A4-4F9E-4033-9115-81C6007DE8B4|117||AUCLST|AUC TO LAST NONZERO CONC||||||||NOT DONE||ALVEOLAR AIR|||OPEN LABEL TREATMENT|1963-03-15||1971-01-30|1961-04-02|1972-05-23
TRIAL STUDY 134XCP|PP|B224E72B-65ED-48A0-AB8E-A6BF0B25D8C3|118||CLOUB|TOTAL CL OBS FOR UNBOUND DRUG||||||||NOT DONE||PLATELET RICH PLASMA|||RUN-IN|1963-03-13||1965-11-24|1972-02-25|1973-06-29
TRIAL STUDY 134XCP|PP|4779A01C-1219-46AC-B0F7-71C9717A2B45|119||CMINB|MIN CONC NORM BY BMI||||||||NOT DONE||TUMOR TISSUE|||FOLLOW-UP|1969-11-12||1971-08-15|1970-04-24|1965-01-04
TRIAL STUDY 134XCP|PP|5F5C5DED-7547-40D2-9B34-77B37CCD7732|120||VZFOD|VZ OBS BY F NORM BY DOSE||||||||NOT DONE||MIXED VENOUS BLOOD|||OBSERVATION|1972-09-08||1971-01-28|1960-07-11|1967-09-28
TRIAL STUDY 134XCP|PP|9EE4A7A5-2E5A-4BB0-BC6D-87D65BC76857|121||CLP|TOTAL CL PRED||||||||NOT DONE||GASTRIC FLUID|||OBSERVATION|1973-01-30||1967-05-14|1969-09-08|1970-12-27
TRIAL STUDY 134XCP|PP|48348DF0-33DA-457F-86C6-797FF7B32857|122||RCAMINTS|AMT REC FROM T1 TO T2 NORM BY SA||||||||NOT DONE||PROSTATIC FLUID|||TREATMENT|1967-04-09||1960-09-05|1968-03-02|1962-06-25
TRIAL STUDY 134XCP|PP|B2D1E5B2-17A6-4677-999E-A3F3B24FBBB4|123||VZFOS|VZ OBS BY F NORM BY SA||||||||NOT DONE||PERIPHERAL BLOOD MONONUCLEAR CELL|||TREATMENT|1966-11-29||1967-05-15|1966-10-29|1970-03-05
TRIAL STUDY 134XCP|PP|396CC122-5F23-418D-A75E-572ADF4FD6C1|124||CLFTAUB|TOTAL CL BY F FOR DOSE INT NORM BY BMI||||||||NOT DONE||CAPILLARY BLOOD|||BASELINE|1968-07-24||1972-10-03|1970-11-19|1970-03-29
TRIAL STUDY 134XCP|PP|9CF3CD51-5D5B-40E6-8F13-B314911BE461|125||RNCLTAUW|RENAL CL FOR DOSE INT NORM BY WT||||||||NOT DONE||EPITHELIAL CELL|||INDUCTION TREATMENT|1962-05-30||1972-05-15|1968-11-15|1968-07-20
TRIAL STUDY 134XCP|PP|CB3B9054-5CDC-418D-8071-7429B1702587|126||SRAUC|STATIONARITY RATIO AUC||||||||NOT DONE||PLASMA|||BLINDED TREATMENT|1962-02-09||1969-10-05|1965-07-05|1963-04-12
TRIAL STUDY 134XCP|PP|1AC4DE34-3486-41FB-A979-8B368912F75A|127||AURCALLS|AURC ALL NORM BY SA||||||||NOT DONE||INFRANATANT, PLASMA|||RUN-IN|1970-04-13||1961-12-22|1967-06-29|1972-07-06
TRIAL STUDY 134XCP|PP|FF8E387C-7596-4408-9B7F-5DF85EC62F2E|128||RENALCLW|RENAL CL NORM BY WT||||||||NOT DONE||LUNG SURFACTANT|||CONTINUATION TREATMENT|1964-09-02||1968-04-06|1973-08-30|1961-04-06
TRIAL STUDY 134XCP|PP|2276DCED-0CA7-4F0B-8FBF-5B6D50DE9585|129||VZTAUS|VZ FOR DOSE INT NORM BY SA||||||||NOT DONE||CAPILLARY PLASMA|||INDUCTION TREATMENT|1966-09-03||1971-03-16|1968-04-29|1966-08-22
TRIAL STUDY 134XCP|PP|14CEF8E1-9A4F-4AC4-B452-410E24BC79EF|130||CLFP|TOTAL CL PRED BY F||||||||NOT DONE||LEUKOCYTE|||WASHOUT|1965-08-30||1961-01-09|1972-09-23|1965-04-05
TRIAL STUDY 134XCP|PP|0194CD2F-7ABE-4BEE-A6FC-61298880173D|131||AUMCLSTD|AUMC TO LAST NONZERO CONC NORM BY DOSE||||||||NOT DONE||DIALYSIS FLUID|||LONG-TERM FOLLOW-UP|1962-06-20||1967-03-11|1961-03-04|1960-01-20
TRIAL STUDY 134XCP|PP|A6E531C7-1BC1-402E-9B2E-03B44313487B|132||CLFUB|APPARENT CL FOR UNBOUND DRUG||||||||NOT DONE||KERATINOCYTE|||INDUCTION TREATMENT|1969-02-24||1970-06-18|1968-06-30|1970-04-03
TRIAL STUDY 134XCP|PP|47C0D833-BEAB-4BF2-B028-891808E729F1|133||AUCPBEO|AUC %BACK EXTRAPOLATION OBS||||||||NOT DONE||ARTERIAL BLOOD|||SCREENING|1961-04-05||1968-06-23|1961-07-27|1972-05-17
TRIAL STUDY 134XCP|PP|BA1773BD-AA89-45FC-B7C6-C5267770B197|134||NRENLCLB|NONRENAL CL NORM BY BMI||||||||NOT DONE||PLEURAL TISSUE|||FOLLOW-UP|1960-09-19||1961-01-17|1971-08-14|1961-03-22
TRIAL STUDY 134XCP|PP|03D3DDC6-03FA-469A-B8A4-D504919B68F1|135||CONCS|CONC BY SA||||||||NOT DONE||SEMEN|||RUN-IN|1968-12-21||1962-05-27|1964-04-09|1963-02-12
TRIAL STUDY 134XCP|PP|6AE1E2D2-C023-42DB-A906-39440CB6AAA8|136||FU|FRACTION UNBOUND||||||||NOT DONE||SUPERNATANT, SERUM OR PLASMA|||TREATMENT|1964-09-18||1967-11-23|1962-04-05|1961-02-19
TRIAL STUDY 134XCP|PP|1873D4CC-40B7-4303-9F07-8FE0E4595361|137||MRCMAX|METABOLITE RATIO FOR MAX CONC||||||||NOT DONE||EXHALED BREATH CONDENSATE|||CONTINUATION TREATMENT|1965-07-12||1962-02-05|1965-10-09|1967-01-26
TRIAL STUDY 134XCP|PP|23E5569E-B324-4399-AC8A-5EC7C343C1D3|138||VZFTAUB|VZ FOR DOSE INT BY F NORM BY BMI||||||||NOT DONE||SERUM OR PLASMA OR BLOOD|||WASHOUT|1968-11-12||1967-01-31|1965-04-17|1970-04-20
TRIAL STUDY 134XCP|PP|B349DD89-C41F-470E-8B54-B3589F0982FE|139||AUCINTDW|AUCINT NORM BY DOSE/WT||||||||NOT DONE||VENOUS BLOOD|||TREATMENT|1970-03-02||1966-04-10|1965-01-11|1973-03-27
TRIAL STUDY 134XCP|PP|415D178A-275A-440C-8617-154441A48F8D|140||VZOD|VZ OBS NORM BY DOSE||||||||NOT DONE||LAVAGE FLUID|||RUN-IN|1964-05-15||1967-07-11|1973-03-12|1971-04-19
TRIAL STUDY 134XCP|PP|C23917E6-6CA5-4314-A59D-A0298483BF53|141||VZFOS|VZ OBS BY F NORM BY SA||||||||NOT DONE||LEUKOCYTE|||RUN-IN|1969-04-21||1968-11-05|1963-11-22|1972-07-09
TRIAL STUDY 134XCP|PP|4F449A9E-D7BA-47D4-A4D8-5A39E698F51E|142||RENALCLS|RENAL CL NORM BY SA||||||||NOT DONE||EMOTIONAL TEAR|||OBSERVATION|1967-10-04||1971-06-17|1972-10-29|1973-05-07
TRIAL STUDY 134XCP|PP|4AB3006A-5B82-4841-800F-D2D6DFCA0DD2|143||MRTIVLST|MRT INTRAVASC TO LAST NONZERO CONC||||||||NOT DONE||VITREOUS HUMOR|||BASELINE|1973-07-18||1962-02-17|1968-05-22|1970-05-27
TRIAL STUDY 134XCP|PP|95EFAA78-A1BB-40D0-8A6D-B0EF20332820|144||VZPW|VZ PRED NORM BY WT||||||||NOT DONE||ADIPOSE TISSUE|||TREATMENT|1962-06-12||1971-08-09|1971-07-13|1973-09-06
TRIAL STUDY 134XCP|PP|9E60B53A-37D9-45AE-AC8B-F3B049617CDF|145||ERMAXW|MAX EXCRETION RATE NORM BY WT||||||||NOT DONE||DERMAL TISSUE|||INDUCTION TREATMENT|1968-04-09||1971-03-31|1961-02-02|1963-07-28
TRIAL STUDY 134XCP|PP|94DD5640-E6E6-47FA-A91B-D84E330EDCC6|146||RCAMIFPW|AMT REC INFINITY PRED NORM BY WT||||||||NOT DONE||HAIR|||INDUCTION TREATMENT|1970-08-19||1961-09-26|1964-04-15|1971-07-29
TRIAL STUDY 134XCP|PP|5F1262FB-AAA2-4F2F-BF2B-F72527AFA115|147||FB|FRACTION BOUND||||||||NOT DONE||MECONIUM|||INDUCTION TREATMENT|1968-11-23||1966-01-28|1962-05-17|1968-04-30
TRIAL STUDY 134XCP|PP|EDB6B55B-7903-4F89-805C-32F067C2A230|148||RCPCLST|PCT REC TO LAST NONZERO CONC||||||||NOT DONE||FLUID|||TREATMENT|1971-12-07||1969-11-01|1962-07-13|1963-07-30
TRIAL STUDY 134XCP|PP|8F6772DE-E4CA-4706-8754-740D3859ABDF|149||AILAMZ|ACCUMULATION INDEX USING LAMBDA Z||||||||NOT DONE||SMEGMA|||BASELINE|1973-08-24||1969-07-25|1966-09-25|1965-11-19
TRIAL STUDY 134XCP|PP|FE7829C8-7961-4169-B5DD-9DD94B8EF0CD|150||AUMCLSTD|AUMC TO LAST NONZERO CONC NORM BY DOSE||||||||NOT DONE||ADIPOSE TISSUE|||LONG-TERM FOLLOW-UP|1964-01-26||1961-09-19|1967-06-13|1961-06-14
TRIAL STUDY 134XCP|PP|D1DEBD72-05CA-4F47-8727-73C44D6A3EFB|151||ERLSTW|LAST MEAS EXCRETION RATE NORM BY WT||||||||NOT DONE||GASTRIC CONTENTS|||OBSERVATION|1964-02-08||1961-11-30|1968-08-23|1962-08-12
TRIAL STUDY 134XCP|PP|0FF48C06-03EA-47DA-84D1-3FA28D5D39D7|152||CLO|TOTAL CL OBS||||||||NOT DONE||LYSATE|||FOLLOW-UP|1970-09-07||1965-12-08|1965-09-03|1961-07-01
TRIAL STUDY 134XCP|PP|B3987A78-0D92-419D-A289-039C87C6C202|153||AUMCIFO|AUMC INFINITY OBS||||||||NOT DONE||CELL PELLET|||LONG-TERM FOLLOW-UP|1965-01-12||1972-02-18|1970-03-25|1969-05-18
TRIAL STUDY 134XCP|PP|2A0D27D8-EC46-4B40-B1BB-078268E03355|154||CTROUGHD|CONC TROUGH BY DOSE||||||||NOT DONE||MENSTRUAL BLOOD|||WASHOUT|1965-12-19||1961-03-10|1973-07-15|1969-02-01
TRIAL STUDY 134XCP|PP|65EBB2AF-B97A-403A-9FB5-31C1559074C4|155||VSSPBD|VOL DIST STEADY STATE PRED BY B||||||||NOT DONE||BASAL TEAR|||INDUCTION TREATMENT|1969-09-19||1966-03-24|1970-11-07|1969-08-05
TRIAL STUDY 134XCP|PP|90892428-99C3-4E7D-B3A8-3C526812EDD2|156||AUMCIFPW|AUMC INFINITY PRED NORM BY WT||||||||NOT DONE||INTERSTITIAL FLUID|||INDUCTION TREATMENT|1964-02-07||1964-06-20|1966-05-28|1969-02-28
TRIAL STUDY 134XCP|PP|4B99A0CB-4DEA-4C46-8B01-FCC0BED015FF|157||RNCLINTB|RENAL CL FROM T1 TO T2 NORM BY BMI||||||||NOT DONE||DISCHARGE|||FOLLOW-UP|1972-04-29||1968-12-23|1972-08-07|1970-08-29
TRIAL STUDY 134XCP|PP|2B443EEA-B98B-47D9-8D27-801582804AB5|158||V0B|VOL DIST INITIAL NORM BY BMI||||||||NOT DONE||MUSCLE TISSUE|||WASHOUT|1966-07-18||1962-12-26|1969-07-15|1961-04-07
TRIAL STUDY 134XCP|PP|0278D57A-30D6-4B7A-A45C-EB973F6686C6|159||CLPD|TOTAL CL PRED NORM BY DOSE||||||||NOT DONE||CARDIAC MUSCLE TISSUE|||INDUCTION TREATMENT|1971-10-12||1966-05-14|1970-08-18|1961-11-09
TRIAL STUDY 134XCP|PP|2FE6BF52-4EA8-4AAE-865C-22BA7CD26BF6|160||AUCIFOW|AUC INFINITY OBS NORM BY WT||||||||NOT DONE||SWABBED MATERIAL|||OPEN LABEL TREATMENT|1972-09-21||1960-01-14|1970-02-15|1964-04-24
TRIAL STUDY 134XCP|PP|67D6A191-10C7-4414-BA63-DB7701998DF0|161||C0|INITIAL CONC||||||||NOT DONE||SUPERNATANT, SERUM|||FOLLOW-UP|1969-02-03||1961-04-26|1971-02-26|1964-05-02
TRIAL STUDY 134XCP|PP|499B5A47-893A-40DE-9B64-60967378C81A|162||CAVGDW|AVERAGE CONCENTRATION NORM BY DOSE/WT||||||||NOT DONE||VENOUS BLOOD|||CONTINUATION TREATMENT|1973-08-05||1971-09-06|1960-12-15|1963-05-30
TRIAL STUDY 134XCP|PP|984103CA-F301-4510-A9DD-4916FA858EA2|163||FREL|RELATIVE BIOAVAILABILITY||||||||NOT DONE||VITREOUS HUMOR|||BLINDED TREATMENT|1966-01-29||1961-12-09|1971-08-17|1961-08-10
TRIAL STUDY 134XCP|PP|50E626B3-9133-4A50-8907-2388DAC22AD1|164||VSSP|VOL DIST STEADY STATE PRED||||||||NOT DONE||PERSPIRATION|||BASELINE|1969-02-10||1965-08-08|1961-05-31|1972-10-14
TRIAL STUDY 134XCP|PP|C20A4F0A-7E0A-4A53-A47D-ECFB5062FB21|165||RCPCTAUW|PCT REC OVER DOSING INTERVAL NORM BY WT||||||||NOT DONE||MENSTRUAL BLOOD|||FOLLOW-UP|1972-07-10||1961-11-16|1962-04-23|1970-07-26
TRIAL STUDY 134XCP|PP|4D0E7297-DA42-4819-8D28-979D3D3BE1A0|166||AUMCIFOD|AUMC INFINITY OBS NORM BY DOSE||||||||NOT DONE||LYSATE|||SCREENING|1962-02-02||1968-03-25|1962-08-30|1968-10-06
TRIAL STUDY 134XCP|PP|F8F17A43-A74B-4570-8A06-D7657A4636B4|167||AUCALLS|AUC ALL NORM BY SA||||||||NOT DONE||LAVAGE FLUID|||OPEN LABEL TREATMENT|1964-06-21||1962-07-07|1967-02-13|1969-07-29
TRIAL STUDY 134XCP|PP|37EDE304-7A3A-4CC4-BD04-FD36EA27BF74|168||RACMAXD|RATIO MAX CONC NORM BY DOSE||||||||NOT DONE||BONE|||WASHOUT|1960-09-29||1972-01-14|1972-11-22|1966-06-03
TRIAL STUDY 134XCP|PP|1177FD36-AAE8-4139-991A-A8C98B607565|169||VZFO|VZ OBS BY F||||||||NOT DONE||BUFFY COAT|||LONG-TERM FOLLOW-UP|1971-07-13||1967-04-09|1960-11-04|1966-01-03
TRIAL STUDY 134XCP|PP|8C57F469-7CDF-493A-9839-C179D912A8A5|170||EFFHL|EFFECTIVE HALF-LIFE||||||||NOT DONE||BONE|||OBSERVATION|1965-07-05||1966-02-04|1969-01-28|1963-12-29
TRIAL STUDY 134XCP|PP|8F3EA8B7-0A0B-45DE-AF82-4DD335C40FE0|171||RCAMINT|AMT REC FROM T1 TO T2||||||||NOT DONE||CERUMEN|||BASELINE|1966-01-05||1965-02-13|1967-09-26|1967-10-31
TRIAL STUDY 134XCP|PP|CAFEA1D3-8DB8-4CDE-89BF-FA604EE2AF9A|172||RCPCINTB|PCT REC FROM T1 TO T2 NORM BY BMI||||||||NOT DONE||INFRANATANT, PLEURAL FLUID|||WASHOUT|1970-01-25||1963-04-19|1963-01-08|1969-08-11
TRIAL STUDY 134XCP|PP|0AE36450-F37E-4F97-A250-79166011FCD7|173||VZPB|VZ PRED NORM BY BMI||||||||NOT DONE||SERUM OR PLASMA|||WASHOUT|1969-08-21||1971-08-21|1967-12-24|1965-06-25
TRIAL STUDY 134XCP|PP|8D5230FF-DE90-48E7-8CE2-F9B0ED562098|174||CLST|LAST NONZERO CONC||||||||NOT DONE||TUMOR TISSUE|||SCREENING|1960-10-17||1962-09-04|1972-04-10|1968-06-18
TRIAL STUDY 134XCP|PP|707FC46F-B8B1-456B-9E09-CABC86EA61D5|175||AUCIFP|AUC INFINITY PRED||||||||NOT DONE||MUSCLE TISSUE|||BLINDED TREATMENT|1964-04-16||1962-09-01|1967-06-18|1973-05-14
TRIAL STUDY 134XCP|PP|E9745E48-1B55-49C6-9AB6-5EF7CC950C9F|176||CLFOS|TOTAL CL OBS BY F NORM BY SA||||||||NOT DONE||ARTERIALIZED CAPILLARY BLOOD|||INDUCTION TREATMENT|1967-02-27||1968-01-09|1960-11-16|1963-06-15
TRIAL STUDY 134XCP|PP|70196099-5D40-4048-AABF-EB40CE345328|177||AURCIFPS|AURC INFINITY PRED NORM BY SA||||||||NOT DONE||ISOLATE|||SCREENING|1966-04-04||1968-11-20|1966-09-14|1969-12-24
TRIAL STUDY 134XCP|PP|F9D4C544-F217-4676-AC40-F71CC48045AF|178||TLAG|TIME UNTIL FIRST NONZERO CONC||||||||NOT DONE||PERITONEAL FLUID|||INDUCTION TREATMENT|1964-07-11||1965-04-22|1968-10-25|1960-02-02
TRIAL STUDY 134XCP|PP|E6A42133-B082-4BD7-B840-A60E49E0562B|179||AUCIFO|AUC INFINITY OBS||||||||NOT DONE||ISOLATE|||BASELINE|1968-04-16||1971-12-22|1968-02-25|1968-02-06
TRIAL STUDY 134XCP|PP|72C9FDBC-AA86-4001-9820-90AAF5422074|180||VZFO|VZ OBS BY F||||||||NOT DONE||EXUDATE|||INDUCTION TREATMENT|1970-03-14||1963-02-27|1971-12-17|1962-12-01
TRIAL STUDY 134XCP|PP|186520B9-8AAD-4063-B48F-16040EF49944|181||CMAXS|MAX CONC NORM BY SA||||||||NOT DONE||MONOCYTE|||BASELINE|1965-11-08||1967-09-02|1963-01-28|1972-01-31
TRIAL STUDY 134XCP|PP|31DD3952-685F-4941-A68A-2D0C6FB5ECEF|182||RNCLINTW|RENAL CL FROM T1 TO T2 NORM BY WT||||||||NOT DONE||RETICULOCYTES|||FOLLOW-UP|1961-07-23||1962-03-13|1964-01-04|1965-08-27
TRIAL STUDY 134XCP|PP|5292AC86-EB26-4CA7-8DD0-F353948FD4B1|183||CMAXDW|MAX CONC NORM BY DOSE/WT||||||||NOT DONE||PLEURAL TISSUE|||INDUCTION TREATMENT|1965-01-06||1969-12-02|1967-01-19|1969-07-02
TRIAL STUDY 134XCP|PP|9BC8E789-B7D5-40A9-A4EE-9E88234992CB|184||AILAMZ|ACCUMULATION INDEX USING LAMBDA Z||||||||NOT DONE||PROSTATIC FLUID|||SCREENING|1971-12-22||1968-03-10|1973-01-20|1961-01-07
TRIAL STUDY 134XCP|PP|90176B5E-72C3-4FAB-AEF3-E75B9BCFE3CE|185||RENALCLW|RENAL CL NORM BY WT||||||||NOT DONE||MENSTRUAL BLOOD|||OPEN LABEL TREATMENT|1971-02-12||1971-07-14|1963-03-21|1969-12-17
TRIAL STUDY 134XCP|PP|20B6D4E0-EE72-467E-9A1D-DFAC0137A3BA|186||AURCINTS|AURC FROM T1 TO T2 NORM BY SA||||||||NOT DONE||PERITONEAL FLUID|||FOLLOW-UP|1970-10-28||1965-12-09|1961-08-18|1962-03-03
TRIAL STUDY 134XCP|PP|460486B3-B7C8-4B54-848B-21BA899EAAD6|187||SRAUC|STATIONARITY RATIO AUC||||||||NOT DONE||TRANSUDATE|||LONG-TERM FOLLOW-UP|1973-06-04||1963-11-13|1969-05-19|1966-07-08
TRIAL STUDY 134XCP|PP|A068436F-E26E-44C5-8959-0BCBA28832D1|188||HDER|HEMODIALYSIS EXTRACTION RATIO||||||||NOT DONE||BONE MARROW MONONUCLEAR CELL|||RUN-IN|1967-08-18||1970-12-31|1972-04-19|1963-02-21
TRIAL STUDY 134XCP|PP|00B423B2-C33A-4EA2-A5C8-78D3C6531DD5|189||AUCINTB|AUC FROM T1 TO T2 NORM BY BMI||||||||NOT DONE||BUFFY COAT|||BASELINE|1972-09-24||1966-10-23|1968-12-21|1971-08-20
TRIAL STUDY 134XCP|PP|E065D436-92D2-453F-86A7-27F70FE1FD03|190||CLFUB|APPARENT CL FOR UNBOUND DRUG||||||||NOT DONE||PLEURAL TISSUE|||SCREENING|1971-01-03||1969-08-30|1962-10-06|1964-11-18
TRIAL STUDY 134XCP|PP|E7F5795C-FF55-4DFF-B461-AE4F04BD52F7|191||AURCIFO|AURC INFINITY OBS||||||||NOT DONE||GASTRIC FLUID|||OPEN LABEL TREATMENT|1966-10-01||1966-04-03|1965-07-23|1963-06-28
TRIAL STUDY 134XCP|PP|CF5D1305-9DB3-4AA9-A3E1-DFB0BB70E77D|192||VSSPW|VOL DIST STEADY STATE PRED NORM BY WT||||||||NOT DONE||WHITE MATTER TISSUE|||FOLLOW-UP|1961-01-23||1962-12-07|1960-06-27|1969-11-19
TRIAL STUDY 134XCP|PP|D108D040-7177-4A14-8CA7-748D59DC5F8B|193||AUCTAUW|AUC OVER DOSING INTERVAL NORM BY WT||||||||NOT DONE||HAIR|||FOLLOW-UP|1971-09-09||1970-12-31|1969-12-25|1968-04-15
TRIAL STUDY 134XCP|PP|6AACC77F-96D3-472F-BDB6-90CC0AF4CAB8|194||AURCLSTD|AURC DOSING TO LAST CONC NORM BY DOSE||||||||NOT DONE||RETICULOCYTES|||BLINDED TREATMENT|1967-02-19||1964-04-10|1972-05-10|1968-01-04
TRIAL STUDY 134XCP|PP|F7738305-F17D-4E83-BCD7-5ACAFE10DFD1|195||AURCIFO|AURC INFINITY OBS||||||||NOT DONE||DIALYSIS FLUID, PERITONEAL|||TREATMENT|1971-05-17||1965-04-03|1972-05-22|1960-09-15
TRIAL STUDY 134XCP|PP|580CCA66-3D51-4A5C-80E1-361A90369055|196||CMAXW|MAX CONC NORM BY WT||||||||NOT DONE||FLUID|||BASELINE|1963-11-09||1965-05-23|1965-03-11|1960-05-01
TRIAL STUDY 134XCP|PP|DAB276EB-3581-4C20-88AC-5A3D267E54D8|197||RACMAXD|RATIO MAX CONC NORM BY DOSE||||||||NOT DONE||LUNG SURFACTANT|||LONG-TERM FOLLOW-UP|1970-01-23||1968-03-16|1965-08-11|1971-01-19
TRIAL STUDY 134XCP|PP|D251DB10-ACF2-46DD-AC91-43D06F2C1E02|198||AUCIFPUB|AUC INFINITY PRED, UNBOUND DRUG||||||||NOT DONE||GASTRIC CONTENTS|||INDUCTION TREATMENT|1963-10-03||1967-03-03|1970-11-27|1966-02-08
TRIAL STUDY 134XCP|PP|5B703A43-A280-4D6A-AC40-FF5187521DB2|199||VZFPD|VZ PRED BY F NORM BY DOSE||||||||NOT DONE||LOCHIA|||CONTINUATION TREATMENT|1971-08-06||1970-10-21|1964-10-09|1961-03-16
TRIAL STUDY 134XCP|PP|91862A60-6EB7-40AC-9B43-CCD6E75E86A4|200||CMAXLN|MAX CONC LN TRANSFORMED||||||||NOT DONE||SUPERNATANT, PLASMA|||INDUCTION TREATMENT|1967-10-18||1971-10-01|1961-04-07|1962-06-16
TRIAL STUDY 134XCP|PP|7C09FD7B-2BC4-4C9F-852B-234A769F73F6|201||AUCTAUB|AUC OVER DOSING INTERVAL NORM BY BMI||||||||NOT DONE||ALVEOLAR AIR|||LONG-TERM FOLLOW-UP|1969-03-13||1968-02-08|1961-01-04|1960-07-27
TRIAL STUDY 134XCP|PP|51F3D3C1-3361-499F-B037-CCE8AB989989|202||C0W|INITIAL CONC NORM BY WT||||||||NOT DONE||SEBUM|||RUN-IN|1960-10-24||1965-01-24|1969-10-09|1969-03-06
TRIAL STUDY 134XCP|PP|231D401F-CA93-49E0-AC5C-C7F636343D2F|203||AUCTAUS|AUC OVER DOSING INTERVAL NORM BY SA||||||||NOT DONE||SUPERNATANT, SERUM|||SCREENING|1964-09-23||1964-11-10|1970-08-13|1964-02-21
TRIAL STUDY 134XCP|PP|2704A3C0-3345-48E5-AC9B-C00EA51AB085|204||AURCALLD|AURC ALL NORM BY DOSE||||||||NOT DONE||CAPILLARY BLOOD|||LONG-TERM FOLLOW-UP|1970-12-06||1966-11-18|1967-04-11|1965-06-16
TRIAL STUDY 134XCP|PP|2F636370-94FE-4BC0-9E16-DDD42D19A985|205||SRAUC|STATIONARITY RATIO AUC||||||||NOT DONE||SKIN TISSUE|||OBSERVATION|1965-03-25||1964-11-23|1966-04-11|1972-03-07
TRIAL STUDY 134XCP|PP|39445F0B-0D22-4B4F-B4AE-C5A90F28F735|206||AURCALLB|AURC ALL NORM BY BMI||||||||NOT DONE||SEMINAL FLUID|||WASHOUT|1960-07-05||1967-09-09|1965-02-27|1968-06-08
TRIAL STUDY 134XCP|PP|BB7AC683-29D3-4EF7-BA05-A03DE1FB8966|207||RENALCLB|RENAL CL NORM BY BMI||||||||NOT DONE||MONOCYTE|||TREATMENT|1972-10-08||1966-09-16|1967-09-10|1965-04-12
TRIAL STUDY 134XCP|PP|4BB1CEB1-6D60-48D8-BED0-EFA03F873B50|208||V0W|VOL DIST INITIAL NORM BY WT||||||||NOT DONE||EMESIS|||CONTINUATION TREATMENT|1963-03-23||1970-04-09|1972-02-06|1972-10-02
TRIAL STUDY 134XCP|PP|A1FAB383-1757-4832-B888-90C133842EF8|209||AUCIFOB|AUC INFINITY OBS NORM BY BMI||||||||NOT DONE||NAIL|||SCREENING|1971-07-28||1968-10-12|1966-09-25|1969-12-11
TRIAL STUDY 134XCP|PP|72AA1945-E676-4485-BD7F-6B969E314D83|210||VSSO|VOL DIST STEADY STATE OBS||||||||NOT DONE||PLEURAL FLUID|||SCREENING|1972-02-28||1960-05-23|1962-11-13|1965-10-09
TRIAL STUDY 134XCP|PP|B297C689-0D99-4E36-9F27-F93D4F43E2DD|211||NRENLCLB|NONRENAL CL NORM BY BMI||||||||NOT DONE||BUFFY COAT|||FOLLOW-UP|1967-09-11||1970-11-19|1968-12-16|1972-04-05
TRIAL STUDY 134XCP|PP|BEED1D48-A50C-4B72-8815-B8CA9F90D01E|212||RARECIFO|RATIO AMT REC INFINITY OBS||||||||NOT DONE||PERSPIRATION|||OPEN LABEL TREATMENT|1973-01-04||1963-12-27|1966-06-24|1971-09-08
TRIAL STUDY 134XCP|PP|3F18534E-367D-45C8-BB08-C82151A0CF00|213||AUCPEO|AUC %EXTRAPOLATION OBS||||||||NOT DONE||LOCHIA|||INDUCTION TREATMENT|1972-09-10||1972-03-24|1970-08-17|1971-06-12
TRIAL STUDY 134XCP|PP|81C10FB0-3B47-46D8-B8B7-9C772246CA55|214||RCPCINTS|PCT REC FROM T1 TO T2 NORM BY SA||||||||NOT DONE||SUPERNATANT, PLASMA|||BLINDED TREATMENT|1970-10-21||1961-04-18|1965-02-24|1973-05-15
TRIAL STUDY 134XCP|PP|67C99F41-D839-4B8E-9220-6EC161FCD457|215||CONCD|CONC BY DOSE||||||||NOT DONE||NAIL|||SCREENING|1966-06-05||1967-07-18|1962-12-31|1967-06-15
TRIAL STUDY 134XCP|PP|76B9C25F-B418-4979-9E18-4372C8AA700C|216||RCAMTAUB|AMT REC OVER DOSING INTERVAL NORM BY BMI||||||||NOT DONE||SERUM|||TREATMENT|1964-05-22||1969-05-21|1962-11-16|1970-05-25
TRIAL STUDY 134XCP|PP|9F622B53-71F8-4362-99A5-251993E3A946|217||AUCTAU|AUC OVER DOSING INTERVAL||||||||NOT DONE||HAIR FOLLICLE|||TREATMENT|1966-03-02||1963-10-23|1972-01-18|1967-01-31
TRIAL STUDY 134XCP|PP|8F2DC6EB-0264-4112-B379-17896F4266E4|218||CONCDW|CONCENTRATION NORM BY DOSE/WT||||||||NOT DONE||GASTRIC FLUID|||BASELINE|1966-09-12||1967-06-01|1970-05-18|1969-01-03
TRIAL STUDY 134XCP|PP|448246D1-5625-4F69-B214-3A8848E86C28|219||AUCTAU|AUC OVER DOSING INTERVAL||||||||NOT DONE||LYMPH|||TREATMENT|1968-11-25||1961-07-15|1960-09-08|1964-08-10
TRIAL STUDY 134XCP|PP|F1D22A3B-8514-4036-BBE5-6765B2F0EBB6|220||CAVGB|AVERAGE CONC NORM BY BMI||||||||NOT DONE||LUNG SURFACTANT|||LONG-TERM FOLLOW-UP|1962-03-31||1962-09-10|1969-08-25|1969-06-06
TRIAL STUDY 134XCP|PP|27DDBB16-ED11-45B6-987D-FB0D8223B993|221||CTROUGH|CONC TROUGH||||||||NOT DONE||HAIR|||RUN-IN|1967-11-29||1960-01-20|1969-03-18|1967-09-02
TRIAL STUDY 134XCP|PP|5545846C-F90F-4346-A075-05999641B872|222||CAVGDW|AVERAGE CONCENTRATION NORM BY DOSE/WT||||||||NOT DONE||CEREBROSPINAL FLUID|||LONG-TERM FOLLOW-UP|1960-03-12||1966-07-17|1970-10-04|1969-06-01
TRIAL STUDY 134XCP|PP|F5E96D41-8C4C-45E4-9FB8-C6513C1DE4C1|223||AUMCTAUW|AUMC OVER DOSING INTERVAL NORM BY WT||||||||NOT DONE||SUPERNATANT, PLASMA|||FOLLOW-UP|1967-12-08||1971-02-05|1972-02-07|1960-12-23
TRIAL STUDY 134XCP|PP|111541DB-D863-4C68-9E62-B8741A62401C|224||ARAUCIPD|ACCUM RATIO AUCIFP NORM BY DOSE||||||||NOT DONE||PLEURAL FLUID|||TREATMENT|1970-01-18||1972-05-14|1964-12-25|1968-08-05
TRIAL STUDY 134XCP|PP|5095C113-7278-4D41-B860-0DF6B9B98738|225||ERTLST|MIDPOINT OF INTERVAL OF LAST NONZERO ER||||||||NOT DONE||PLASMA|||LONG-TERM FOLLOW-UP|1964-02-07||1973-03-25|1962-11-12|1964-07-27
TRIAL STUDY 134XCP|PP|61319D2E-A512-425F-9301-BAD27B5F5C9B|226||AUMCLST|AUMC TO LAST NONZERO CONC||||||||NOT DONE||SWABBED MATERIAL|||FOLLOW-UP|1970-04-18||1972-05-18|1973-07-18|1972-10-30
TRIAL STUDY 134XCP|PP|3B865A8F-949B-4B64-A818-85472EABB8FB|227||RCAMIFPW|AMT REC INFINITY PRED NORM BY WT||||||||NOT DONE||BILE|||OPEN LABEL TREATMENT|1973-03-19||1965-05-03|1967-12-27|1966-07-03
TRIAL STUDY 134XCP|PP|A6909912-22B9-4EE7-AEDF-F791F243A6B7|228||AUCIFPS|AUC INFINITY PRED NORM BY SA||||||||NOT DONE||VENOUS CORD BLOOD|||LONG-TERM FOLLOW-UP|1972-07-08||1970-02-21|1968-11-09|1962-06-21
TRIAL STUDY 134XCP|PP|83C8AAD3-B22D-42C6-870A-D069FAC601F3|229||VZPB|VZ PRED NORM BY BMI||||||||NOT DONE||PROSTATIC FLUID|||TREATMENT|1970-12-04||1969-05-18|1962-01-06|1961-12-04
TRIAL STUDY 134XCP|PP|4EE77C34-2BA7-482D-81DE-49BBA9AEE4E5|230||CMINW|MIN CONC NORM BY WT||||||||NOT DONE||GASTRIC CONTENTS|||LONG-TERM FOLLOW-UP|1969-04-02||1963-02-14|1963-09-27|1968-06-21
TRIAL STUDY 134XCP|PP|937BF41A-157D-45F6-9797-2C5D19D100E6|231||RCAMIFOB|AMT REC INFINITY OBS NORM BY BMI||||||||NOT DONE||SALIVA|||WASHOUT|1964-05-24||1964-11-12|1969-05-06|1970-11-30
TRIAL STUDY 134XCP|PP|1BA56D89-E536-491E-AD6A-190A07331BEA|232||RCAMINT|AMT REC FROM T1 TO T2||||||||NOT DONE||SPUTUM|||RUN-IN|1970-02-21||1968-10-18|1964-04-20|1965-08-30
TRIAL STUDY 134XCP|PP|BE208D93-7322-427F-A8E5-1DBE5040BE8F|233||ERLSTS|LAST MEAS EXCRETION RATE NORM BY SA||||||||NOT DONE||PERIPHERAL BLOOD MONONUCLEAR CELL|||BLINDED TREATMENT|1963-02-21||1966-01-10|1967-12-06|1962-04-02
TRIAL STUDY 134XCP|PP|A58C5E7B-21EC-4F59-BB74-3264AC945F61|234||VSSP|VOL DIST STEADY STATE PRED||||||||NOT DONE||TRANSUDATE|||BASELINE|1964-10-24||1968-04-15|1962-11-11|1971-04-28
TRIAL STUDY 134XCP|PP|470EB5DB-57D1-4D39-8C30-1444C88DB4E2|235||AUCINTD|AUC FROM T1 TO T2 NORM BY DOSE||||||||NOT DONE||BONE|||OBSERVATION|1961-12-04||1969-08-29|1964-06-24|1960-12-08
TRIAL STUDY 134XCP|PP|434B4F6A-C436-4F92-8FA5-9C2F1964098A|236||CMAXB|MAX CONC NORM BY BMI||||||||NOT DONE||BONE MARROW|||SCREENING|1969-08-16||1961-11-04|1963-11-01|1964-03-23
TRIAL STUDY 134XCP|PP|F50D12BE-0D22-4347-BE0B-A61EF6CC1FC7|237||MRAUCLST|METABOLITE RATIO AUC LAST NONZERO CONC||||||||NOT DONE||TISSUE|||FOLLOW-UP|1972-11-04||1961-09-12|1963-05-16|1967-07-23
TRIAL STUDY 134XCP|PP|EAEE4DF4-21F6-41EA-9CA0-CC49C9B323EB|238||AUCLSTS|AUC TO LAST NONZERO CONC NORM BY SA||||||||NOT DONE||DISCHARGE|||TREATMENT|1967-04-14||1969-04-11|1962-09-26|1961-04-13
TRIAL STUDY 134XCP|PP|73C4A4D7-2177-47F3-818A-C0774F5E4A08|239||VZPS|VZ PRED NORM BY SA||||||||NOT DONE||CALCULUS|||BASELINE|1963-09-24||1961-01-12|1963-11-01|1970-11-26
TRIAL STUDY 134XCP|PP|4E3929B3-63F2-4E89-8EB4-60991E7284E1|240||RAAUCLST|RATIO AUC TO LAST NONZERO CONC||||||||NOT DONE||LYSATE|||WASHOUT|1963-07-16||1965-02-08|1962-08-11|1970-03-09
TRIAL STUDY 134XCP|PP|F26E2F67-3F90-448C-92BB-AD60E71D5664|241||CONC|CONCENTRATION||||||||NOT DONE||ERYTHROCYTES|||LONG-TERM FOLLOW-UP|1972-02-18||1961-08-31|1968-01-18|1966-08-12
TRIAL STUDY 134XCP|PP|3D3F1B3A-DDC4-43C1-A4C1-AA775C3AC980|242||AURCIFP|AURC INFINITY PRED||||||||NOT DONE||SOFT TISSUE|||WASHOUT|1971-01-06||1960-05-28|1968-12-17|1967-04-24
TRIAL STUDY 134XCP|PP|F2F1151C-F987-49CE-BC16-719DD339DBE7|243||CLFPW|TOTAL CL PRED BY F NORM BY WT||||||||NOT DONE||SPUTUM|||BLINDED TREATMENT|1962-06-03||1965-04-01|1973-05-22|1961-11-28
TRIAL STUDY 134XCP|PP|F88FCFA6-90D7-4033-86DF-223A63A6152D|244||CLPB|TOTAL CL PRED NORM BY BMI||||||||NOT DONE||BLOOD|||OBSERVATION|1966-12-04||1970-06-09|1960-10-20|1971-01-23
TRIAL STUDY 134XCP|PP|F8D7D2AA-6125-450D-B71D-6109FFA1AC3E|245||CAVGINTD|AVERAGE CONC FROM T1 TO T2 NORM BY DOSE||||||||NOT DONE||VENOUS CORD BLOOD|||BASELINE|1966-08-16||1967-05-10|1964-05-21|1967-07-08
TRIAL STUDY 134XCP|PP|7D35B2F5-7334-448B-B4E1-14671B850B6A|246||VSSPBD|VOL DIST STEADY STATE PRED BY B||||||||NOT DONE||SALIVA|||LONG-TERM FOLLOW-UP|1971-02-02||1960-12-05|1970-10-31|1964-03-01
TRIAL STUDY 134XCP|PP|8FDF7A91-BB16-4A4D-8D35-F1B1B40719E9|247||TAU|DOSING INTERVAL||||||||NOT DONE||ERYTHROCYTES|||OPEN LABEL TREATMENT|1971-04-14||1972-01-23|1963-08-30|1967-05-01
TRIAL STUDY 134XCP|PP|B09D371C-2E5C-4F84-986E-5A603C0C4A28|248||AUCIFPD|AUC INFINITY PRED NORM BY DOSE||||||||NOT DONE||VENOUS BLOOD|||CONTINUATION TREATMENT|1973-03-01||1973-04-17|1963-11-19|1970-07-08
TRIAL STUDY 134XCP|PP|11CB653E-F113-4639-B15C-B236A2F65F47|249||VZO|VZ OBS||||||||NOT DONE||STOOL|||INDUCTION TREATMENT|1964-04-12||1971-10-30|1971-06-08|1969-03-25
TRIAL STUDY 134XCP|PP|2AB992E7-55B7-4327-987C-47FD605B7D78|250||LAMZUL|LAMBDA Z UPPER LIMIT||||||||NOT DONE||ABSCESS FLUID|||OBSERVATION|1960-07-03||1966-02-09|1961-05-03|1967-03-27
TRIAL STUDY 134XCP|PP|6AF1B0B0-9923-459A-8629-5E628400AD00|251||RACMAXD|RATIO MAX CONC NORM BY DOSE||||||||NOT DONE||DERMAL TISSUE|||LONG-TERM FOLLOW-UP|1971-07-22||1970-07-31|1960-07-21|1972-05-18
TRIAL STUDY 134XCP|PP|E1305E4E-DF64-4FD1-B0B2-131459AB629D|252||AUCALLS|AUC ALL NORM BY SA||||||||NOT DONE||SOFT TISSUE|||BASELINE|1971-01-25||1969-03-02|1964-11-07|1963-03-30
TRIAL STUDY 134XCP|PP|9FEA7E3E-BEB9-4FD6-930D-5D724262B066|253||AUCTAUW|AUC OVER DOSING INTERVAL NORM BY WT||||||||NOT DONE||DERMAL TISSUE|||OBSERVATION|1972-11-10||1969-10-24|1967-10-28|1973-04-10
TRIAL STUDY 134XCP|PP|0FD7F837-3D76-4A1C-B414-373B55A39506|254||RCPCIFO|PCT REC INFINITY OBS||||||||NOT DONE||SALIVA|||BASELINE|1964-03-14||1965-04-05|1971-05-09|1967-01-26
TRIAL STUDY 134XCP|PP|B9FE22A2-67DF-44AC-BBC6-B911BB5957AA|255||CLFPB|TOTAL CL PRED BY F NORM BY BMI||||||||NOT DONE||BILE|||OBSERVATION|1969-10-14||1965-11-04|1972-05-11|1962-08-18
TRIAL STUDY 134XCP|PP|92FB0125-67D2-41CC-9116-8C949F15614A|256||CLPS|TOTAL CL PRED NORM BY SA||||||||NOT DONE||SALIVA|||CONTINUATION TREATMENT|1968-12-05||1970-03-06|1972-10-16|1960-08-30
TRIAL STUDY 134XCP|PP|7042617F-0C29-4928-B3ED-9549A53BC195|257||RCAMINTS|AMT REC FROM T1 TO T2 NORM BY SA||||||||NOT DONE||INFRANATANT, PLASMA|||INDUCTION TREATMENT|1968-05-28||1969-07-12|1961-12-01|1967-08-15
TRIAL STUDY 134XCP|PP|C6707A8F-FA0D-4A20-BDF3-62F12465EEDD|258||RAMAXMIN|RATIO OF CMAX TO CMIN||||||||NOT DONE||SUPERNATANT, PLASMA|||BASELINE|1967-08-20||1964-03-18|1962-05-25|1963-05-28
TRIAL STUDY 134XCP|PP|6633CC54-D711-4780-A833-A71756D8B234|259||AURCINT|AURC FROM T1 TO T2||||||||NOT DONE||WHITE MATTER TISSUE|||WASHOUT|1967-12-04||1971-10-12|1967-09-10|1964-05-21
TRIAL STUDY 134XCP|PP|84C642FE-6D84-4525-AB1C-15FAF740D63B|260||RAMAXMIN|RATIO OF CMAX TO CMIN||||||||NOT DONE||PERSPIRATION|||CONTINUATION TREATMENT|1971-12-25||1971-07-15|1960-02-16|1972-11-22
TRIAL STUDY 134XCP|PP|1445FD45-1E9D-41C0-B81C-37E2FD2F20D7|261||RCPCIFPB|PCT REC INFINITY PRED NORM BY BMI||||||||NOT DONE||STOOL|||SCREENING|1960-12-09||1961-02-09|1970-02-28|1968-02-24
TRIAL STUDY 134XCP|PP|AAF75D2D-0DF1-4A15-B7FC-1EEE65FFAC62|262||HDCL|HEMODIALYSIS CLEARANCE||||||||NOT DONE||MONOCYTE|||OPEN LABEL TREATMENT|1967-09-27||1966-09-03|1970-10-25|1963-07-10
TRIAL STUDY 134XCP|PP|A0757669-2DF6-4E78-A021-9C777BEF5697|263||ERINTB|EXCRET RATE FROM T1 TO T2 NORM BY BMI||||||||NOT DONE||BILE|||BLINDED TREATMENT|1963-01-07||1964-02-12|1963-02-12|1973-03-14
TRIAL STUDY 134XCP|PP|DAF7255A-888D-43D3-97B8-5E432938747F|264||CMINS|MIN CONC NORM BY SA||||||||NOT DONE||SOFT TISSUE|||RUN-IN|1960-07-03||1967-10-25|1964-04-21|1972-12-15
TRIAL STUDY 134XCP|PP|51989FEC-B63E-4F58-B748-2FF5E73E5D14|265||R2|R SQUARED||||||||NOT DONE||BONE|||RUN-IN|1972-02-05||1961-11-08|1967-02-13|1962-02-07
TRIAL STUDY 134XCP|PP|776299DC-1CD5-448F-82C2-C1659CEE689D|266||RAAUC|RATIO AUC||||||||NOT DONE||SPERMATOZOON|||LONG-TERM FOLLOW-UP|1969-08-28||1971-05-10|1964-02-26|1964-02-29
TRIAL STUDY 134XCP|PP|1E9755DC-A5EA-4DAF-A95E-47D8FA3765D7|267||RCAMIFOW|AMT REC INFINITY OBS NORM BY WT||||||||NOT DONE||STRIATED MUSCLE TISSUE|||RUN-IN|1966-01-22||1960-06-18|1968-03-16|1967-08-01
TRIAL STUDY 134XCP|PP|2844C9EF-3DEE-4C8E-A89C-0206F4073CB1|268||CMAXUB|MAX CONC, UNBOUND DRUG||||||||NOT DONE||STRIATED MUSCLE TISSUE|||LONG-TERM FOLLOW-UP|1960-01-18||1969-10-14|1972-04-13|1966-05-11
TRIAL STUDY 134XCP|PP|054D4740-C675-4904-B912-B00A0B089F12|269||AUCINTD|AUC FROM T1 TO T2 NORM BY DOSE||||||||NOT DONE||ABSCESS FLUID|||INDUCTION TREATMENT|1962-02-23||1970-09-22|1971-11-15|1973-01-22
TRIAL STUDY 134XCP|PP|9548556E-EECF-4460-A7DD-D93F853E9EA8|270||AUMCPEP|AUMC % EXTRAPOLATION PRED||||||||NOT DONE||EPIDERMAL TISSUE|||TREATMENT|1969-06-27||1973-03-10|1972-10-24|1969-02-14
TRIAL STUDY 134XCP|PP|0BCF6152-3718-402C-9333-A3EFBB3086FF|271||RACMAXD|RATIO MAX CONC NORM BY DOSE||||||||NOT DONE||SWABBED MATERIAL|||SCREENING|1965-04-30||1961-01-05|1964-08-08|1969-09-10
TRIAL STUDY 134XCP|PP|3EC28B44-0649-4C7F-8840-E0E9FC404DA7|272||VZFTAUD|VZ FOR DOSE INT BY F NORM BY DOSE||||||||NOT DONE||TUMOR TISSUE|||FOLLOW-UP|1970-06-16||1966-09-18|1964-03-11|1973-08-20
TRIAL STUDY 134XCP|PP|EED12AC0-1CBD-4D42-8786-91834AB33A46|273||CAVGINT|AVERAGE CONC FROM T1 TO T2||||||||NOT DONE||BUFFY COAT|||BASELINE|1963-02-17||1969-10-18|1971-05-12|1960-03-05
TRIAL STUDY 134XCP|PP|F30DC3E9-E919-4920-87FE-103CD85D89FA|274||RAAUCIFO|RATIO AUC INFINITY OBS||||||||NOT DONE||COLOSTRUM|||WASHOUT|1965-04-12||1963-10-17|1972-03-03|1969-06-08
TRIAL STUDY 134XCP|PP|EBECDED4-D06C-49D4-95F2-C6E9CDBA802B|275||CLFTAUD|TOTAL CL BY F FOR DOSE INT NORM BY DOSE||||||||NOT DONE||MECONIUM|||OBSERVATION|1965-08-02||1960-11-12|1965-01-18|1965-05-17
TRIAL STUDY 134XCP|PP|729D254F-628C-4D35-8906-A1344833A610|276||VOLPK|SUM OF URINE VOL||||||||NOT DONE||PLEURAL TISSUE|||RUN-IN|1972-03-22||1966-01-20|1969-07-01|1960-06-03
TRIAL STUDY 134XCP|PP|A78936A2-B8B1-4D07-8679-E324F6447EFF|277||CAVGINTS|AVERAGE CONC FROM T1 TO T2 NORM BY SA||||||||NOT DONE||BASAL TEAR|||LONG-TERM FOLLOW-UP|1962-06-21||1970-09-22|1972-08-14|1964-11-23
TRIAL STUDY 134XCP|PP|239B331A-08CD-41D9-BBB8-CE229480FC12|278||CLOUB|TOTAL CL OBS FOR UNBOUND DRUG||||||||NOT DONE||GASTRIC FLUID|||TREATMENT|1968-09-04||1967-01-30|1972-08-23|1973-08-28
TRIAL STUDY 134XCP|PP|958D39CD-D511-40C8-A0A6-8A138225470B|279||AUCLSTS|AUC TO LAST NONZERO CONC NORM BY SA||||||||NOT DONE||PERIPHERAL BLOOD MONONUCLEAR CELL|||LONG-TERM FOLLOW-UP|1965-12-31||1969-03-28|1967-02-15|1960-10-22
TRIAL STUDY 134XCP|PP|5DA21FE5-E5B9-4461-9509-94AA264B59A8|280||CLFPD|TOTAL CL PRED BY F NORM BY DOSE||||||||NOT DONE||PLEURAL FLUID|||CONTINUATION TREATMENT|1972-04-08||1970-06-15|1963-12-12|1973-02-11
TRIAL STUDY 134XCP|PP|B125DCB9-1705-430B-9982-A20E7C4CA6A8|281||C0B|INITIAL CONC NORM BY BMI||||||||NOT DONE||AMNIOTIC FLUID|||CONTINUATION TREATMENT|1970-05-20||1960-10-07|1970-10-04|1973-08-25
TRIAL STUDY 134XCP|PP|95C72325-301E-40D4-AA2D-49B80067FE23|282||ERMAXW|MAX EXCRETION RATE NORM BY WT||||||||NOT DONE||MONOCYTE|||LONG-TERM FOLLOW-UP|1960-01-11||1969-02-15|1965-10-29|1965-05-11
TRIAL STUDY 134XCP|PP|7FFBD039-64CD-4D6F-85EC-83F0D11C57E5|283||CAVGINTD|AVERAGE CONC FROM T1 TO T2 NORM BY DOSE||||||||NOT DONE||PLATELET RICH PLASMA|||SCREENING|1965-12-31||1969-02-02|1970-01-09|1972-04-28
TRIAL STUDY 134XCP|PP|7DF25CA4-0846-4180-9356-F53C704F0233|284||CLFTAUD|TOTAL CL BY F FOR DOSE INT NORM BY DOSE||||||||NOT DONE||VITREOUS HUMOR|||CONTINUATION TREATMENT|1963-06-22||1966-08-23|1971-03-05|1971-03-24
TRIAL STUDY 134XCP|PP|92FB74AC-D410-4E35-AD9E-5F5A350B26C5|285||CLFOS|TOTAL CL OBS BY F NORM BY SA||||||||NOT DONE||EXUDATE|||OPEN LABEL TREATMENT|1962-04-09||1971-03-21|1968-06-17|1965-07-14
TRIAL STUDY 134XCP|PP|5ABEF81B-9399-4A5D-B57B-2CD0DE531EF6|286||ERINTB|EXCRET RATE FROM T1 TO T2 NORM BY BMI||||||||NOT DONE||SMOOTH MUSCLE TISSUE|||BASELINE|1960-03-05||1961-08-08|1965-09-11|1972-06-10
TRIAL STUDY 134XCP|PP|895AAD86-9D50-41E1-AD1B-95CD9A7911C6|287||CLFTAUW|TOTAL CL BY F FOR DOSE INT NORM BY WT||||||||NOT DONE||CORD SERUM|||CONTINUATION TREATMENT|1973-02-20||1962-12-03|1969-06-24|1960-05-11
TRIAL STUDY 134XCP|PP|2C15756E-1096-403B-989D-D2C3D31396A9|288||CLSTS|LAST NONZERO CONC NORM BY SA||||||||NOT DONE||SALIVA|||SCREENING|1967-06-30||1970-10-01|1972-08-01|1964-10-16
TRIAL STUDY 134XCP|PP|CD103276-37FC-4E40-A0C8-8D1300D21AE1|289||RCPCIFOW|PCT REC INFINITY OBS NORM BY WT||||||||NOT DONE||DIALYSIS FLUID, PERITONEAL|||FOLLOW-UP|1968-03-11||1960-07-03|1967-11-14|1973-04-27
TRIAL STUDY 134XCP|PP|B9868C79-E6CC-4588-B5FA-3C9457D3C9C9|290||AURCLSTD|AURC DOSING TO LAST CONC NORM BY DOSE||||||||NOT DONE||SMEGMA|||OBSERVATION|1970-01-05||1973-03-23|1964-11-13|1965-05-01
TRIAL STUDY 134XCP|PP|EBF85B6C-B5DE-4E96-A9F8-96E24920545A|291||CAVGS|AVERAGE CONC NORM BY SA||||||||NOT DONE||BLOOD|||WASHOUT|1964-02-03||1973-01-11|1969-09-06|1962-08-09
TRIAL STUDY 134XCP|PP|7B583F10-E460-4B25-8A6B-530A154442CD|292||VZTAUB|VZ FOR DOSE INT NORM BY BMI||||||||NOT DONE||LEUKOCYTE|||SCREENING|1970-11-05||1963-07-13|1963-10-08|1966-06-26
TRIAL STUDY 134XCP|PP|85FCA6B5-F6DC-4ED6-BBFD-92DB6DC4FEC6|293||ERTMAX|MIDPOINT OF INTERVAL OF MAXIMUM ER||||||||NOT DONE||STOOL|||INDUCTION TREATMENT|1966-10-02||1971-03-03|1965-03-19|1964-01-22
TRIAL STUDY 134XCP|PP|E8D7AE54-09E7-429B-BD5B-318A1A4923CA|294||RCAMIFOS|AMT REC INFINITY OBS NORM BY SA||||||||NOT DONE||INFRANATANT, PLASMA|||INDUCTION TREATMENT|1961-02-25||1966-11-10|1972-10-24|1964-02-28
TRIAL STUDY 134XCP|PP|51FE575E-2161-414B-B772-9F1888E7C5CC|295||CLOD|TOTAL CL OBS NORM BY DOSE||||||||NOT DONE||ARTERIAL CORD BLOOD|||WASHOUT|1965-08-06||1965-04-22|1964-01-01|1966-01-29
TRIAL STUDY 134XCP|PP|991C72FC-777F-4CED-824B-A4DECA57BE99|296||VZFOS|VZ OBS BY F NORM BY SA||||||||NOT DONE||MUSCLE TISSUE|||INDUCTION TREATMENT|1969-08-30||1965-01-24|1965-11-11|1969-01-07
TRIAL STUDY 134XCP|PP|FFECA538-8D16-421C-ACA2-4A769BC15D7D|297||AUCIFPS|AUC INFINITY PRED NORM BY SA||||||||NOT DONE||LUNG SURFACTANT|||INDUCTION TREATMENT|1971-11-16||1969-12-07|1965-05-12|1960-01-22
TRIAL STUDY 134XCP|PP|72FB03F9-3FF5-4039-98AE-8FC966A6E01E|298||CLP|TOTAL CL PRED||||||||NOT DONE||MUCUS|||INDUCTION TREATMENT|1971-06-18||1971-07-27|1961-12-02|1965-10-05
TRIAL STUDY 134XCP|PP|54507F00-0C16-4F35-A762-104B47390283|299||LAMZNPT|NUMBER OF POINTS FOR LAMBDA Z||||||||NOT DONE||PERSPIRATION|||OPEN LABEL TREATMENT|1969-01-07||1966-05-15|1967-11-22|1964-11-17
TRIAL STUDY 134XCP|PP|2CFF24EC-FBE1-4A45-9FCE-9DAAD35D9566|300||RAAUCIFO|RATIO AUC INFINITY OBS||||||||NOT DONE||INFRANATANT, PLEURAL FLUID|||WASHOUT|1961-06-07||1961-05-05|1973-05-06|1961-04-15
TRIAL STUDY 134XCP|PP|C16428B9-880B-47B9-BF1D-2CF87DE8ECE1|301||AUCIFOS|AUC INFINITY OBS NORM BY SA||||||||NOT DONE||PERITONEAL FLUID|||OBSERVATION|1972-09-17||1966-06-28|1973-02-19|1972-02-11
TRIAL STUDY 134XCP|PP|CF8F9036-3380-4A0B-B17A-7EF814B02700|302||CAVGINTW|AVERAGE CONC FROM T1 TO T2 NORM BY WT||||||||NOT DONE||SEMINAL FLUID|||OBSERVATION|1968-01-19||1966-08-31|1964-08-09|1965-01-02
TRIAL STUDY 134XCP|PP|0DE06EA9-D4D1-4E52-8FF6-29B334E9BB8D|303||V0B|VOL DIST INITIAL NORM BY BMI||||||||NOT DONE||VENOUS CORD BLOOD|||SCREENING|1973-02-10||1963-02-14|1964-03-30|1972-07-29
TRIAL STUDY 134XCP|PP|58360390-F6AB-41D7-9A0D-1039E795403E|304||C0S|INITIAL CONC NORM BY SA||||||||NOT DONE||MIXED VENOUS BLOOD|||INDUCTION TREATMENT|1965-08-27||1969-03-22|1962-10-24|1972-08-02
TRIAL STUDY 134XCP|PP|61B02780-0C99-47F8-93B2-CA839876604E|305||RENCLTAU|RENAL CL FOR DOSE INT||||||||NOT DONE||EPIDERMAL TISSUE|||INDUCTION TREATMENT|1964-09-28||1968-04-23|1971-08-27|1964-08-19
TRIAL STUDY 134XCP|PP|1381458A-D702-467D-ADCA-984EE7BD894D|306||VSSPW|VOL DIST STEADY STATE PRED NORM BY WT||||||||NOT DONE||ATHEROSCLEROTIC PLAQUE|||OBSERVATION|1968-02-26||1970-03-03|1973-05-26|1963-01-15
TRIAL STUDY 134XCP|PP|04211DA3-CFD5-4750-9D61-C91FF7BC338A|307||RACMAXD|RATIO MAX CONC NORM BY DOSE||||||||NOT DONE||MENSTRUAL BLOOD|||BLINDED TREATMENT|1971-08-15||1969-03-24|1972-11-21|1970-09-16
TRIAL STUDY 134XCP|PP|EF707A48-6FAD-47C0-913A-5CBCACA539E0|308||AURCIFP|AURC INFINITY PRED||||||||NOT DONE||VITREOUS HUMOR|||BASELINE|1967-04-07||1964-12-25|1967-10-23|1968-10-21
TRIAL STUDY 134XCP|PP|C896767E-2418-4226-A8AE-D875DA40F9FB|309||TMAX|TIME OF CMAX||||||||NOT DONE||EMESIS|||SCREENING|1963-07-15||1972-01-23|1967-03-30|1962-03-23
TRIAL STUDY 134XCP|PP|666BC019-B828-4DB4-BD2F-973BA689C9E7|310||AURCLSTS|AURC DOSING TO LAST CONC NORM BY SA||||||||NOT DONE||AMNIOTIC FLUID|||INDUCTION TREATMENT|1964-09-18||1963-10-19|1960-03-03|1966-06-11
TRIAL STUDY 134XCP|PP|91282D87-4943-4527-8F33-27A5C153951C|311||CLOW|TOTAL CL OBS NORM BY WT||||||||NOT DONE||VENOUS CORD BLOOD|||FOLLOW-UP|1967-06-03||1966-03-05|1970-02-06|1970-07-20
TRIAL STUDY 134XCP|PP|1A56C9D3-ADEE-42C0-BF43-CE42F70E9A6A|312||AURCIFP|AURC INFINITY PRED||||||||NOT DONE||CERVICOVAGINAL SECRETION|||WASHOUT|1963-07-29||1971-08-16|1968-04-09|1970-10-11
TRIAL STUDY 134XCP|PP|0D0EC1C5-B2B7-4D1C-9986-5F9915B81DE2|313||AUCTAUB|AUC OVER DOSING INTERVAL NORM BY BMI||||||||NOT DONE||DIALYSIS FLUID, PERITONEAL|||OBSERVATION|1970-05-02||1963-09-19|1963-09-26|1961-04-11
TRIAL STUDY 134XCP|PP|5A3D2F32-F73C-4ADF-988C-8AB33B0754B1|314||MRTIVLST|MRT INTRAVASC TO LAST NONZERO CONC||||||||NOT DONE||LUNG SURFACTANT|||CONTINUATION TREATMENT|1971-05-11||1967-03-01|1970-03-11|1969-09-06
TRIAL STUDY 134XCP|PP|9D32C2B3-CC4A-4C8C-9D91-6726F4D280C6|315||CLO|TOTAL CL OBS||||||||NOT DONE||ABSCESS FLUID|||INDUCTION TREATMENT|1961-08-17||1962-05-13|1966-03-05|1962-06-19
TRIAL STUDY 134XCP|PP|0320460C-3770-486A-85EB-ECD133AE6EFA|316||VZFTAUS|VZ FOR DOSE INT BY F NORM BY SA||||||||NOT DONE||INFRANATANT, SERUM|||SCREENING|1971-10-06||1966-12-22|1963-10-15|1960-08-24
TRIAL STUDY 134XCP|PP|810B0B08-9236-41EC-8879-924661FA224E|317||CAVINTDW|CAVGINT NORM BY DOSE/WT||||||||NOT DONE||CAPILLARY BLOOD|||INDUCTION TREATMENT|1960-09-30||1967-10-01|1964-05-18|1973-08-31
TRIAL STUDY 134XCP|PP|BA3B0D91-DC95-4916-8ACA-71451447BE81|318||ARCTROUG|ACCUMULATION RATIO CTROUGH||||||||NOT DONE||SUPERNATANT, CEREBROSPINAL FLUID|||INDUCTION TREATMENT|1966-09-15||1962-07-27|1972-12-31|1970-01-28
TRIAL STUDY 134XCP|PP|DE385129-5FB9-43C3-9FB1-005886674C9B|319||VSSOF|VOL DIST STEADY STATE OBS BY F||||||||NOT DONE||EPIDERMAL TISSUE|||CONTINUATION TREATMENT|1964-05-22||1963-08-03|1968-12-12|1972-07-14
TRIAL STUDY 134XCP|PP|8AE8077F-A13C-4593-B012-213A5EBE0A1D|320||VSSPW|VOL DIST STEADY STATE PRED NORM BY WT||||||||NOT DONE||LEUKOCYTE|||INDUCTION TREATMENT|1973-07-27||1966-09-27|1972-05-16|1972-04-30
TRIAL STUDY 134XCP|PP|72FCE18B-B3D6-45AC-993F-9883E4D11313|321||ARAUC|ACCUMULATION RATIO AUCTAU||||||||NOT DONE||BILE|||RUN-IN|1970-05-01||1962-02-22|1962-10-27|1963-03-29
TRIAL STUDY 134XCP|PP|1123F894-0821-41DF-9C28-ED6BC4A7098C|322||CMAXS|MAX CONC NORM BY SA||||||||NOT DONE||MECONIUM|||LONG-TERM FOLLOW-UP|1960-01-24||1968-08-09|1961-07-11|1973-08-15
TRIAL STUDY 134XCP|PP|42DD827A-E788-4E61-8E9F-421136A16166|323||VZOW|VZ OBS NORM BY WT||||||||NOT DONE||LAVAGE FLUID|||BASELINE|1964-08-15||1972-07-14|1960-01-30|1968-06-07
TRIAL STUDY 134XCP|PP|CC1E2338-4454-4CBA-8848-0B994C459F05|324||RAAUCTAU|RATIO AUC OVER DOSING INTERVAL||||||||NOT DONE||CERVICOVAGINAL SECRETION|||OPEN LABEL TREATMENT|1960-08-10||1969-06-22|1973-07-10|1962-10-20
TRIAL STUDY 134XCP|PP|ED04E60D-256A-4DB9-9290-4EFD0602A130|325||SRAUC|STATIONARITY RATIO AUC||||||||NOT DONE||ERYTHROCYTES|||CONTINUATION TREATMENT|1969-03-27||1968-12-31|1970-01-18|1964-08-15
TRIAL STUDY 134XCP|PP|C70F82F6-3280-429D-9657-CDFBA6B7F626|326||CMAXLN|MAX CONC LN TRANSFORMED||||||||NOT DONE||PLEURAL FLUID|||TREATMENT|1972-02-29||1963-10-22|1963-04-15|1962-08-22
TRIAL STUDY 134XCP|PP|D735D137-2C27-4F27-BA18-9A0F7FF0B145|327||V0|VOL DIST INITIAL||||||||NOT DONE||URINE|||BLINDED TREATMENT|1971-01-17||1973-04-08|1963-05-26|1966-09-23
TRIAL STUDY 134XCP|PP|B00194E0-0E85-46DD-86C3-CD9048535986|328||AUCLST|AUC TO LAST NONZERO CONC||||||||NOT DONE||URINE|||LONG-TERM FOLLOW-UP|1972-11-24||1963-05-09|1970-01-26|1967-08-16
TRIAL STUDY 134XCP|PP|B4F372E9-C461-414A-95B4-93CA0221D396|329||CLFOS|TOTAL CL OBS BY F NORM BY SA||||||||NOT DONE||EXPIRED AIR|||SCREENING|1961-09-17||1967-02-11|1961-11-01|1960-03-03
TRIAL STUDY 134XCP|PP|54C204AA-3DEF-4CB6-A0B6-3AA4090C02D7|330||AUCTAUS|AUC OVER DOSING INTERVAL NORM BY SA||||||||NOT DONE||SERUM|||FOLLOW-UP|1961-10-26||1967-03-06|1967-04-14|1960-12-06
TRIAL STUDY 134XCP|PP|E43169E4-8B57-47D7-9C91-D42E40DD579B|331||AUMCLST|AUMC TO LAST NONZERO CONC||||||||NOT DONE||SMOOTH MUSCLE TISSUE|||BASELINE|1968-09-25||1964-03-19|1963-04-14|1965-02-24
TRIAL STUDY 134XCP|PP|066393EE-D112-41DD-AF8F-65EF57A4415B|332||VSSOUB|VOL DIST STEADY STATE OBS BY UB||||||||NOT DONE||SPUTUM|||TREATMENT|1962-11-20||1961-05-08|1961-12-01|1973-03-29
TRIAL STUDY 134XCP|PP|573C9228-D341-491C-9D66-0D0435E2C631|333||RNCLINTB|RENAL CL FROM T1 TO T2 NORM BY BMI||||||||NOT DONE||SERUM OR PLASMA|||INDUCTION TREATMENT|1969-02-01||1966-01-13|1971-05-29|1960-11-20
TRIAL STUDY 134XCP|PP|7BEDACC1-33A3-4A05-BE16-5D00D7A6BE36|334||ARAUCIND|ACCUM RATIO AUC T1 TO T2 NORM BY DOSE||||||||NOT DONE||EXPIRED AIR|||OPEN LABEL TREATMENT|1972-06-11||1966-08-05|1969-08-27|1969-12-27
TRIAL STUDY 134XCP|PP|9AFEAA8A-AF9C-4C16-ACFA-1E37D258F5FF|335||RNCLINTB|RENAL CL FROM T1 TO T2 NORM BY BMI||||||||NOT DONE||SERUM OR PLASMA OR BLOOD|||OPEN LABEL TREATMENT|1966-12-01||1973-03-25|1971-01-10|1960-04-27
TRIAL STUDY 134XCP|PP|61C75130-5C1A-4B8D-804C-92D3288B55D2|336||ERLSTS|LAST MEAS EXCRETION RATE NORM BY SA||||||||NOT DONE||ADIPOSE TISSUE|||OPEN LABEL TREATMENT|1963-01-19||1961-09-15|1968-04-25|1970-09-04
TRIAL STUDY 134XCP|PP|90AFB57A-125C-4C08-AE92-061F66FC2DAC|337||RAAUCINT|RATIO AUC FROM T1 TO T2||||||||NOT DONE||REFLEX TEAR|||OBSERVATION|1960-02-21||1964-04-01|1972-07-21|1973-05-14
TRIAL STUDY 134XCP|PP|B980E6D5-3883-4A1C-A7BA-FC4BA768B3E4|338||CAVGINTB|AVERAGE CONC FROM T1 TO T2 NORM BY BMI||||||||NOT DONE||NAIL|||BLINDED TREATMENT|1970-11-20||1961-03-15|1963-05-14|1972-06-05
TRIAL STUDY 134XCP|PP|01A42FAE-1EE2-4203-A62E-E368F31434F7|339||VSSO|VOL DIST STEADY STATE OBS||||||||NOT DONE||EPITHELIAL CELL|||WASHOUT|1962-04-19||1973-01-28|1960-05-22|1968-12-28
TRIAL STUDY 134XCP|PP|4764675D-2F2B-4CE1-AF43-E2A28A30FB74|340||AURCINTB|AURC FROM T1 TO T2 NORM BY BMI||||||||NOT DONE||ENDOTRACHEAL FLUID|||WASHOUT|1961-05-22||1973-06-06|1963-03-10|1964-07-29
TRIAL STUDY 134XCP|PP|92232C8B-0D28-4E2A-AA56-BA938429CCBF|341||AUCLSTDW|AUCLST NORM BY DOSE/WT||||||||NOT DONE||MUSCLE TISSUE|||BASELINE|1962-02-14||1969-03-30|1963-07-25|1960-10-09
TRIAL STUDY 134XCP|PP|F4F12AAA-E825-45D7-B414-A06F2D20381A|342||CLTAUS|TOTAL CL FOR DOSE INT NORM BY SA||||||||NOT DONE||MIXED VENOUS BLOOD|||OBSERVATION|1970-12-24||1970-08-15|1970-11-26|1960-07-26
TRIAL STUDY 134XCP|PP|6CF611F2-686E-4AE9-B491-32157710F46D|343||AUCIFOW|AUC INFINITY OBS NORM BY WT||||||||NOT DONE||SEMEN|||LONG-TERM FOLLOW-UP|1960-09-12||1965-01-19|1966-09-26|1961-10-10
TRIAL STUDY 134XCP|PP|417DBC64-7BF9-4EB8-A14B-C5F63541F826|344||VZTAU|VZ FOR DOSE INT||||||||NOT DONE||PERIPHERAL BLOOD MONONUCLEAR CELL|||WASHOUT|1966-11-05||1963-12-28|1970-04-15|1967-07-25
TRIAL STUDY 134XCP|PP|C3EF644E-25DC-4E0D-9073-735AED77EFAF|345||CLPB|TOTAL CL PRED NORM BY BMI||||||||NOT DONE||PERSPIRATION|||OBSERVATION|1966-07-23||1961-09-24|1960-11-15|1970-04-04
TRIAL STUDY 134XCP|PP|CAE5F41C-0560-4782-BA27-E314BF7E66B6|346||ERINTD|EXCRET RATE FROM T1 TO T2 NORM BY DOSE||||||||NOT DONE||SKELETAL MUSCLE TISSUE|||INDUCTION TREATMENT|1962-01-13||1963-07-29|1966-01-13|1962-02-25
TRIAL STUDY 134XCP|PP|08CEB6E7-DE68-4F9D-902C-08F6D069EF05|347||CAVGS|AVERAGE CONC NORM BY SA||||||||NOT DONE||LYSATE|||LONG-TERM FOLLOW-UP|1962-01-19||1964-03-07|1970-02-25|1970-05-01
TRIAL STUDY 134XCP|PP|F34E7DCC-8637-463D-88E6-28AEBF495E9B|348||TLST|TIME OF LAST NONZERO CONC||||||||NOT DONE||ERYTHROCYTES|||WASHOUT|1969-12-08||1962-06-12|1960-06-10|1973-05-01
TRIAL STUDY 134XCP|PP|69530FE0-6896-4585-8B20-29AE90DB91F5|349||AILAMZ|ACCUMULATION INDEX USING LAMBDA Z||||||||NOT DONE||INFRANATANT, PLASMA|||OPEN LABEL TREATMENT|1965-12-25||1961-03-29|1970-06-30|1965-03-14
TRIAL STUDY 134XCP|PP|64FA868A-1774-484C-BA89-4A2ACEF3A8A6|350||RCPCINTB|PCT REC FROM T1 TO T2 NORM BY BMI||||||||NOT DONE||CERUMEN|||LONG-TERM FOLLOW-UP|1964-02-10||1963-03-30|1968-10-14|1969-06-17
TRIAL STUDY 134XCP|PP|F1EF928C-B819-4620-8991-ABDC4E182217|351||RARECIFO|RATIO AMT REC INFINITY OBS||||||||NOT DONE||MUCUS|||BLINDED TREATMENT|1969-10-24||1965-06-02|1970-03-18|1967-04-07
TRIAL STUDY 134XCP|PP|3AE9E2AF-41FA-4B19-8885-C7E9B4CAD2AC|352||VZFOUB|VZ OBS BY F FOR UB||||||||NOT DONE||VENOUS BLOOD|||OPEN LABEL TREATMENT|1962-01-20||1973-05-10|1960-02-07|1971-09-27
TRIAL STUDY 134XCP|PP|41EF9E3A-3B71-4D35-B25F-29E6E3FC3BB1|353||RENCLTAU|RENAL CL FOR DOSE INT||||||||NOT DONE||ARTERIALIZED CAPILLARY BLOOD|||FOLLOW-UP|1965-08-15||1960-01-26|1971-05-16|1969-09-26
TRIAL STUDY 134XCP|PP|27D5690D-BCB3-4FEC-988C-666C29D5239A|354||CMIND|MIN CONC NORM BY DOSE||||||||NOT DONE||SOFT TISSUE|||CONTINUATION TREATMENT|1960-01-28||1964-12-17|1963-05-19|1962-09-24
TRIAL STUDY 134XCP|PP|7639ABA6-8AC8-4066-BF07-AEC230A2BF69|355||LAMZTAU|LAMBDA Z TAU||||||||NOT DONE||EMESIS|||OPEN LABEL TREATMENT|1966-05-18||1968-04-13|1969-10-16|1968-06-21
TRIAL STUDY 134XCP|PP|8E25F21F-A565-40CB-B0D7-6CC496171293|356||RAAUCLST|RATIO AUC TO LAST NONZERO CONC||||||||NOT DONE||ARTERIALIZED CAPILLARY BLOOD|||TREATMENT|1971-08-29||1968-08-15|1967-03-30|1968-12-26
TRIAL STUDY 134XCP|PP|8CDD2247-485D-495C-9186-FF4CA3FFC32E|357||LAMZLTAU|LAMBDA Z LOWER LIMIT TAU||||||||NOT DONE||SERUM OR PLASMA OR BLOOD|||OBSERVATION|1960-04-19||1972-06-26|1972-04-13|1966-05-28
TRIAL STUDY 134XCP|PP|E50F5B98-1DC4-41A8-8D68-A4E98D9E6B13|358||C0|INITIAL CONC||||||||NOT DONE||PLEURAL FLUID|||LONG-TERM FOLLOW-UP|1961-05-18||1971-08-23|1967-02-19|1963-08-03
TRIAL STUDY 134XCP|PP|C004A8EB-220F-4FC5-A150-B5159DCA84D9|359||RAAUCINT|RATIO AUC FROM T1 TO T2||||||||NOT DONE||URINE SEDIMENT|||LONG-TERM FOLLOW-UP|1970-09-11||1965-07-23|1973-01-20|1967-05-29
TRIAL STUDY 134XCP|PP|5F3947A1-23B5-45DD-AFF6-A9285C85CD3E|360||VSSOS|VOL DIST STEADY STATE OBS NORM BY SA||||||||NOT DONE||AMNIOTIC FLUID|||WASHOUT|1965-08-12||1960-06-21|1970-07-14|1965-01-07
TRIAL STUDY 134XCP|PP|AE127EDD-D708-4B1A-95F7-176A541A9584|361||AURCIFPW|AURC INFINITY PRED NORM BY WT||||||||NOT DONE||SUPERNATANT, SERUM OR PLASMA|||INDUCTION TREATMENT|1963-06-08||1969-07-25|1962-07-22|1960-09-19
TRIAL STUDY 134XCP|PP|F642D4A0-A67F-4A10-BB21-E4644E963D45|362||NRENALCL|NONRENAL CL||||||||NOT DONE||CAPILLARY PLASMA|||FOLLOW-UP|1963-10-01||1965-03-06|1963-07-04|1972-10-22
TRIAL STUDY 134XCP|PP|933A6DFF-D519-46F4-AB52-78E6A898E4A1|363||AUCIFOW|AUC INFINITY OBS NORM BY WT||||||||NOT DONE||MECONIUM|||BASELINE|1969-08-03||1961-04-24|1965-02-11|1962-04-06
TRIAL STUDY 134XCP|PP|CF880C64-8AA1-4A19-B8A3-821F3EDF83FD|364||AUMCTAUW|AUMC OVER DOSING INTERVAL NORM BY WT||||||||NOT DONE||CAPILLARY BLOOD|||RUN-IN|1970-03-30||1960-11-07|1965-05-26|1967-11-28
TRIAL STUDY 134XCP|PP|38E177D4-1A58-4E78-90B7-85F76BF66826|365||CLFTAUS|TOTAL CL BY F FOR DOSE INT NORM BY SA||||||||NOT DONE||SPUTUM|||BLINDED TREATMENT|1963-09-02||1969-03-05|1968-07-08|1960-01-19
TRIAL STUDY 134XCP|PP|43EFF4FE-66EE-45FD-8CA1-CDE9404CA2D9|366||CLSTB|LAST NONZERO CONC NORM BY BMI||||||||NOT DONE||DISCHARGE|||BASELINE|1969-02-24||1968-11-04|1960-06-01|1971-04-28
TRIAL STUDY 134XCP|PP|2FC40644-58C4-44B4-AF2A-D1D2EB66980B|367||MRAUCTAU|METABOLITE RATIO FOR AUC DOSING INTERVAL||||||||NOT DONE||INFRANATANT, SERUM|||BASELINE|1967-02-16||1963-11-29|1968-02-13|1968-12-08
TRIAL STUDY 134XCP|PP|50CFC814-7135-4356-BAC2-3F975B9F6AE3|368||CMAXUB|MAX CONC, UNBOUND DRUG||||||||NOT DONE||LYMPH|||TREATMENT|1965-11-30||1965-08-15|1961-08-03|1969-11-12
TRIAL STUDY 134XCP|PP|8A639816-D878-4FD7-AF28-CF9EA2236462|369||VZOS|VZ OBS NORM BY SA||||||||NOT DONE||DIALYSIS FLUID|||OBSERVATION|1969-10-07||1962-10-19|1970-12-11|1968-12-21
TRIAL STUDY 134XCP|PP|AB5AD6EB-8F8D-45B6-9FAB-9B6B43614A19|370||MRAUCINT|METABOLITE RATIO AUC FROM T1 TO T2||||||||NOT DONE||CAPILLARY BLOOD|||BLINDED TREATMENT|1963-09-01||1962-01-10|1965-02-03|1966-03-20
TRIAL STUDY 134XCP|PP|B48ADEF8-4C6D-4DFC-8623-8C677DF57BB3|371||AURCIFPW|AURC INFINITY PRED NORM BY WT||||||||NOT DONE||SERUM OR PLASMA|||SCREENING|1964-05-28||1969-12-19|1967-11-17|1969-04-22
TRIAL STUDY 134XCP|PP|3BF3C4EE-9526-4E22-956C-E72A1D9D9790|372||ERINTB|EXCRET RATE FROM T1 TO T2 NORM BY BMI||||||||NOT DONE||DIALYSIS FLUID|||RUN-IN|1962-06-13||1965-10-17|1972-08-27|1964-05-16
TRIAL STUDY 134XCP|PP|0E9EBFA5-BA5B-4578-945F-4A3F5192BB43|373||VZTAUS|VZ FOR DOSE INT NORM BY SA||||||||NOT DONE||BASAL TEAR|||LONG-TERM FOLLOW-UP|1963-06-08||1964-04-03|1960-04-14|1960-12-19
TRIAL STUDY 134XCP|PP|30419F44-B519-488C-A505-F23D88A46024|374||RCPCINTS|PCT REC FROM T1 TO T2 NORM BY SA||||||||NOT DONE||PLEURAL FLUID|||TREATMENT|1961-01-04||1964-09-04|1961-02-05|1972-04-07
TRIAL STUDY 134XCP|PP|2AF06F66-5E51-4AC9-AF62-A34329724F7D|375||VSSPW|VOL DIST STEADY STATE PRED NORM BY WT||||||||NOT DONE||CORD SERUM|||BLINDED TREATMENT|1960-05-24||1960-10-03|1970-09-16|1960-07-13
TRIAL STUDY 134XCP|PP|DAE5B7A9-FB1D-4743-B6A5-C05FFC9AF829|376||AUCPBEP|AUC %BACK EXTRAPOLATION PRED||||||||NOT DONE||CERVICOVAGINAL SECRETION|||BASELINE|1961-12-28||1968-07-06|1972-10-05|1960-06-16
TRIAL STUDY 134XCP|PP|94F4C997-3114-4444-BF89-E762226AAC89|377||CMAXB|MAX CONC NORM BY BMI||||||||NOT DONE||SUPERNATANT, CEREBROSPINAL FLUID|||OPEN LABEL TREATMENT|1971-09-17||1963-06-08|1968-07-09|1968-02-08
TRIAL STUDY 134XCP|PP|5EBDAAC2-9202-4BE7-BD9A-7CCBBC963DB7|378||AURCLSTB|AURC DOSING TO LAST CONC NORM BY BMI||||||||NOT DONE||ERYTHROCYTES|||OBSERVATION|1968-06-08||1972-05-28|1961-09-11|1965-08-25
TRIAL STUDY 134XCP|PP|D20DE6F0-DA30-4453-8F80-61093BF046A6|379||AUMCIFPB|AUMC INFINITY PRED NORM BY BMI||||||||NOT DONE||EXHALED BREATH CONDENSATE|||RUN-IN|1967-04-07||1960-12-16|1970-09-05|1973-08-25
TRIAL STUDY 134XCP|PP|9F6968CB-46E4-4DF7-B07D-33355B18A5F3|380||MRTIVLST|MRT INTRAVASC TO LAST NONZERO CONC||||||||NOT DONE||HAIR|||RUN-IN|1973-01-23||1971-06-09|1964-03-04|1969-10-11
TRIAL STUDY 134XCP|PP|F20939CF-C668-4514-A2CF-63723560FA46|381||RNCLINTB|RENAL CL FROM T1 TO T2 NORM BY BMI||||||||NOT DONE||MENSTRUAL BLOOD|||FOLLOW-UP|1963-05-02||1960-05-25|1962-08-08|1970-09-29
TRIAL STUDY 134XCP|PP|CECB0ED0-5ADE-46DC-B56B-6AC63A89D791|382||AUCIFOUB|AUC INFINITY OBS, UNBOUND DRUG||||||||NOT DONE||SUPERNATANT, PLEURAL FLUID|||BASELINE|1969-09-22||1971-11-13|1968-06-04|1961-04-01
TRIAL STUDY 134XCP|PP|9A60A414-54A0-4A7F-84EE-FCB8246D2477|383||VSSPB|VOL DIST STEADY STATE PRED NORM BY BMI||||||||NOT DONE||PLATELET POOR PLASMA|||OBSERVATION|1962-02-12||1967-10-05|1965-10-14|1961-06-24
TRIAL STUDY 134XCP|PP|8D546F1C-E719-4C03-A66A-9916EFF2A144|384||VSSOBD|VOL DIST STEADY STATE OBS BY B||||||||NOT DONE||TRANSUDATE|||INDUCTION TREATMENT|1960-12-24||1972-07-30|1969-09-09|1970-11-14
TRIAL STUDY 134XCP|PP|B998085D-F227-46C8-B2D8-37E97BA799D2|385||VZFTAUB|VZ FOR DOSE INT BY F NORM BY BMI||||||||NOT DONE||URINE|||BASELINE|1970-08-30||1960-11-20|1971-12-04|1965-10-03
TRIAL STUDY 134XCP|PP|DDAF2BC7-9329-4528-B1D5-00C8E0D284D9|386||RCAMIFPB|AMT REC INFINITY PRED NORM BY BMI||||||||NOT DONE||GASTRIC FLUID|||FOLLOW-UP|1970-09-11||1970-07-26|1968-11-04|1970-06-05
TRIAL STUDY 134XCP|PP|537CE647-EA58-430C-B37B-F56BF20B5AF0|387||AUCIFP|AUC INFINITY PRED||||||||NOT DONE||VENOUS BLOOD|||BASELINE|1960-05-09||1965-08-02|1963-08-22|1960-07-31
TRIAL STUDY 134XCP|PP|3464201C-9704-40B6-B3B3-2BADE02BD58F|388||AUMCIFO|AUMC INFINITY OBS||||||||NOT DONE||ALVEOLAR AIR|||SCREENING|1969-05-21||1968-08-04|1970-04-03|1969-10-08
TRIAL STUDY 134XCP|PP|1CB9F8AF-8CC3-44B2-8B93-24CADF4225C7|389||AURCIFOW|AURC INFINITY OBS NORM BY WT||||||||NOT DONE||MUSCLE TISSUE|||CONTINUATION TREATMENT|1965-01-29||1966-03-08|1965-04-23|1970-08-28
TRIAL STUDY 134XCP|PP|7E66F52C-0967-4F56-9E1D-C3C3DC7F76FB|390||CLOS|TOTAL CL OBS NORM BY SA||||||||NOT DONE||SUPERNATANT, CEREBROSPINAL FLUID|||OBSERVATION|1969-01-28||1963-09-01|1969-08-08|1967-09-12
TRIAL STUDY 134XCP|PP|916EA783-F2CD-4C42-BA37-EF0F86C2F5DD|391||AUMCTAU|AUMC OVER DOSING INTERVAL||||||||NOT DONE||BONE MARROW|||RUN-IN|1963-04-30||1973-08-31|1970-01-04|1971-10-10
TRIAL STUDY 134XCP|PP|11A6144A-895B-4143-85D2-69952C6D452C|392||AUCPEP|AUC %EXTRAPOLATION PRED||||||||NOT DONE||HAIR|||CONTINUATION TREATMENT|1969-10-05||1963-05-20|1962-02-27|1969-10-26
TRIAL STUDY 134XCP|PP|8958D35E-F685-4542-AE01-625133F1EF7D|393||CLOB|TOTAL CL OBS NORM BY BMI||||||||NOT DONE||BONE MARROW|||TREATMENT|1973-07-08||1972-08-04|1962-02-20|1966-07-26
TRIAL STUDY 134XCP|PP|00982640-C826-4CD4-B927-A311227E63CC|394||RNCLINT|RENAL CL FROM T1 TO T2||||||||NOT DONE||ARTERIAL BLOOD|||LONG-TERM FOLLOW-UP|1966-01-18||1970-09-19|1963-06-11|1961-01-02
TRIAL STUDY 134XCP|PP|C213CAA8-2FAC-402C-A19E-11A60708A71A|395||CLPS|TOTAL CL PRED NORM BY SA||||||||NOT DONE||ARTERIAL CORD BLOOD|||INDUCTION TREATMENT|1969-09-10||1967-06-02|1967-07-20|1973-03-23
TRIAL STUDY 134XCP|PP|F0559682-CD36-4ED0-8082-A54D40305512|396||RCPCIFPB|PCT REC INFINITY PRED NORM BY BMI||||||||NOT DONE||CORD SERUM|||RUN-IN|1972-07-07||1969-07-30|1965-03-11|1968-09-23
TRIAL STUDY 134XCP|PP|C004A4D5-DBD0-4967-9597-8C1653AB8298|397||VZOD|VZ OBS NORM BY DOSE||||||||NOT DONE||MIXED VENOUS BLOOD|||RUN-IN|1961-07-11||1968-11-03|1973-01-13|1964-07-15
TRIAL STUDY 134XCP|PP|ABB838A1-2387-471E-8F50-1F48205BC8EE|398||AUMCTAUW|AUMC OVER DOSING INTERVAL NORM BY WT||||||||NOT DONE||BUFFY COAT|||WASHOUT|1972-11-08||1966-08-02|1967-12-20|1960-04-13
TRIAL STUDY 134XCP|PP|88126417-8564-4659-AA60-63642067113D|399||RCPCIFP|PCT REC INFINITY PRED||||||||NOT DONE||MUSCLE TISSUE|||BASELINE|1965-01-31||1961-12-31|1971-03-19|1960-08-16
TRIAL STUDY 134XCP|PP|6ADA444E-F1B4-4E59-9F2D-26DC78845397|400||C0S|INITIAL CONC NORM BY SA||||||||NOT DONE||LOCHIA|||OPEN LABEL TREATMENT|1963-04-15||1967-01-12|1965-08-25|1968-09-01
TRIAL STUDY 134XCP|PP|85060A90-92F7-4440-AD1C-62A70C2FD5CB|401||AUCTAUW|AUC OVER DOSING INTERVAL NORM BY WT||||||||NOT DONE||ARTERIALIZED CAPILLARY BLOOD|||RUN-IN|1960-02-14||1971-12-20|1967-10-21|1969-03-11
TRIAL STUDY 134XCP|PP|719D483D-67B4-49DE-A86A-CBE7D4CBB8D0|402||CLFOB|TOTAL CL OBS BY F NORM BY BMI||||||||NOT DONE||SPERMATOZOON|||OBSERVATION|1965-09-05||1967-12-28|1971-12-01|1966-03-26
TRIAL STUDY 134XCP|PP|170052E6-031C-48EF-9CE4-CA84ED6B77FF|403||CLP|TOTAL CL PRED||||||||NOT DONE||SUPERNATANT, SERUM|||OPEN LABEL TREATMENT|1969-04-20||1961-08-15|1972-12-03|1960-12-09
TRIAL STUDY 134XCP|PP|D3F628DE-8358-4C2C-B474-763E48719E5E|404||AUCIFO|AUC INFINITY OBS||||||||NOT DONE||CORD BLOOD|||SCREENING|1965-04-16||1972-08-25|1971-11-19|1966-05-10
TRIAL STUDY 134XCP|PP|33137C67-0DA6-49EB-AF5D-6B6AFB44738F|405||AUCIFPW|AUC INFINITY PRED NORM BY WT||||||||NOT DONE||CELL PELLET|||OBSERVATION|1966-06-19||1967-07-26|1961-03-30|1961-04-26
TRIAL STUDY 134XCP|PP|4395486D-C521-4478-9442-68CF0344C6FB|406||AURCIFPD|AURC INFINITY PRED NORM BY DOSE||||||||NOT DONE||PERITONEAL FLUID|||TREATMENT|1972-08-21||1971-04-04|1968-12-10|1960-09-03
TRIAL STUDY 134XCP|PP|4818BCD8-8B7B-46B1-86C5-F5D2067FD317|407||AUMCPEP|AUMC % EXTRAPOLATION PRED||||||||NOT DONE||CEREBROSPINAL FLUID|||TREATMENT|1968-10-06||1965-10-15|1971-02-23|1969-03-26
TRIAL STUDY 134XCP|PP|2E2BF203-2C02-4D9A-AA64-7AE7968282A1|408||RCPCIFPS|PCT REC INFINITY PRED NORM BY SA||||||||NOT DONE||SKELETAL MUSCLE TISSUE|||FOLLOW-UP|1963-01-07||1966-09-26|1970-06-14|1962-12-08
TRIAL STUDY 134XCP|PP|8C5C83B7-2373-4A72-8E55-A779EB08D9A9|409||VZTAUS|VZ FOR DOSE INT NORM BY SA||||||||NOT DONE||SUPERNATANT, SERUM OR PLASMA|||RUN-IN|1973-05-25||1971-05-19|1962-10-23|1972-07-02
TRIAL STUDY 134XCP|PP|19394300-46A6-484F-AE02-50BDD39096E3|410||RCAMTAUW|AMT REC OVER DOSING INTERVAL NORM BY WT||||||||NOT DONE||CEREBROSPINAL FLUID|||BLINDED TREATMENT|1967-09-08||1966-05-15|1967-01-29|1965-09-06
TRIAL STUDY 134XCP|PP|8C89BD60-3504-4F8B-8F33-7F0C949DB407|411||AURCLSTW|AURC DOSING TO LAST CONC NORM BY WT||||||||NOT DONE||SUPERNATANT, PLASMA|||BASELINE|1963-09-07||1964-06-13|1963-10-04|1965-05-23
TRIAL STUDY 134XCP|PP|4746A481-011E-4376-9D2F-5E57F560A6DE|412||RNCLINT|RENAL CL FROM T1 TO T2||||||||NOT DONE||BLOOD|||CONTINUATION TREATMENT|1972-11-11||1962-08-02|1970-02-16|1965-03-08
TRIAL STUDY 134XCP|PP|CE1DB395-A3FC-4F3A-B039-411A6266F7C0|413||AUCINTDW|AUCINT NORM BY DOSE/WT||||||||NOT DONE||PUS|||CONTINUATION TREATMENT|1967-09-17||1969-07-29|1971-05-28|1960-12-16
TRIAL STUDY 134XCP|PP|04F5220E-7A8C-4982-9379-496306612E33|414||AUCINTB|AUC FROM T1 TO T2 NORM BY BMI||||||||NOT DONE||AQUEOUS HUMOR|||LONG-TERM FOLLOW-UP|1969-03-05||1967-05-22|1972-01-02|1960-06-11
TRIAL STUDY 134XCP|PP|2D77B739-5C67-443E-B7A1-5E6E11CFE19B|415||ERMAXD|MAX EXCRETION RATE NORM BY DOSE||||||||NOT DONE||MUSCLE TISSUE|||WASHOUT|1972-02-01||1971-10-01|1969-01-24|1970-01-06
TRIAL STUDY 134XCP|PP|73BDFAA2-6260-4E1D-8039-7523F0C52873|416||VZTAU|VZ FOR DOSE INT||||||||NOT DONE||PLATELET|||OBSERVATION|1967-06-23||1960-12-07|1960-04-10|1972-03-18
TRIAL STUDY 134XCP|PP|147C2E77-A2C5-4219-9BB5-D209813E563B|417||ARAUCIPD|ACCUM RATIO AUCIFP NORM BY DOSE||||||||NOT DONE||PLASMA|||WASHOUT|1960-02-06||1966-03-05|1973-05-11|1967-06-21
TRIAL STUDY 134XCP|PP|880428B0-DFA1-4CD6-B0C5-76D1192D46D6|418||AUMCIFOB|AUMC INFINITY OBS NORM BY BMI||||||||NOT DONE||COLOSTRUM|||WASHOUT|1970-10-11||1967-05-02|1973-03-04|1973-04-12
TRIAL STUDY 134XCP|PP|BDDC8BA7-3EB9-44E8-91CC-D05391C1187E|419||NRENLCLW|NONRENAL CL NORM BY WT||||||||NOT DONE||ENDOTRACHEAL FLUID|||OPEN LABEL TREATMENT|1967-10-17||1968-09-14|1973-07-23|1966-10-23
TRIAL STUDY 134XCP|PP|25E17A89-8A2F-4870-B076-1D32634F5620|420||AUCLSTD|AUC TO LAST NONZERO CONC NORM BY DOSE||||||||NOT DONE||ATHEROSCLEROTIC PLAQUE|||LONG-TERM FOLLOW-UP|1967-12-18||1968-04-25|1971-09-17|1961-01-31
TRIAL STUDY 134XCP|PP|B7B67C06-0802-4E69-A5A1-469213BE7E48|421||CONCDW|CONCENTRATION NORM BY DOSE/WT||||||||NOT DONE||EMESIS|||OBSERVATION|1970-11-07||1960-08-23|1971-01-19|1960-06-11
TRIAL STUDY 134XCP|PP|626E3EA7-423B-434F-89E4-CA076A39B8DB|422||CLOD|TOTAL CL OBS NORM BY DOSE||||||||NOT DONE||REFLEX TEAR|||INDUCTION TREATMENT|1968-01-29||1962-10-04|1972-02-10|1973-05-18
TRIAL STUDY 134XCP|PP|98ED3A38-1E74-470E-BF45-0D1E905BEF36|423||RACONC|RATIO CONCENTRATION||||||||NOT DONE||CERUMEN|||SCREENING|1966-12-07||1971-08-06|1963-11-11|1971-01-13
TRIAL STUDY 134XCP|PP|99DF7819-987E-4E55-89FD-FF49E7C02A5A|424||AUMCPEP|AUMC % EXTRAPOLATION PRED||||||||NOT DONE||EPITHELIAL CELL|||OPEN LABEL TREATMENT|1971-11-27||1963-08-10|1964-06-26|1967-12-06
TRIAL STUDY 134XCP|PP|05481BE7-9309-4356-B46E-9C2525D2C54E|425||CLFPW|TOTAL CL PRED BY F NORM BY WT||||||||NOT DONE||ADIPOSE TISSUE|||INDUCTION TREATMENT|1966-06-27||1970-07-17|1972-02-24|1972-03-10
TRIAL STUDY 134XCP|PP|2F49D512-0A23-4D2D-959B-A1756991E817|426||ARAUCD|ACCUM RATIO AUCTAU NORM BY DOSE||||||||NOT DONE||SYNOVIAL FLUID|||WASHOUT|1963-04-05||1971-03-27|1971-05-22|1973-07-19
TRIAL STUDY 134XCP|PP|E884C56C-1612-49CC-A594-B65E7B354842|427||VZFTAUW|VZ FOR DOSE INT BY F NORM BY WT||||||||NOT DONE||SPERMATOZOON|||RUN-IN|1968-01-18||1969-07-16|1968-12-10|1961-01-11
TRIAL STUDY 134XCP|PP|673EFD33-EEDA-4C97-A9F0-86377D7F8CDF|428||FABS|ABSOLUTE BIOAVAILABILITY||||||||NOT DONE||CERUMEN|||BLINDED TREATMENT|1973-08-22||1965-06-08|1962-09-12|1963-03-15
TRIAL STUDY 134XCP|PP|38AFE156-84DA-4A6D-BF49-9B634D4DD27E|429||VSSOBD|VOL DIST STEADY STATE OBS BY B||||||||NOT DONE||TUMOR TISSUE|||OBSERVATION|1963-02-13||1970-06-11|1972-05-16|1970-04-16
TRIAL STUDY 134XCP|PP|4E8E9ED2-EC93-4023-8F5D-BCD759F92604|430||VZFOB|VZ OBS BY F NORM BY BMI||||||||NOT DONE||CEREBROSPINAL FLUID|||BLINDED TREATMENT|1965-11-26||1961-11-06|1960-06-08|1961-05-06
TRIAL STUDY 134XCP|PP|0B140787-9458-4F66-B7E9-1FAFF239085E|431||VZFPB|VZ PRED BY F NORM BY BMI||||||||NOT DONE||LOCHIA|||RUN-IN|1960-03-03||1963-12-01|1966-09-13|1961-12-24
TRIAL STUDY 134XCP|PP|FB91BADF-308B-4F6A-90D0-032E93E20C4A|432||CLOB|TOTAL CL OBS NORM BY BMI||||||||NOT DONE||EXUDATE|||CONTINUATION TREATMENT|1963-04-20||1961-09-03|1966-11-04|1971-02-08
TRIAL STUDY 134XCP|PP|5ECBD8DD-9C87-4FEC-9BFB-4D026F7870DC|433||CLFTAUS|TOTAL CL BY F FOR DOSE INT NORM BY SA||||||||NOT DONE||LOCHIA|||INDUCTION TREATMENT|1962-03-18||1963-12-22|1972-02-16|1967-01-02
TRIAL STUDY 134XCP|PP|35FD6533-D67E-4A66-BB63-B9FC87E5B1D1|434||CLOW|TOTAL CL OBS NORM BY WT||||||||NOT DONE||TISSUE|||TREATMENT|1963-07-19||1960-09-09|1962-05-18|1965-11-13
TRIAL STUDY 134XCP|PP|3B583022-3A2C-4387-80A5-035E3FD111BD|435||LAMZHL|HALF-LIFE LAMBDA Z||||||||NOT DONE||LYMPH|||FOLLOW-UP|1964-06-26||1962-05-22|1968-02-28|1972-12-22
TRIAL STUDY 134XCP|PP|62435514-5F72-4B2C-A6CE-CD80C06BF5AC|436||RCPCINTS|PCT REC FROM T1 TO T2 NORM BY SA||||||||NOT DONE||BASAL TEAR|||CONTINUATION TREATMENT|1960-03-30||1968-02-06|1968-09-24|1969-07-08
TRIAL STUDY 134XCP|PP|B5370AC4-3185-48DC-B1BC-A00AE8496783|437||RAAUCLST|RATIO AUC TO LAST NONZERO CONC||||||||NOT DONE||MONOCYTE|||OBSERVATION|1970-11-09||1969-08-26|1963-12-25|1966-04-02
TRIAL STUDY 134XCP|PP|1112A903-1F2A-4583-BB9A-41DD206D5B4A|438||RENALCLD|RENAL CL NORM BY DOSE||||||||NOT DONE||EPITHELIAL CELL|||CONTINUATION TREATMENT|1961-09-26||1968-09-25|1963-10-14|1966-02-04
TRIAL STUDY 134XCP|PP|9629DBBC-72CC-4724-B78A-1B0DF9D801C8|439||MRAUCIFO|METABOLITE RATIO FOR AUC INFINITY OBS||||||||NOT DONE||ATHEROSCLEROTIC PLAQUE|||INDUCTION TREATMENT|1971-01-12||1969-09-28|1970-12-21|1964-12-09
TRIAL STUDY 134XCP|PP|D09F047E-E380-453B-875D-FF3C8C5EA839|440||RCAMTAUB|AMT REC OVER DOSING INTERVAL NORM BY BMI||||||||NOT DONE||CEREBROSPINAL FLUID|||BASELINE|1964-05-08||1962-01-19|1972-08-10|1965-01-22
TRIAL STUDY 134XCP|PP|E1B16559-B9CA-4B14-A77A-4AD546EF5262|441||MAT|MEAN ABSORPTION TIME||||||||NOT DONE||SEMEN|||BLINDED TREATMENT|1963-12-06||1963-12-13|1961-09-01|1971-04-05
TRIAL STUDY 134XCP|PP|9B2E46E3-B769-40D8-8484-DA3D2BFF2EAA|442||AUCALLS|AUC ALL NORM BY SA||||||||NOT DONE||STOOL|||INDUCTION TREATMENT|1968-03-05||1971-10-30|1971-04-25|1964-11-18
TRIAL STUDY 134XCP|PP|7541A7A7-9A6D-4973-80B6-D4D85459C4D2|443||AUCTAUDW|AUCTAU NORM BY DOSE/WT||||||||NOT DONE||CALCULUS|||LONG-TERM FOLLOW-UP|1971-12-12||1969-11-23|1970-05-28|1960-08-12
TRIAL STUDY 134XCP|PP|0EEE28CE-22B1-4908-9FCE-CE8BB4ED12D8|444||MRTEVIFO|MRT EXTRAVASC INFINITY OBS||||||||NOT DONE||MUSCLE TISSUE|||OBSERVATION|1970-04-23||1965-04-11|1960-06-19|1960-09-10
TRIAL STUDY 134XCP|PP|44199000-F1B7-4187-9E5A-AA5F69E831C3|445||CAVGDW|AVERAGE CONCENTRATION NORM BY DOSE/WT||||||||NOT DONE||SPERMATOZOON|||RUN-IN|1967-09-26||1966-01-10|1969-11-26|1967-12-25
TRIAL STUDY 134XCP|PP|1D487F49-92DB-4132-BD95-1B8797594DE7|446||AUMCLSTD|AUMC TO LAST NONZERO CONC NORM BY DOSE||||||||NOT DONE||BILE|||OBSERVATION|1965-12-31||1970-04-04|1966-01-11|1970-11-20
TRIAL STUDY 134XCP|PP|D282956F-CE78-4E8D-B99C-A3D75E09D2F5|447||CLFPB|TOTAL CL PRED BY F NORM BY BMI||||||||NOT DONE||ARTERIAL CORD BLOOD|||BLINDED TREATMENT|1964-07-02||1969-12-30|1970-01-15|1971-10-30
TRIAL STUDY 134XCP|PP|C0A58AAC-7317-4204-9C9D-974DB1BB38EF|448||FREXINT|FRACT EXCR FROM T1 TO T2||||||||NOT DONE||STOOL|||TREATMENT|1972-09-29||1965-08-03|1967-04-03|1973-06-13
TRIAL STUDY 134XCP|PP|B4AA4759-A825-4E0A-B55D-39B8F473B6A5|449||RCAMINTS|AMT REC FROM T1 TO T2 NORM BY SA||||||||NOT DONE||STOOL|||BASELINE|1961-09-13||1967-03-31|1960-09-16|1968-01-31
TRIAL STUDY 134XCP|PP|33233744-4E16-437D-852B-B5F2CCC94B1A|450||AUCIFOUB|AUC INFINITY OBS, UNBOUND DRUG||||||||NOT DONE||ALVEOLAR AIR|||TREATMENT|1967-02-26||1970-01-07|1972-07-18|1965-12-05
TRIAL STUDY 134XCP|PP|B27DC754-F6E2-41E3-9804-0F92AE0006B4|451||VZP|VZ PRED||||||||NOT DONE||HAIR|||INDUCTION TREATMENT|1960-06-08||1964-12-30|1967-10-03|1961-01-02
TRIAL STUDY 134XCP|PP|7C02E71C-2BCF-4F4A-BC4C-1A7C72264CE6|452||CONCS|CONC BY SA||||||||NOT DONE||ATHEROSCLEROTIC PLAQUE|||SCREENING|1969-10-28||1969-06-02|1965-08-03|1968-09-08
TRIAL STUDY 134XCP|PP|BDE843D8-2F69-4542-BC47-D52302FD4898|453||CLFOD|TOTAL CL OBS BY F NORM BY DOSE||||||||NOT DONE||SALIVA|||SCREENING|1966-12-31||1968-06-23|1967-06-13|1961-07-22
TRIAL STUDY 134XCP|PP|A8C8CB0C-C575-414C-BF1C-846361DB03BC|454||AURCALL|AURC ALL||||||||NOT DONE||URINE|||LONG-TERM FOLLOW-UP|1969-07-26||1965-07-23|1971-07-01|1966-03-05
TRIAL STUDY 134XCP|PP|77CD8958-0AEF-463F-8F72-2BD24B23AD3A|455||ERMAXW|MAX EXCRETION RATE NORM BY WT||||||||NOT DONE||SUPERNATANT, CEREBROSPINAL FLUID|||FOLLOW-UP|1965-05-27||1960-09-07|1967-07-02|1968-06-26
TRIAL STUDY 134XCP|PP|86198851-0F45-45E0-A0CE-C50FEC078456|456||ERINTD|EXCRET RATE FROM T1 TO T2 NORM BY DOSE||||||||NOT DONE||ARTERIALIZED CAPILLARY BLOOD|||OBSERVATION|1971-10-17||1971-06-26|1964-05-03|1973-01-02
TRIAL STUDY 134XCP|PP|9CD28016-BED9-4159-9C1B-60821D74615B|457||RAAUC|RATIO AUC||||||||NOT DONE||STRIATED MUSCLE TISSUE|||INDUCTION TREATMENT|1971-03-12||1960-04-25|1961-05-28|1973-04-11
TRIAL STUDY 134XCP|PP|BE578D25-C23E-416F-8A57-C901F7B58596|458||VSSOF|VOL DIST STEADY STATE OBS BY F||||||||NOT DONE||PROSTATIC FLUID|||OPEN LABEL TREATMENT|1973-08-24||1961-03-31|1964-10-27|1963-12-06
TRIAL STUDY 134XCP|PP|A60D5FE6-26BA-487D-98E0-5F464305924C|459||CMINB|MIN CONC NORM BY BMI||||||||NOT DONE||EXUDATE|||CONTINUATION TREATMENT|1961-03-28||1968-08-21|1971-06-23|1967-02-14
TRIAL STUDY 134XCP|PP|1984ECA3-6E24-44F0-AEDA-FC9772B60F82|460||C0D|INITIAL CONC NORM BY DOSE||||||||NOT DONE||VENOUS BLOOD|||BASELINE|1964-12-03||1964-01-22|1960-10-01|1960-03-08
TRIAL STUDY 134XCP|PP|89739AE0-A8B9-44DE-970E-9D679ED58C4F|461||RCAMTAUB|AMT REC OVER DOSING INTERVAL NORM BY BMI||||||||NOT DONE||CIRCULATING TUMOR CELL|||OBSERVATION|1965-11-30||1963-02-21|1965-09-23|1973-06-20
TRIAL STUDY 134XCP|PP|FEDCB4C0-17C0-4252-A09E-602D7D863FF8|462||AUCLSTW|AUC TO LAST NONZERO CONC NORM BY WT||||||||NOT DONE||SOFT TISSUE|||OPEN LABEL TREATMENT|1961-02-28||1966-02-13|1966-03-06|1967-03-18
TRIAL STUDY 134XCP|PP|2ABA4AB2-E2E5-4C24-B73B-389EBB7EF427|463||RENCLTAU|RENAL CL FOR DOSE INT||||||||NOT DONE||TISSUE|||CONTINUATION TREATMENT|1969-07-08||1965-04-30|1961-10-01|1963-05-25
TRIAL STUDY 134XCP|PP|CED88848-769E-41C1-9ACD-99E45766D27B|464||CMIN|MIN CONC||||||||NOT DONE||PERSPIRATION|||BASELINE|1967-04-27||1964-08-04|1973-03-31|1970-03-05
TRIAL STUDY 134XCP|PP|E7958F8B-D987-4929-993A-8960EB30A309|465||AUCIFOLN|AUC INFINITY OBS LN TRANSFORMED||||||||NOT DONE||EPIDERMAL TISSUE|||TREATMENT|1970-10-01||1969-08-02|1970-04-14|1968-01-17
TRIAL STUDY 134XCP|PP|A633D973-B611-4014-A43E-C8C2D21DBFC2|466||MRCMAX|METABOLITE RATIO FOR MAX CONC||||||||NOT DONE||ARTERIAL BLOOD|||SCREENING|1961-06-23||1970-11-20|1964-06-14|1960-11-03
TRIAL STUDY 134XCP|PP|6F8063F9-DA4E-42F9-941B-3AA78FDE69F7|467||AURCIFOB|AURC INFINITY OBS NORM BY BMI||||||||NOT DONE||SYNOVIAL FLUID|||LONG-TERM FOLLOW-UP|1960-09-29||1968-08-02|1967-07-19|1961-09-06
TRIAL STUDY 134XCP|PP|FABDB6DB-1E35-4B0E-9D79-9F1207A3B0A6|468||AURCIFOW|AURC INFINITY OBS NORM BY WT||||||||NOT DONE||LUNG SURFACTANT|||FOLLOW-UP|1969-11-12||1960-02-10|1961-01-28|1968-05-07
TRIAL STUDY 134XCP|PP|264AA652-A25E-43CE-A54F-6FEB54AB62F3|469||LAMZSPN|LAMBDA Z SPAN||||||||NOT DONE||TISSUE|||OBSERVATION|1963-06-27||1963-08-12|1970-12-15|1970-05-19
TRIAL STUDY 134XCP|PP|4DE042DC-2F1E-425C-BA36-F64A3493CE76|470||VZPUB|VZ PRED FOR UB||||||||NOT DONE||INFRANATANT, PLEURAL FLUID|||SCREENING|1972-09-15||1962-02-22|1969-04-21|1968-10-19
TRIAL STUDY 134XCP|PP|872942E9-A575-4929-9B21-D30DE51B367B|471||RCAMIFPS|AMT REC INFINITY PRED NORM BY SA||||||||NOT DONE||ISOLATE|||FOLLOW-UP|1961-02-05||1968-12-12|1969-07-11|1960-05-03
TRIAL STUDY 134XCP|PP|628822F3-4983-44F8-B98D-7A35AAFF2962|472||AURCIFOD|AURC INFINITY OBS NORM BY DOSE||||||||NOT DONE||CERVICOVAGINAL SECRETION|||RUN-IN|1965-02-26||1969-02-08|1964-06-04|1965-09-07
TRIAL STUDY 134XCP|PP|E711F224-DE78-4B2E-9BF7-A5FEAAC4AB1A|473||AUMCTAUB|AUMC OVER DOSING INTERVAL NORM BY BMI||||||||NOT DONE||SPUTUM|||WASHOUT|1964-12-15||1961-07-30|1962-11-04|1962-08-11
TRIAL STUDY 134XCP|PP|6045DFAB-0734-4E6D-A492-34BD613EC783|474||LAMZLTAU|LAMBDA Z LOWER LIMIT TAU||||||||NOT DONE||STOOL|||SCREENING|1960-05-16||1965-03-14|1966-02-20|1968-10-17
TRIAL STUDY 134XCP|PP|482F0519-E738-46DE-A5C4-4AC76B6E7011|475||ERLST|LAST MEAS EXCRETION RATE||||||||NOT DONE||SALIVA|||BLINDED TREATMENT|1973-07-15||1961-01-06|1966-08-17|1973-07-01
TRIAL STUDY 134XCP|PP|DFDD42F5-749C-4AF0-8351-780DB9614F61|476||CONCB|CONC BY BMI||||||||NOT DONE||PLASMA ULTRAFILTRATE|||OPEN LABEL TREATMENT|1973-08-09||1961-02-09|1966-01-15|1973-08-14
TRIAL STUDY 134XCP|PP|34BCECC4-8420-4B88-BD2E-0A20C4DCC5E0|477||CONCS|CONC BY SA||||||||NOT DONE||ARTERIALIZED CAPILLARY BLOOD|||WASHOUT|1963-02-12||1969-03-08|1971-07-28|1965-10-31
TRIAL STUDY 134XCP|PP|4C4DCB9C-A2FB-4648-B2EF-DD484D221099|478||VSSPBD|VOL DIST STEADY STATE PRED BY B||||||||NOT DONE||BONE MARROW MONONUCLEAR CELL|||FOLLOW-UP|1968-02-25||1961-09-22|1969-01-03|1962-01-08
TRIAL STUDY 134XCP|PP|E0434C66-0F59-476F-9913-55766C4AED1B|479||ERINTB|EXCRET RATE FROM T1 TO T2 NORM BY BMI||||||||NOT DONE||VENOUS BLOOD|||TREATMENT|1972-02-09||1967-08-18|1967-02-27|1966-07-30
TRIAL STUDY 134XCP|PP|60B57F98-61FF-4322-8084-7A536964F60A|480||VZTAUS|VZ FOR DOSE INT NORM BY SA||||||||NOT DONE||KERATINOCYTE|||OBSERVATION|1966-01-05||1972-11-02|1961-10-08|1963-02-08
TRIAL STUDY 134XCP|PP|C79CA198-24E2-4A76-8C32-F3AA973EA41E|481||ERINTS|EXCRET RATE FROM T1 TO T2 NORM BY SA||||||||NOT DONE||SMEGMA|||LONG-TERM FOLLOW-UP|1965-07-29||1965-11-23|1964-10-08|1961-09-06
TRIAL STUDY 134XCP|PP|D250194D-9BBD-40D3-A13B-BBCEB53DB450|482||V0|VOL DIST INITIAL||||||||NOT DONE||LUNG SURFACTANT|||FOLLOW-UP|1962-08-17||1972-05-24|1973-04-19|1969-10-10
TRIAL STUDY 134XCP|PP|369AE0AF-8693-4363-9A6E-CD30567BD614|483||NRENLCLB|NONRENAL CL NORM BY BMI||||||||NOT DONE||COLOSTRUM|||WASHOUT|1973-03-20||1965-11-22|1961-03-29|1966-08-09
TRIAL STUDY 134XCP|PP|4497DB94-5B91-4169-9D73-73EE5C1D9B76|484||ERLSTB|LAST MEAS EXCRETION RATE NORM BY BMI||||||||NOT DONE||PERIPHERAL BLOOD MONONUCLEAR CELL|||BLINDED TREATMENT|1966-09-23||1969-11-05|1965-05-20|1972-11-21
TRIAL STUDY 134XCP|PP|487D7E2D-6E7E-4A5E-ADC7-72B888746263|485||RNCLINT|RENAL CL FROM T1 TO T2||||||||NOT DONE||PROSTATIC FLUID|||BLINDED TREATMENT|1970-09-16||1973-01-28|1969-02-02|1962-08-31
TRIAL STUDY 134XCP|PP|7A0B521C-9CAB-4415-87C3-AF7A33AE9895|486||KDIST|K SLOPE OF DISTRIBUTION||||||||NOT DONE||PLEURAL FLUID|||SCREENING|1964-04-24||1967-01-13|1960-01-21|1967-07-18
TRIAL STUDY 134XCP|PP|EA12FF8E-3FA0-4C21-8FA4-FFC1D6817D3A|487||AUCPEO|AUC %EXTRAPOLATION OBS||||||||NOT DONE||SKIN TISSUE|||OBSERVATION|1966-10-09||1973-07-12|1963-06-08|1970-02-20
TRIAL STUDY 134XCP|PP|8BF6E538-2F39-48E4-B115-AE1693843BBC|488||RENALCLD|RENAL CL NORM BY DOSE||||||||NOT DONE||INFRANATANT, SERUM|||RUN-IN|1972-12-24||1961-02-17|1960-03-11|1960-02-06
TRIAL STUDY 134XCP|PP|57F001BC-36EB-44AF-9487-373FA31B7311|489||AUCIFO|AUC INFINITY OBS||||||||NOT DONE||RETICULOCYTES|||LONG-TERM FOLLOW-UP|1960-09-19||1963-06-15|1963-07-03|1963-03-24
TRIAL STUDY 134XCP|PP|3FBDC961-EB02-4B28-8672-2A0A0A33529E|490||EFFHL|EFFECTIVE HALF-LIFE||||||||NOT DONE||SYNOVIAL FLUID|||CONTINUATION TREATMENT|1963-01-29||1963-03-04|1960-09-18|1968-06-07
TRIAL STUDY 134XCP|PP|1B524FC4-365B-4A16-A4D7-ED818C6E6086|491||RCAMIFP|AMT REC INFINITY PRED||||||||NOT DONE||PLATELET|||BASELINE|1969-04-16||1973-08-06|1964-09-03|1969-09-19
TRIAL STUDY 134XCP|PP|CC020A55-6788-43C6-9D9F-91EFA1ECD46C|492||ERLSTW|LAST MEAS EXCRETION RATE NORM BY WT||||||||NOT DONE||BREAST MILK|||TREATMENT|1968-07-12||1964-01-01|1962-04-06|1972-10-16
TRIAL STUDY 134XCP|PP|27671577-2C6D-429F-BED9-0EDAB15CCB33|493||MRAUCIFO|METABOLITE RATIO FOR AUC INFINITY OBS||||||||NOT DONE||BASAL TEAR|||INDUCTION TREATMENT|1969-03-12||1966-07-23|1970-04-14|1971-06-19
TRIAL STUDY 134XCP|PP|CD69750D-957B-405C-A397-AFA331D30535|494||FU|FRACTION UNBOUND||||||||NOT DONE||ARTERIAL CORD BLOOD|||TREATMENT|1965-05-20||1966-11-09|1973-05-09|1971-01-31
TRIAL STUDY 134XCP|PP|5BFDDFC2-7D15-4B01-8140-62376D160EF0|495||AUMCIFOB|AUMC INFINITY OBS NORM BY BMI||||||||NOT DONE||SERUM|||FOLLOW-UP|1970-01-18||1973-06-08|1970-03-04|1963-07-21
TRIAL STUDY 134XCP|PP|DEA8E573-2709-41F9-AB0D-8C39F5169B48|496||AUCTAUDW|AUCTAU NORM BY DOSE/WT||||||||NOT DONE||EXUDATE|||CONTINUATION TREATMENT|1963-06-14||1964-11-22|1964-12-09|1966-01-24
TRIAL STUDY 134XCP|PP|7A5D0D82-4B9C-47A8-8BB1-C3DB4525942F|497||LAMZUL|LAMBDA Z UPPER LIMIT||||||||NOT DONE||CALCULUS|||OBSERVATION|1973-07-19||1960-04-06|1961-07-19|1969-12-29
TRIAL STUDY 134XCP|PP|77CF8795-CFF5-40C6-A811-624972806A38|498||ERMAXW|MAX EXCRETION RATE NORM BY WT||||||||NOT DONE||LAVAGE FLUID|||BLINDED TREATMENT|1966-01-13||1967-12-26|1961-06-10|1962-04-29
TRIAL STUDY 134XCP|PP|D43B827C-D393-41D4-81C5-AACB1A7673A1|499||RCPCIFOB|PCT REC INFINITY OBS NORM BY BMI||||||||NOT DONE||SERUM|||CONTINUATION TREATMENT|1964-05-20||1969-06-23|1964-03-03|1964-07-11
TRIAL STUDY 134XCP|PP|6F4B91C6-AFBB-49B6-BF12-22DD1B04F161|500||CLFTAUB|TOTAL CL BY F FOR DOSE INT NORM BY BMI||||||||NOT DONE||INFRANATANT, PLASMA|||RUN-IN|1962-01-13||1961-06-21|1970-03-28|1972-06-28
TRIAL STUDY 134XCP|PP|0671FB62-42B8-4882-93ED-0E11CFE07DE9|501||DISTHL|HALF-LIFE DISTRIBUTION||||||||NOT DONE||BREAST MILK|||TREATMENT|1969-03-25||1961-08-19|1967-07-13|1965-10-01
TRIAL STUDY 134XCP|PP|BB1EBF44-CC91-4B86-91E5-2B1000161DFD|502||CONC|CONCENTRATION||||||||NOT DONE||GASTRIC FLUID|||BLINDED TREATMENT|1972-03-25||1960-10-21|1965-02-16|1968-05-30
TRIAL STUDY 134XCP|PP|E9161164-3B91-4855-AFBA-12C6BD93F95F|503||CMAXLN|MAX CONC LN TRANSFORMED||||||||NOT DONE||SWABBED MATERIAL|||BLINDED TREATMENT|1972-01-31||1967-05-04|1969-07-04|1970-11-21
TRIAL STUDY 134XCP|PP|FBB66C13-05F5-4337-B34A-9900EB5F50F3|504||VOLPK|SUM OF URINE VOL||||||||NOT DONE||CAPILLARY BLOOD|||RUN-IN|1960-07-14||1973-09-02|1970-04-13|1969-11-26
TRIAL STUDY 134XCP|PP|FCBAAB24-FEC0-46F2-AA07-99B20123E67C|505||TMAX|TIME OF CMAX||||||||NOT DONE||SERUM OR PLASMA OR BLOOD|||LONG-TERM FOLLOW-UP|1960-07-25||1961-02-19|1972-09-26|1962-12-28
TRIAL STUDY 134XCP|PP|2F1EE4FC-4E1F-4BB7-81AA-5AE6133A75A9|506||ERINTD|EXCRET RATE FROM T1 TO T2 NORM BY DOSE||||||||NOT DONE||CERUMEN|||SCREENING|1966-07-02||1971-03-28|1963-02-23|1973-03-26
TRIAL STUDY 134XCP|PP|21223189-5527-4B3F-AFD5-21F77AC0DEBE|507||AURCLSTD|AURC DOSING TO LAST CONC NORM BY DOSE||||||||NOT DONE||VENOUS CORD BLOOD|||BLINDED TREATMENT|1962-05-29||1963-01-21|1968-07-25|1968-06-27
TRIAL STUDY 134XCP|PP|CA6ECC17-3E3B-435C-A485-8612C267E52B|508||AUCTAUD|AUC OVER DOSING INTERVAL NORM BY DOSE||||||||NOT DONE||VENOUS CORD BLOOD|||SCREENING|1965-12-30||1962-08-16|1960-12-09|1967-11-11
TRIAL STUDY 134XCP|PP|BCB41507-87B3-4773-B1E5-AE039853DED0|509||CLFPW|TOTAL CL PRED BY F NORM BY WT||||||||NOT DONE||PLEURAL FLUID|||LONG-TERM FOLLOW-UP|1966-12-09||1962-07-27|1960-04-18|1971-09-10
TRIAL STUDY 134XCP|PP|A8F9A1A9-2348-4E0E-93E5-E11A9EBDE02A|510||RCAMTAU|AMT REC OVER DOSING INTERVAL||||||||NOT DONE||HAIR FOLLICLE|||OPEN LABEL TREATMENT|1962-03-25||1960-09-17|1964-07-08|1968-12-01
TRIAL STUDY 134XCP|PP|EC726B09-0B0F-4933-94F4-8941DF68EDE6|511||RCPCINTB|PCT REC FROM T1 TO T2 NORM BY BMI||||||||NOT DONE||MONOCYTE|||TREATMENT|1967-04-10||1970-02-15|1963-12-10|1964-05-21
TRIAL STUDY 134XCP|PP|9F703096-9152-422E-AEAB-AD22F00863ED|512||RCPCINT|PCT REC FROM T1 TO T2||||||||NOT DONE||MENSTRUAL BLOOD|||CONTINUATION TREATMENT|1961-07-11||1960-05-13|1961-08-27|1973-01-15
TRIAL STUDY 134XCP|PP|57455593-8872-4B17-8B3F-8A02FE855290|513||RCPCLST|PCT REC TO LAST NONZERO CONC||||||||NOT DONE||SMOOTH MUSCLE TISSUE|||WASHOUT|1962-06-26||1961-03-22|1962-01-02|1972-02-18
TRIAL STUDY 134XCP|PP|97F58005-7367-49DC-967B-FAD681B55DF8|514||AUCIFPD|AUC INFINITY PRED NORM BY DOSE||||||||NOT DONE||SYNOVIAL FLUID|||CONTINUATION TREATMENT|1963-09-27||1966-01-06|1972-09-11|1965-08-31
TRIAL STUDY 134XCP|PP|83AC0828-3C22-4F7C-9D22-F044BB5B630D|515||AURCIFOW|AURC INFINITY OBS NORM BY WT||||||||NOT DONE||FLUID|||RUN-IN|1968-04-21||1971-04-20|1966-07-31|1963-06-20
TRIAL STUDY 134XCP|PP|1C380A81-79B1-48EA-9C50-9B1E3B401BCC|516||CAVGD|AVERAGE CONC NORM BY DOSE||||||||NOT DONE||BLOOD|||TREATMENT|1968-03-16||1964-01-09|1970-11-27|1960-10-11
TRIAL STUDY 134XCP|PP|E22C5D53-74B1-402F-9A9C-3E48F1A9AD5E|517||C0|INITIAL CONC||||||||NOT DONE||ARTERIALIZED CAPILLARY BLOOD|||FOLLOW-UP|1966-11-25||1969-03-16|1961-08-12|1973-08-04
TRIAL STUDY 134XCP|PP|B386B813-1175-4421-9C86-F9AB597877FA|518||VSSOW|VOL DIST STEADY STATE OBS NORM BY WT||||||||NOT DONE||PLATELET|||BASELINE|1965-09-29||1960-01-27|1968-01-15|1965-04-29
TRIAL STUDY 134XCP|PP|5ADBD73B-1E68-466B-8CF6-D7FB85D80906|519||CLOB|TOTAL CL OBS NORM BY BMI||||||||NOT DONE||ARTERIAL BLOOD|||OPEN LABEL TREATMENT|1965-03-24||1963-04-28|1961-08-29|1964-12-24
TRIAL STUDY 134XCP|PP|7B33775D-1DFF-49A6-820E-7981F5C16AFF|520||AUMCIFO|AUMC INFINITY OBS||||||||NOT DONE||PERITONEAL FLUID|||SCREENING|1969-06-11||1973-01-24|1966-10-06|1968-04-30
TRIAL STUDY 134XCP|PP|DC48DD03-B87E-422D-A2EE-D87342260E19|521||CAVGD|AVERAGE CONC NORM BY DOSE||||||||NOT DONE||EXUDATE|||SCREENING|1965-02-02||1972-01-14|1962-07-19|1964-10-28
TRIAL STUDY 134XCP|PP|2E084441-61A3-4B8B-9050-A5D7B38CA978|522||RENALCLB|RENAL CL NORM BY BMI||||||||NOT DONE||ISOLATE|||OBSERVATION|1961-05-24||1970-02-05|1972-05-23|1961-09-24
TRIAL STUDY 134XCP|PP|601D563B-AA21-4859-A87E-B2068C1E3F53|523||FREXINT|FRACT EXCR FROM T1 TO T2||||||||NOT DONE||URINE SEDIMENT|||BASELINE|1961-05-02||1970-12-10|1967-08-25|1965-05-15
TRIAL STUDY 134XCP|PP|D8FE5979-24C7-478F-8612-0102F28F5ADE|524||VSSOW|VOL DIST STEADY STATE OBS NORM BY WT||||||||NOT DONE||URINE SEDIMENT|||BASELINE|1967-12-11||1970-09-01|1966-01-31|1969-01-29
TRIAL STUDY 134XCP|PP|D275315F-D3C5-4260-8BD6-37DDB67262B0|525||LAMZ|LAMBDA Z||||||||NOT DONE||SUPERNATANT, SERUM|||OBSERVATION|1969-11-03||1971-07-19|1962-04-19|1967-04-23
TRIAL STUDY 134XCP|PP|34127CD2-378B-4335-AD4B-F305D0A21AF4|526||VZFPB|VZ PRED BY F NORM BY BMI||||||||NOT DONE||ENDOMETRIAL TISSUE|||FOLLOW-UP|1970-09-06||1973-06-21|1962-12-09|1961-01-25
TRIAL STUDY 134XCP|PP|6A15A97E-5B6F-483A-A9C7-94AC81B977A3|527||AUMCIFPD|AUMC INFINITY PRED NORM BY DOSE||||||||NOT DONE||BONE|||CONTINUATION TREATMENT|1970-04-22||1963-10-25|1961-01-12|1967-09-10
TRIAL STUDY 134XCP|PP|6EE04A90-681B-439E-9783-04B40A4AF240|528||AUMCTAUS|AUMC OVER DOSING INTERVAL NORM BY SA||||||||NOT DONE||ERYTHROCYTES|||LONG-TERM FOLLOW-UP|1969-07-17||1964-08-02|1960-08-30|1970-02-12
TRIAL STUDY 134XCP|PP|A5C0B034-1226-40EE-87E3-D46A7342B550|529||ERLSTS|LAST MEAS EXCRETION RATE NORM BY SA||||||||NOT DONE||CERUMEN|||WASHOUT|1962-09-04||1961-03-05|1960-04-05|1965-06-20
TRIAL STUDY 134XCP|PP|215DE9E0-6E47-448D-BE13-7CF5DB1A3865|530||ERMAXB|MAX EXCRETION RATE NORM BY BMI||||||||NOT DONE||GASTRIC CONTENTS|||OBSERVATION|1965-08-20||1963-02-27|1963-11-20|1961-04-24
TRIAL STUDY 134XCP|PP|A99FE1E2-ED93-4550-9AE7-3AC117D8619B|531||MRAUCINT|METABOLITE RATIO AUC FROM T1 TO T2||||||||NOT DONE||INTERSTITIAL FLUID|||INDUCTION TREATMENT|1964-08-25||1973-06-14|1963-07-06|1963-09-23
TRIAL STUDY 134XCP|PP|2360DE4B-4EF2-4ECA-8663-9DA9306F1DB7|532||AUMCIFPS|AUMC INFINITY PRED NORM BY SA||||||||NOT DONE||MONOCYTE|||FOLLOW-UP|1964-04-15||1972-05-16|1962-12-15|1971-03-07
TRIAL STUDY 134XCP|PP|D58A8C37-6659-4B00-8BED-256E8754F93C|533||C0W|INITIAL CONC NORM BY WT||||||||NOT DONE||CIRCULATING TUMOR CELL|||RUN-IN|1963-10-25||1971-08-16|1971-03-15|1963-06-23
TRIAL STUDY 134XCP|PP|F2649193-70EA-4B76-A08C-EBAFE4FE69BD|534||VZP|VZ PRED||||||||NOT DONE||PLATELET POOR PLASMA|||SCREENING|1963-05-28||1961-10-14|1969-09-25|1966-01-16
TRIAL STUDY 134XCP|PP|5440F45F-C220-46E7-8354-6AF34A003E5E|535||CTROUGHB|CONC TROUGH BY BMI||||||||NOT DONE||PLATELET|||RUN-IN|1966-05-17||1967-07-08|1960-02-09|1969-02-03
TRIAL STUDY 134XCP|PP|3B6FE075-9BC0-48D8-8DE9-0D3FB82B4B0C|536||AURCALLB|AURC ALL NORM BY BMI||||||||NOT DONE||ADIPOSE TISSUE|||SCREENING|1968-08-14||1972-02-20|1965-05-16|1960-05-12
TRIAL STUDY 134XCP|PP|A83EFC3A-F107-4FCE-96E7-0C327244F2F5|537||AUCINTW|AUC FROM T1 TO T2 NORM BY WT||||||||NOT DONE||DISCHARGE|||SCREENING|1964-07-19||1960-11-09|1967-08-23|1965-07-25
TRIAL STUDY 134XCP|PP|274C7FAB-FC7F-4D2E-A2C4-32C202EB7A59|538||AUCINTW|AUC FROM T1 TO T2 NORM BY WT||||||||NOT DONE||ENDOMETRIAL TISSUE|||BLINDED TREATMENT|1964-07-03||1968-04-06|1968-05-16|1973-01-10
TRIAL STUDY 134XCP|PP|EA7375B6-38F0-49AE-8AD7-65CB0D30147B|539||AURCINTB|AURC FROM T1 TO T2 NORM BY BMI||||||||NOT DONE||LEUKOCYTE|||CONTINUATION TREATMENT|1963-11-17||1968-06-21|1971-05-01|1965-08-17
TRIAL STUDY 134XCP|PP|78FC925A-2702-41B4-8F7D-D20AB74EE8A9|540||VZPS|VZ PRED NORM BY SA||||||||NOT DONE||PERITONEAL FLUID|||FOLLOW-UP|1965-01-24||1973-04-17|1966-01-08|1971-10-30
TRIAL STUDY 134XCP|PP|1E9C7E41-8565-4C60-9EEB-814914081596|541||ARCMAXD|ACCUM RATIO CMAX NORM BY DOSE||||||||NOT DONE||CEREBROSPINAL FLUID|||BASELINE|1961-07-15||1965-02-24|1963-02-10|1965-10-11
TRIAL STUDY 134XCP|PP|D7A008CF-5990-4D74-934A-A4DD3180EBD4|542||AURCINTB|AURC FROM T1 TO T2 NORM BY BMI||||||||NOT DONE||INFRANATANT, SERUM|||TREATMENT|1967-02-20||1971-12-31|1963-12-14|1961-11-16
TRIAL STUDY 134XCP|PP|C168FA23-40EE-46D8-9A56-8B80490A0EFB|543||CLFTAUS|TOTAL CL BY F FOR DOSE INT NORM BY SA||||||||NOT DONE||CORD SERUM|||TREATMENT|1962-09-22||1961-11-23|1970-08-31|1963-01-11
TRIAL STUDY 134XCP|PP|215E4E69-70C3-493C-9D67-F717363E8138|544||RNCLINTW|RENAL CL FROM T1 TO T2 NORM BY WT||||||||NOT DONE||AQUEOUS HUMOR|||CONTINUATION TREATMENT|1962-11-24||1960-09-13|1972-06-16|1963-05-26
TRIAL STUDY 134XCP|PP|962CD4CA-AF22-42FB-ADB5-85F76850CA81|545||MRAUCTAU|METABOLITE RATIO FOR AUC DOSING INTERVAL||||||||NOT DONE||INFRANATANT, SERUM|||FOLLOW-UP|1963-02-05||1966-04-28|1971-03-14|1971-08-02
TRIAL STUDY 134XCP|PP|B77019D6-644D-4FAF-ACBF-B4DEB4C12792|546||AUMCIFOS|AUMC INFINITY OBS NORM BY SA||||||||NOT DONE||PLATELET|||BASELINE|1967-03-01||1967-10-14|1962-08-04|1962-03-11
TRIAL STUDY 134XCP|PP|681FAE2B-387D-4B58-B2A6-4682B9F18EAD|547||AUMCLSTS|AUMC TO LAST NONZERO CONC NORM BY SA||||||||NOT DONE||SUPERNATANT, PLASMA|||LONG-TERM FOLLOW-UP|1965-08-30||1960-03-11|1963-04-17|1961-10-22
TRIAL STUDY 134XCP|PP|EC3C1DFC-5FA4-4F2E-9486-C2D17486EEF7|548||CTROUGH|CONC TROUGH||||||||NOT DONE||PLATELET POOR PLASMA|||RUN-IN|1968-12-13||1970-04-23|1966-10-25|1971-04-22
TRIAL STUDY 134XCP|PP|4A5A02C2-F875-4146-B58D-9E0E4F00527D|549||VZFPS|VZ PRED BY F NORM BY SA||||||||NOT DONE||ALVEOLAR AIR|||CONTINUATION TREATMENT|1962-08-11||1968-07-18|1963-12-09|1960-11-19
TRIAL STUDY 134XCP|PP|5529CF4E-3210-4D8E-80E8-2D7DDFB81EA6|550||AUMCIFP|AUMC INFINITY PRED||||||||NOT DONE||SUPERNATANT, PLEURAL FLUID|||SCREENING|1962-12-02||1964-11-21|1963-06-17|1961-06-29
TRIAL STUDY 134XCP|PP|859D9297-58D0-4740-899D-E7BEC931D419|551||AURCIFOB|AURC INFINITY OBS NORM BY BMI||||||||NOT DONE||ARTERIAL CORD BLOOD|||FOLLOW-UP|1961-07-30||1965-02-02|1963-01-30|1962-03-26
TRIAL STUDY 134XCP|PP|A1E34C29-91C2-4C2B-942E-84CD6A10A056|552||AUCLSTUB|AUC TO LAST NONZERO CONC, UNBOUND DRUG||||||||NOT DONE||INFRANATANT, SERUM|||CONTINUATION TREATMENT|1960-12-02||1963-06-23|1973-04-28|1965-05-22
TRIAL STUDY 134XCP|PP|4E5FF284-E15A-421D-BC13-94655EEFE540|553||RCAMTAUW|AMT REC OVER DOSING INTERVAL NORM BY WT||||||||NOT DONE||PLEURAL TISSUE|||BLINDED TREATMENT|1965-04-02||1960-12-12|1962-04-07|1962-02-20
TRIAL STUDY 134XCP|PP|30BAB760-662A-41DF-9599-CBE0BC3A57D9|554||CMIN|MIN CONC||||||||NOT DONE||VENOUS CORD BLOOD|||OPEN LABEL TREATMENT|1972-01-10||1964-07-05|1961-05-14|1964-07-03
TRIAL STUDY 134XCP|PP|8747C2AB-18EB-430B-8E89-CF9183DBF322|555||RAAUC|RATIO AUC||||||||NOT DONE||SEBUM|||BASELINE|1973-06-01||1971-08-29|1963-05-22|1973-01-09
TRIAL STUDY 134XCP|PP|5A0FF15D-E779-47BA-8D3C-247A0FA57854|556||CMINS|MIN CONC NORM BY SA||||||||NOT DONE||GASTRIC FLUID|||OPEN LABEL TREATMENT|1970-09-29||1962-12-11|1968-04-04|1962-04-11
TRIAL STUDY 134XCP|PP|73260E60-6ADB-44DA-9A45-776B91F8B453|557||VSSOS|VOL DIST STEADY STATE OBS NORM BY SA||||||||NOT DONE||DIALYSIS FLUID, PERITONEAL|||LONG-TERM FOLLOW-UP|1970-10-30||1968-05-24|1961-12-17|1962-07-10
TRIAL STUDY 134XCP|PP|7B64252E-9A08-4177-BFA9-45B0C0E53097|558||TMAX|TIME OF CMAX||||||||NOT DONE||TUMOR TISSUE|||INDUCTION TREATMENT|1966-03-14||1963-12-24|1965-07-15|1961-03-22
TRIAL STUDY 134XCP|PP|D56FE2B1-BCCC-4113-A1C1-CBFE9A46CB75|559||RNCLTAUS|RENAL CL FOR DOSE INT NORM BY SA||||||||NOT DONE||PLASMA ULTRAFILTRATE|||WASHOUT|1971-04-12||1965-05-02|1962-09-28|1968-02-02
TRIAL STUDY 134XCP|PP|77F7428C-A160-4EC1-A2F5-96DACA1DEFA3|560||RENALCLW|RENAL CL NORM BY WT||||||||NOT DONE||TUMOR TISSUE|||WASHOUT|1960-10-27||1965-03-08|1966-10-05|1970-07-31
TRIAL STUDY 134XCP|PP|4BB780B0-E326-44B5-8EA7-88C92CE5ABE1|561||RCPCTAU|PCT REC OVER DOSING INTERVAL||||||||NOT DONE||REFLEX TEAR|||OBSERVATION|1972-03-31||1961-08-28|1970-08-22|1964-12-17
TRIAL STUDY 134XCP|PP|1B0EE182-6729-4333-BB9B-5561CAB31D26|562||RENALCLS|RENAL CL NORM BY SA||||||||NOT DONE||SALIVA|||SCREENING|1966-03-24||1973-06-14|1967-03-06|1960-05-25
TRIAL STUDY 134XCP|PP|1F3AD620-4B16-4EFF-8F5A-45105841BE02|563||VZFPUB|VZ PRED BY F FOR UB||||||||NOT DONE||ALVEOLAR AIR|||WASHOUT|1969-08-10||1966-02-18|1961-09-24|1972-12-29
TRIAL STUDY 134XCP|PP|05C77EE2-E4D7-4C2F-AF32-55FA95F1C791|564||LAMZSPN|LAMBDA Z SPAN||||||||NOT DONE||SKELETAL MUSCLE TISSUE|||RUN-IN|1970-06-15||1969-01-15|1960-07-05|1969-03-21
TRIAL STUDY 134XCP|PP|152147B0-6EAD-4124-8E1A-BD7707850B60|565||CLFUB|APPARENT CL FOR UNBOUND DRUG||||||||NOT DONE||INFRANATANT, SERUM|||SCREENING|1965-12-30||1972-10-24|1973-05-15|1968-03-23
TRIAL STUDY 134XCP|PP|3CCF019C-5663-4670-B2D1-EC01D6B58D06|566||NRENLCLW|NONRENAL CL NORM BY WT||||||||NOT DONE||EMESIS|||CONTINUATION TREATMENT|1960-10-01||1968-11-23|1963-07-15|1968-02-15
TRIAL STUDY 134XCP|PP|6599D082-A8A0-412D-BBDF-CD786C581905|567||MAT|MEAN ABSORPTION TIME||||||||NOT DONE||SUPERNATANT, PLEURAL FLUID|||LONG-TERM FOLLOW-UP|1960-03-18||1964-04-27|1966-07-21|1971-08-20
TRIAL STUDY 134XCP|PP|BC6984EB-5C48-4299-BDCB-2063BC44A1F4|568||VZPW|VZ PRED NORM BY WT||||||||NOT DONE||PERSPIRATION|||OPEN LABEL TREATMENT|1971-01-11||1967-11-29|1966-08-23|1969-10-13
TRIAL STUDY 134XCP|PP|AAC3113C-793D-43F4-87E9-111246E03003|569||RENALCLD|RENAL CL NORM BY DOSE||||||||NOT DONE||RETICULOCYTES|||BASELINE|1963-09-11||1967-05-26|1964-08-06|1967-10-07
TRIAL STUDY 134XCP|PP|2A6524EE-F1E9-4D0C-8CA2-E03C6350849A|570||MRCMAX|METABOLITE RATIO FOR MAX CONC||||||||NOT DONE||ADIPOSE TISSUE|||OPEN LABEL TREATMENT|1968-02-25||1971-10-17|1964-10-24|1971-07-12
TRIAL STUDY 134XCP|PP|941A9CF9-872C-42CF-A409-129BE5A88520|571||CLTAU|TOTAL CL FOR DOSE INT||||||||NOT DONE||PLASMA ULTRAFILTRATE|||TREATMENT|1970-08-19||1963-11-19|1963-03-05|1966-08-28
TRIAL STUDY 134XCP|PP|D7F3E205-CF5D-4724-ABE1-CE2DD560FB38|572||MRAUCINT|METABOLITE RATIO AUC FROM T1 TO T2||||||||NOT DONE||SUPERNATANT, CEREBROSPINAL FLUID|||BASELINE|1972-05-28||1961-02-12|1972-05-26|1973-03-20
TRIAL STUDY 134XCP|PP|10814ECC-AEDF-4B8C-B514-BADC4D388ADE|573||TROUGHPR|TROUGH PEAK RATIO||||||||NOT DONE||BLOOD|||LONG-TERM FOLLOW-UP|1966-06-28||1968-01-16|1961-05-24|1967-09-07
TRIAL STUDY 134XCP|PP|06000708-8EBA-4B6C-A8D3-1D0AC4D0E202|574||RCAMIFO|AMT REC INFINITY OBS||||||||NOT DONE||SOFT TISSUE|||FOLLOW-UP|1972-09-19||1966-12-22|1964-11-23|1966-05-26
TRIAL STUDY 134XCP|PP|0BD48B9C-D7D4-47CD-A61D-A4279898D87D|575||AUCIFOS|AUC INFINITY OBS NORM BY SA||||||||NOT DONE||EPIDERMAL TISSUE|||CONTINUATION TREATMENT|1968-08-31||1973-01-06|1961-09-10|1968-06-18
TRIAL STUDY 134XCP|PP|A4A5E66A-E65C-4234-8858-E69D04AB1593|576||CAVGINTW|AVERAGE CONC FROM T1 TO T2 NORM BY WT||||||||NOT DONE||SEMEN|||OPEN LABEL TREATMENT|1963-03-20||1970-02-25|1970-09-05|1970-10-02
TRIAL STUDY 134XCP|PP|0EA46DA5-4291-4585-9745-08BFA60BED3F|577||ARAUCLST|ACCUM RATIO AUC TO LAST NONZERO CONC||||||||NOT DONE||STRIATED MUSCLE TISSUE|||CONTINUATION TREATMENT|1971-03-31||1963-08-14|1961-10-05|1970-10-07
TRIAL STUDY 134XCP|PP|F54E494F-7EC2-41E7-A969-DF7151EA08E9|578||AURCIFO|AURC INFINITY OBS||||||||NOT DONE||LYMPH|||FOLLOW-UP|1968-07-29||1960-05-26|1970-08-01|1966-04-29
TRIAL STUDY 134XCP|PP|3C4215F7-A7FA-4177-8B84-FD26FEB43039|579||SRAUC|STATIONARITY RATIO AUC||||||||NOT DONE||ENDOTRACHEAL FLUID|||CONTINUATION TREATMENT|1962-12-12||1972-06-06|1971-07-31|1969-03-23
TRIAL STUDY 134XCP|PP|797C71A3-375E-466E-BDA8-A2828C9C45BB|580||MRTEVIFP|MRT EXTRAVASC INFINITY PRED||||||||NOT DONE||WHITE MATTER TISSUE|||SCREENING|1967-05-27||1962-09-28|1966-12-09|1969-02-13
TRIAL STUDY 134XCP|PP|F70AD90E-59E4-4017-B23C-D411B5EE8BFA|581||AUCIFOB|AUC INFINITY OBS NORM BY BMI||||||||NOT DONE||ARTERIALIZED CAPILLARY BLOOD|||SCREENING|1961-08-12||1963-02-25|1965-07-28|1967-11-08
TRIAL STUDY 134XCP|PP|5617A5B9-AEE0-4118-9113-3755ED8E961A|582||HTMAX|HALF TMAX||||||||NOT DONE||LUNG SURFACTANT|||FOLLOW-UP|1967-04-13||1968-09-29|1966-02-23|1967-08-05
TRIAL STUDY 134XCP|PP|7ECE0F95-910A-4FB3-9435-73805E498415|583||RCPCIFP|PCT REC INFINITY PRED||||||||NOT DONE||BONE MARROW|||TREATMENT|1969-12-04||1970-06-26|1964-09-30|1973-08-25
TRIAL STUDY 134XCP|PP|83EDB0FE-728D-453F-8DB2-7D44202EEB43|584||CLPW|TOTAL CL PRED NORM BY WT||||||||NOT DONE||STOOL|||INDUCTION TREATMENT|1972-02-27||1967-03-03|1960-08-27|1962-04-29
TRIAL STUDY 134XCP|PP|35589D89-B019-4C5E-8A4B-BFA58E894A9C|585||AUCIFPW|AUC INFINITY PRED NORM BY WT||||||||NOT DONE||SPUTUM|||SCREENING|1960-03-02||1961-05-10|1961-05-21|1970-10-02
TRIAL STUDY 134XCP|PP|45C05CC2-662A-4AB2-9342-7BE56AF1ABDF|586||CLFUB|APPARENT CL FOR UNBOUND DRUG||||||||NOT DONE||DISCHARGE|||OBSERVATION|1969-01-17||1962-08-30|1971-12-20|1963-07-10
TRIAL STUDY 134XCP|PP|21934F6E-8333-413B-931C-DF115519F394|587||VZPUB|VZ PRED FOR UB||||||||NOT DONE||GASTRIC CONTENTS|||INDUCTION TREATMENT|1962-06-11||1965-11-11|1973-02-01|1968-07-30
TRIAL STUDY 134XCP|PP|2EF614BE-3AEA-4BDA-968D-2D2F4EB9A653|588||RCAMIFPB|AMT REC INFINITY PRED NORM BY BMI||||||||NOT DONE||BONE MARROW MONONUCLEAR CELL|||RUN-IN|1960-05-27||1970-02-14|1963-10-06|1962-05-06
TRIAL STUDY 134XCP|PP|E31F3DEB-BCA2-4660-935D-BAEBC4238866|589||AILAMZ|ACCUMULATION INDEX USING LAMBDA Z||||||||NOT DONE||CIRCULATING TUMOR CELL|||RUN-IN|1971-03-19||1968-05-02|1967-01-26|1969-08-31
TRIAL STUDY 134XCP|PP|8310989D-82CC-456C-965A-E38AC9EA073F|590||VZFOW|VZ OBS BY F NORM BY WT||||||||NOT DONE||TRANSUDATE|||TREATMENT|1967-10-09||1971-10-12|1965-04-29|1971-10-03
TRIAL STUDY 134XCP|PP|826D8DC2-E407-481C-93D8-5169DBDF99C4|591||CTROUGHW|CONC TROUGH BY WT||||||||NOT DONE||EMOTIONAL TEAR|||RUN-IN|1966-11-02||1967-01-20|1961-11-13|1966-03-01
TRIAL STUDY 134XCP|PP|F2CEE48B-51B0-4F3E-94B1-FBAC1D0B2CA3|592||FREXINT|FRACT EXCR FROM T1 TO T2||||||||NOT DONE||PERSPIRATION|||RUN-IN|1961-11-21||1961-03-31|1961-08-16|1971-07-26
TRIAL STUDY 134XCP|PP|F8188B3C-FE9F-4589-BD6B-D313618C9FF6|593||ERINTS|EXCRET RATE FROM T1 TO T2 NORM BY SA||||||||NOT DONE||EXUDATE|||FOLLOW-UP|1963-11-09||1969-05-31|1961-04-20|1971-08-27
TRIAL STUDY 134XCP|PP|4F34B7B4-59E4-4D16-A5DD-2D41253FAD5A|594||CMINS|MIN CONC NORM BY SA||||||||NOT DONE||SUPERNATANT, SERUM|||CONTINUATION TREATMENT|1970-11-25||1969-09-04|1960-02-11|1971-11-23
TRIAL STUDY 134XCP|PP|E6D1E0A4-79DF-4964-81C0-09675B53FA6D|595||VSSOF|VOL DIST STEADY STATE OBS BY F||||||||NOT DONE||TISSUE|||LONG-TERM FOLLOW-UP|1961-11-07||1963-11-03|1967-01-15|1965-02-19
TRIAL STUDY 134XCP|PP|5BF2DD06-0BDB-4893-9EF7-9248D9DCE772|596||AUMCIFO|AUMC INFINITY OBS||||||||NOT DONE||PERSPIRATION|||TREATMENT|1966-09-20||1969-11-08|1971-01-11|1960-12-26
TRIAL STUDY 134XCP|PP|B396F12E-7BF5-47CC-AFD1-1B679066B106|597||AURCIFPS|AURC INFINITY PRED NORM BY SA||||||||NOT DONE||PLATELET RICH PLASMA|||LONG-TERM FOLLOW-UP|1968-12-25||1961-11-22|1971-09-17|1963-10-02
TRIAL STUDY 134XCP|PP|2936B26A-9A8D-4C28-90A7-6131837F255F|598||C0B|INITIAL CONC NORM BY BMI||||||||NOT DONE||GASTRIC FLUID|||BLINDED TREATMENT|1969-03-07||1971-05-18|1961-01-18|1964-05-22
TRIAL STUDY 134XCP|PP|901A91DC-9EF3-4A20-A35D-9C426A5C640B|599||RCAMTAUW|AMT REC OVER DOSING INTERVAL NORM BY WT||||||||NOT DONE||ISOLATE|||CONTINUATION TREATMENT|1968-08-07||1969-03-16|1972-07-10|1960-03-10
TRIAL STUDY 134XCP|PP|1944BDC6-B89D-4B9C-B33E-DD7D1D25E1A4|600||CLSTW|LAST NONZERO CONC NORM BY WT||||||||NOT DONE||RETICULOCYTES|||WASHOUT|1966-12-06||1966-02-02|1965-07-20|1973-07-07
TRIAL STUDY 134XCP|PP|5A7F2C89-5398-4119-8EA0-B432FF8942A4|601||AUCALLW|AUC ALL NORM BY WT||||||||NOT DONE||ENDOMETRIAL TISSUE|||BASELINE|1971-10-04||1962-12-18|1970-03-08|1966-02-18
TRIAL STUDY 134XCP|PP|898FB78B-63D1-4ECE-B6B8-34750E958D93|602||AURCIFO|AURC INFINITY OBS||||||||NOT DONE||SMOOTH MUSCLE TISSUE|||CONTINUATION TREATMENT|1960-08-27||1968-03-18|1964-04-27|1962-01-31
TRIAL STUDY 134XCP|PP|AF1E7141-5390-4928-9F49-94E1C7464A63|603||ARAUCIOD|ACCUM RATIO AUCIFO NORM BY DOSE||||||||NOT DONE||LAVAGE FLUID|||FOLLOW-UP|1967-03-20||1971-10-02|1968-10-31|1960-05-09
TRIAL STUDY 134XCP|PP|2188CADE-EE6F-4F14-8049-5EDD72020185|604||AUMCTAU|AUMC OVER DOSING INTERVAL||||||||NOT DONE||CEREBROSPINAL FLUID|||OPEN LABEL TREATMENT|1972-04-07||1968-10-27|1967-04-07|1963-03-11
TRIAL STUDY 134XCP|PP|DFF30783-4496-4134-8201-67C727683A7D|605||ERMAXW|MAX EXCRETION RATE NORM BY WT||||||||NOT DONE||DERMAL TISSUE|||LONG-TERM FOLLOW-UP|1965-09-20||1960-08-02|1965-10-17|1960-12-25
TRIAL STUDY 134XCP|PP|970170C0-8FF0-4D24-84E8-1195272D55C0|606||VZFPD|VZ PRED BY F NORM BY DOSE||||||||NOT DONE||CERVICOVAGINAL SECRETION|||BLINDED TREATMENT|1968-10-26||1969-03-11|1970-04-16|1963-10-28
TRIAL STUDY 134XCP|PP|F8D52828-1C5E-4958-BFDE-77F5171FEFBE|607||CLSTD|LAST NONZERO CONC NORM BY DOSE||||||||NOT DONE||CELL PELLET|||WASHOUT|1964-05-03||1971-12-12|1962-12-24|1964-07-20
TRIAL STUDY 134XCP|PP|69CC47A3-DA90-4919-889E-E0008ED689FA|608||RCPCIFOS|PCT REC INFINITY OBS NORM BY SA||||||||NOT DONE||MENSTRUAL BLOOD|||CONTINUATION TREATMENT|1972-02-13||1960-08-02|1965-04-22|1971-02-05
TRIAL STUDY 134XCP|PP|D4BB8CC7-4EB2-4FCA-94EB-E08D8FE00577|609||AUCIFPW|AUC INFINITY PRED NORM BY WT||||||||NOT DONE||SUPERNATANT, SERUM|||RUN-IN|1963-04-30||1962-12-12|1961-08-28|1965-02-07
TRIAL STUDY 134XCP|PP|72FDC7C1-2734-4CA6-8A9B-CC20E39CD834|610||CLFPB|TOTAL CL PRED BY F NORM BY BMI||||||||NOT DONE||COLOSTRUM|||INDUCTION TREATMENT|1972-06-01||1970-12-14|1963-04-07|1969-03-12
TRIAL STUDY 134XCP|PP|0281E055-F419-4BA2-89CE-23EC7428CDA0|611||RNCLUB|RENAL CL FOR UNBOUND DRUG||||||||NOT DONE||CARDIAC MUSCLE TISSUE|||BLINDED TREATMENT|1960-07-09||1969-10-01|1961-01-27|1971-05-16
TRIAL STUDY 134XCP|PP|23CE1310-DBB3-4135-8E11-2A870CE42D50|612||AURCLSTD|AURC DOSING TO LAST CONC NORM BY DOSE||||||||NOT DONE||TISSUE|||BASELINE|1960-04-02||1967-05-11|1970-08-26|1970-10-14
TRIAL STUDY 134XCP|PP|CC80D8A2-7D71-428B-9599-C0D0312B8691|613||AUMCIFPD|AUMC INFINITY PRED NORM BY DOSE||||||||NOT DONE||AMNIOTIC FLUID|||RUN-IN|1966-10-12||1961-03-08|1961-11-18|1972-03-31
TRIAL STUDY 134XCP|PP|EB6EE887-79FE-4CD1-BA61-C5F29C54830C|614||AUCINT|AUC FROM T1 TO T2||||||||NOT DONE||CAPILLARY PLASMA|||CONTINUATION TREATMENT|1960-12-21||1966-10-04|1967-06-07|1972-01-14
TRIAL STUDY 134XCP|PP|CFD063DA-DB51-45EC-ACCA-8AAB90DC1B82|615||C0S|INITIAL CONC NORM BY SA||||||||NOT DONE||TUMOR TISSUE|||OBSERVATION|1964-09-12||1961-01-16|1972-02-06|1964-02-27
TRIAL STUDY 134XCP|PP|3D25A735-6298-4AF4-91CC-AE8D481DF552|616||FU|FRACTION UNBOUND||||||||NOT DONE||STOOL|||BLINDED TREATMENT|1969-12-01||1963-06-12|1972-05-23|1972-02-05
TRIAL STUDY 134XCP|PP|C249E38B-B454-47D9-8D8B-E2F6A434BA21|617||AUCALLW|AUC ALL NORM BY WT||||||||NOT DONE||DIALYSIS FLUID, PERITONEAL|||OPEN LABEL TREATMENT|1960-05-23||1966-10-16|1969-05-13|1973-01-19
TRIAL STUDY 134XCP|PP|4540D569-1DD0-4984-89DB-6F9A391397FE|618||VZOS|VZ OBS NORM BY SA||||||||NOT DONE||ARTERIALIZED CAPILLARY BLOOD|||FOLLOW-UP|1973-08-10||1965-05-05|1960-12-30|1967-01-27
TRIAL STUDY 134XCP|PP|DC1D666E-4920-4B60-A520-D183BCDE0E85|619||NRENLCLS|NONRENAL CL NORM BY SA||||||||NOT DONE||AQUEOUS HUMOR|||FOLLOW-UP|1972-01-21||1972-11-02|1963-01-24|1967-01-24
TRIAL STUDY 134XCP|PP|A015D12B-C03B-4371-8D1F-F03D60542BA7|620||CLSTW|LAST NONZERO CONC NORM BY WT||||||||NOT DONE||ENDOMETRIAL TISSUE|||TREATMENT|1963-07-31||1960-12-02|1969-09-06|1969-06-25
TRIAL STUDY 134XCP|PP|EB15F3FF-8414-4D5B-A305-EA5B1FE8B8AF|621||MAT|MEAN ABSORPTION TIME||||||||NOT DONE||SEMEN|||SCREENING|1971-08-23||1960-03-09|1961-09-09|1967-08-15
TRIAL STUDY 134XCP|PP|34AC7973-686F-45A2-999A-1A36C7874F91|622||ERMAX|MAX EXCRETION RATE||||||||NOT DONE||KERATINOCYTE|||OPEN LABEL TREATMENT|1967-09-19||1963-05-21|1967-05-02|1969-11-01
TRIAL STUDY 134XCP|PP|5AE66AC0-ECB6-49A2-859F-871B9A15E624|623||TROUGHPR|TROUGH PEAK RATIO||||||||NOT DONE||INFRANATANT, SERUM|||OPEN LABEL TREATMENT|1967-08-22||1969-10-05|1962-06-12|1968-06-10
TRIAL STUDY 134XCP|PP|31C4E0AA-B36B-411C-ABAA-CDEE1190AA22|624||AUCTAU|AUC OVER DOSING INTERVAL||||||||NOT DONE||ARTERIALIZED CAPILLARY BLOOD|||FOLLOW-UP|1966-09-19||1969-06-19|1972-04-10|1973-07-30
TRIAL STUDY 134XCP|PP|59A9826F-4C2F-482A-8888-F649544318BE|625||CLOS|TOTAL CL OBS NORM BY SA||||||||NOT DONE||SPUTUM|||LONG-TERM FOLLOW-UP|1969-02-05||1961-02-14|1973-03-24|1965-01-06
TRIAL STUDY 134XCP|PP|B6E55A62-CF0B-4BC6-84DC-038F29518909|626||AUCLSTW|AUC TO LAST NONZERO CONC NORM BY WT||||||||NOT DONE||EPITHELIAL CELL|||INDUCTION TREATMENT|1970-03-10||1967-05-21|1961-08-22|1969-03-17
TRIAL STUDY 134XCP|PP|3B5E776E-C267-4F99-80AB-AAD96A6B1DA7|627||VZFOD|VZ OBS BY F NORM BY DOSE||||||||NOT DONE||PERSPIRATION|||BASELINE|1962-10-13||1963-11-24|1964-06-16|1971-11-07
TRIAL STUDY 134XCP|PP|5577E914-C90D-4CC4-A7A8-D919C29A61D1|628||MRAUCTAU|METABOLITE RATIO FOR AUC DOSING INTERVAL||||||||NOT DONE||BONE MARROW|||CONTINUATION TREATMENT|1966-09-12||1971-07-09|1964-08-11|1967-02-17
TRIAL STUDY 134XCP|PP|2DBA8940-F59E-4A0D-8858-408D71DD9753|629||ERINTB|EXCRET RATE FROM T1 TO T2 NORM BY BMI||||||||NOT DONE||ARTERIALIZED CAPILLARY BLOOD|||BASELINE|1963-12-22||1967-07-01|1970-08-18|1967-04-23
TRIAL STUDY 134XCP|PP|F62D63CA-BCD9-4D81-B789-0CABDA5F8A99|630||RCPCTAUB|PCT REC OVER DOSING INTERVAL NORM BY BMI||||||||NOT DONE||EXHALED BREATH CONDENSATE|||OBSERVATION|1972-11-08||1968-09-29|1970-11-22|1962-03-14
TRIAL STUDY 134XCP|PP|0250EC5D-B08F-4010-9653-95E20EDD0CCA|631||VZPS|VZ PRED NORM BY SA||||||||NOT DONE||TISSUE|||SCREENING|1970-09-15||1973-08-26|1961-12-01|1970-10-12
TRIAL STUDY 134XCP|PP|C06524C5-BA81-4AC0-9E8A-112D7B7112A6|632||AUCLSTD|AUC TO LAST NONZERO CONC NORM BY DOSE||||||||NOT DONE||CALCULUS|||SCREENING|1969-06-02||1973-09-05|1972-02-24|1964-02-24
TRIAL STUDY 134XCP|PP|140FFC83-72C9-4BD4-AA44-C98CA42147F3|633||ERINT|EXCRET RATE FROM T1 TO T2||||||||NOT DONE||AQUEOUS HUMOR|||OBSERVATION|1968-11-05||1961-10-21|1972-06-03|1965-07-18
TRIAL STUDY 134XCP|PP|7BAC399A-0523-476E-A294-C57309E573AF|634||RENALCLW|RENAL CL NORM BY WT||||||||NOT DONE||SUPERNATANT, CEREBROSPINAL FLUID|||RUN-IN|1963-11-29||1973-04-06|1970-05-25|1965-07-16
TRIAL STUDY 134XCP|PP|D23869D2-DBE2-4687-BE8C-AD4458FD49F5|635||CMINB|MIN CONC NORM BY BMI||||||||NOT DONE||ARTERIAL CORD BLOOD|||WASHOUT|1971-12-18||1965-01-01|1961-12-18|1973-07-22
TRIAL STUDY 134XCP|PP|0F180E62-F840-490F-8EB3-F7DDB7132401|636||ARCMAX|ACCUMULATION RATIO CMAX||||||||NOT DONE||ARTERIALIZED CAPILLARY BLOOD|||OBSERVATION|1972-02-15||1962-09-28|1961-12-26|1968-10-06
TRIAL STUDY 134XCP|PP|80E7A428-CDDE-453F-B7D1-1B282A1835BF|637||RNCLINTW|RENAL CL FROM T1 TO T2 NORM BY WT||||||||NOT DONE||SPERMATOZOON|||TREATMENT|1967-04-06||1964-03-25|1971-02-17|1965-01-23
TRIAL STUDY 134XCP|PP|F1D265C4-B975-4E74-9545-122A10FE100F|638||AUCIFPB|AUC INFINITY PRED NORM BY BMI||||||||NOT DONE||VENOUS BLOOD|||WASHOUT|1967-02-14||1970-01-15|1971-05-23|1968-05-07
TRIAL STUDY 134XCP|PP|7A272C35-DB2C-429D-AF31-CC7386DC8F07|639||HDER|HEMODIALYSIS EXTRACTION RATIO||||||||NOT DONE||EMOTIONAL TEAR|||FOLLOW-UP|1965-10-05||1969-11-22|1968-01-27|1973-03-19
TRIAL STUDY 134XCP|PP|FBF95CF9-933D-406A-8D67-B1F643C5F554|640||RCPCIFOB|PCT REC INFINITY OBS NORM BY BMI||||||||NOT DONE||BONE|||OPEN LABEL TREATMENT|1973-02-09||1968-10-11|1964-02-16|1973-05-28
TRIAL STUDY 134XCP|PP|21E51AFC-91F0-4187-A5DC-9DA9A8C20D09|641||VSSPF|VOL DIST STEADY STATE PRED BY F||||||||NOT DONE||SMEGMA|||RUN-IN|1973-05-13||1961-02-07|1965-06-04|1970-04-29
TRIAL STUDY 134XCP|PP|391D2418-5359-457B-AEC5-6A48DE04DAFD|642||CAVGS|AVERAGE CONC NORM BY SA||||||||NOT DONE||VENOUS CORD BLOOD|||INDUCTION TREATMENT|1960-03-03||1969-06-06|1963-10-21|1971-03-26
TRIAL STUDY 134XCP|PP|68F706F0-2F0B-4D50-B15C-2DFDD186112E|643||ERMAXD|MAX EXCRETION RATE NORM BY DOSE||||||||NOT DONE||GASTRIC FLUID|||RUN-IN|1970-12-25||1960-04-13|1965-09-06|1966-01-15
TRIAL STUDY 134XCP|PP|E8D4AACE-0832-482D-8266-96B7423F9459|644||RAAUCLSD|RATIOAUC TO LAST NONZERO CONC NORMBYDOSE||||||||NOT DONE||BONE MARROW|||FOLLOW-UP|1961-11-15||1963-01-25|1968-11-22|1960-09-20
TRIAL STUDY 134XCP|PP|F358E69F-9B9A-4637-9063-B8FECFF000B2|645||SRAUC|STATIONARITY RATIO AUC||||||||NOT DONE||BREAST MILK|||INDUCTION TREATMENT|1964-01-31||1962-11-17|1964-12-02|1960-12-23
TRIAL STUDY 134XCP|PP|A9B86D67-C9B1-471F-AC6D-2C3F9A7ECB44|646||LAMZLL|LAMBDA Z LOWER LIMIT||||||||NOT DONE||CEREBROSPINAL FLUID|||TREATMENT|1972-10-27||1964-05-11|1963-04-24|1971-06-17
TRIAL STUDY 134XCP|PP|F67596BD-D8EC-4B25-A39C-BD6455F0C0F4|647||VZFOUB|VZ OBS BY F FOR UB||||||||NOT DONE||BONE MARROW|||BASELINE|1964-09-13||1970-01-12|1969-10-26|1966-10-13
TRIAL STUDY 134XCP|PP|586B4529-9808-4205-B3D6-5C4A1DAFA922|648||ARAUC|ACCUMULATION RATIO AUCTAU||||||||NOT DONE||PROSTATIC FLUID|||OPEN LABEL TREATMENT|1960-07-11||1972-06-02|1970-08-04|1963-02-08
TRIAL STUDY 134XCP|PP|54685EFC-EE92-4591-B059-24145A3E6D69|649||AUCTAUB|AUC OVER DOSING INTERVAL NORM BY BMI||||||||NOT DONE||MIXED VENOUS BLOOD|||INDUCTION TREATMENT|1968-06-12||1965-05-05|1972-07-04|1971-11-05
TRIAL STUDY 134XCP|PP|7BD32505-61D5-4862-8896-B3E41D3EE779|650||RAAUCIOD|RATIO AUC INFINITY OBS NORM BY DOSE||||||||NOT DONE||PERSPIRATION|||INDUCTION TREATMENT|1969-04-11||1969-07-22|1973-05-28|1963-06-21
TRIAL STUDY 134XCP|PP|3461C227-E30F-482B-B404-026FE0CA3549|651||VZTAUS|VZ FOR DOSE INT NORM BY SA||||||||NOT DONE||EMESIS|||BLINDED TREATMENT|1965-08-09||1965-01-30|1963-03-19|1965-10-19
TRIAL STUDY 134XCP|PP|4688A17D-8429-4AE7-B3FB-FDCA7EE6C10F|652||MRAUCIFO|METABOLITE RATIO FOR AUC INFINITY OBS||||||||NOT DONE||VENOUS BLOOD|||CONTINUATION TREATMENT|1966-03-22||1973-05-10|1968-09-30|1966-10-02
TRIAL STUDY 134XCP|PP|5B4CCDE8-49E3-40B4-ACB8-721D9E110AB4|653||RENALCLD|RENAL CL NORM BY DOSE||||||||NOT DONE||DIALYSIS FLUID, PERITONEAL|||OBSERVATION|1967-10-14||1971-07-26|1962-04-01|1972-11-21
TRIAL STUDY 134XCP|PP|C7C91F63-87B7-4E62-B5F3-39979F74E955|654||RCPCINT|PCT REC FROM T1 TO T2||||||||NOT DONE||EPIDERMAL TISSUE|||INDUCTION TREATMENT|1960-07-27||1972-12-08|1966-06-16|1964-01-20
TRIAL STUDY 134XCP|PP|D6659F53-6DF6-4F88-BF9A-160E2D057028|655||AUMCTAUW|AUMC OVER DOSING INTERVAL NORM BY WT||||||||NOT DONE||INFRANATANT, SERUM|||OBSERVATION|1973-04-13||1962-03-18|1961-06-11|1972-06-13
TRIAL STUDY 134XCP|PP|AF6FDB1B-0B61-4D2A-8874-808DD5A5B286|656||RNCLTAUB|RENAL CL FOR DOSE INT NORM BY BMI||||||||NOT DONE||CERVICOVAGINAL SECRETION|||CONTINUATION TREATMENT|1963-02-12||1962-06-08|1968-12-18|1966-06-19
TRIAL STUDY 134XCP|PP|91B36C93-3ADF-4570-B355-BC81B097EEFC|657||RCAMTAUS|AMT REC OVER DOSING INTERVAL NORM BY SA||||||||NOT DONE||ENDOTRACHEAL FLUID|||BLINDED TREATMENT|1971-07-26||1971-11-26|1963-05-03|1970-04-16
TRIAL STUDY 134XCP|PP|ADD0DDE5-166F-4C20-B3C3-31B131509771|658||RNCLINTD|RENAL CL FROM T1 TO T2 NORM BY DOSE||||||||NOT DONE||VENOUS PLASMA|||INDUCTION TREATMENT|1973-06-06||1972-03-04|1972-05-08|1960-07-25
TRIAL STUDY 134XCP|PP|4265CC9E-26AF-4A14-B9AA-04A246E2523C|659||CAVGDW|AVERAGE CONCENTRATION NORM BY DOSE/WT||||||||NOT DONE||SALIVA|||OBSERVATION|1965-09-16||1963-04-09|1968-05-02|1962-11-19
TRIAL STUDY 134XCP|PP|96F268D3-7441-415C-95C9-A6B70C1718D5|660||AUMCTAUD|AUMC OVER DOSING INTERVAL NORM BY DOSE||||||||NOT DONE||DIALYSIS FLUID, PERITONEAL|||TREATMENT|1964-03-29||1961-04-24|1969-06-04|1964-11-13
TRIAL STUDY 134XCP|PP|15D32D1F-AEE2-474C-956E-461FB087D7B0|661||CAVGS|AVERAGE CONC NORM BY SA||||||||NOT DONE||TRANSUDATE|||LONG-TERM FOLLOW-UP|1973-09-07||1964-05-15|1972-05-19|1960-02-15
TRIAL STUDY 134XCP|PP|DB42C81A-D644-455D-9D95-42131EF2BFE5|662||KDIST|K SLOPE OF DISTRIBUTION||||||||NOT DONE||PERIPHERAL BLOOD MONONUCLEAR CELL|||CONTINUATION TREATMENT|1966-06-10||1968-06-05|1965-02-28|1963-12-16
TRIAL STUDY 134XCP|PP|4B01CC59-51D3-4499-9AB1-DF446006CB8D|663||AUCTAUDW|AUCTAU NORM BY DOSE/WT||||||||NOT DONE||CORD BLOOD|||FOLLOW-UP|1971-09-21||1966-02-04|1962-08-21|1973-01-29
TRIAL STUDY 134XCP|PP|B69774FC-1151-45DD-B329-6C21C2F29603|664||CLFTAUS|TOTAL CL BY F FOR DOSE INT NORM BY SA||||||||NOT DONE||EPIDERMAL TISSUE|||INDUCTION TREATMENT|1962-11-27||1969-06-10|1965-01-22|1973-07-24
TRIAL STUDY 134XCP|PP|E65C6FBC-3399-4EC7-8802-8AA6BB3FA4E5|665||AURCIFOS|AURC INFINITY OBS NORM BY SA||||||||NOT DONE||ENDOTRACHEAL FLUID|||OPEN LABEL TREATMENT|1961-06-03||1970-07-08|1972-02-26|1967-06-27
TRIAL STUDY 134XCP|PP|4133B8C8-6594-4E12-81C7-0E1C1BEA59D9|666||ERMAXD|MAX EXCRETION RATE NORM BY DOSE||||||||NOT DONE||SMEGMA|||RUN-IN|1965-12-07||1966-12-06|1970-04-15|1962-09-27
TRIAL STUDY 134XCP|PP|674B4474-6D52-4DE2-8342-EDB28F577BB5|667||VZFPB|VZ PRED BY F NORM BY BMI||||||||NOT DONE||SYNOVIAL FLUID|||INDUCTION TREATMENT|1962-05-08||1961-05-29|1968-02-18|1962-08-01
TRIAL STUDY 134XCP|PP|AF634AD4-086A-47EE-A5DB-A4B6833356C7|668||AUMCIFPD|AUMC INFINITY PRED NORM BY DOSE||||||||NOT DONE||ISOLATE|||TREATMENT|1965-03-19||1965-05-08|1960-12-11|1961-09-09
TRIAL STUDY 134XCP|PP|89298058-EB86-4892-97D6-1B87277DF7FC|669||CLFPW|TOTAL CL PRED BY F NORM BY WT||||||||NOT DONE||ATHEROSCLEROTIC PLAQUE|||RUN-IN|1962-07-02||1965-09-26|1961-06-28|1962-02-05
TRIAL STUDY 134XCP|PP|E41FF3D9-9D68-4A3A-BBFB-B4D9030423E5|670||LAMZLTAU|LAMBDA Z LOWER LIMIT TAU||||||||NOT DONE||BONE MARROW|||RUN-IN|1960-06-20||1967-04-12|1962-09-17|1972-08-28
TRIAL STUDY 134XCP|PP|D5235188-810B-431F-A6EF-E50DAA57F5E7|671||ERTLST|MIDPOINT OF INTERVAL OF LAST NONZERO ER||||||||NOT DONE||NAIL|||CONTINUATION TREATMENT|1964-08-30||1968-12-25|1965-01-30|1963-05-03
TRIAL STUDY 134XCP|PP|05CEDBB3-C2F4-4069-A8B0-EF2080C7D1F1|672||CLOUB|TOTAL CL OBS FOR UNBOUND DRUG||||||||NOT DONE||PLEURAL FLUID|||WASHOUT|1969-04-03||1968-06-30|1964-05-19|1966-08-10
TRIAL STUDY 134XCP|PP|E3BB136E-0913-43FB-B760-CBE939F0C4D2|673||CONCS|CONC BY SA||||||||NOT DONE||BASAL TEAR|||BLINDED TREATMENT|1970-01-30||1960-08-10|1962-08-31|1971-06-25
TRIAL STUDY 134XCP|PP|60C25341-42CE-4532-8F99-25B8305C4ED5|674||RACMAXD|RATIO MAX CONC NORM BY DOSE||||||||NOT DONE||LAVAGE FLUID|||TREATMENT|1962-04-09||1964-07-07|1960-11-20|1968-09-27
TRIAL STUDY 134XCP|PP|42B54D88-E5B5-4828-958B-4B64F07E34B3|675||TMAX|TIME OF CMAX||||||||NOT DONE||LYMPH|||TREATMENT|1966-08-27||1968-06-02|1967-12-03|1970-07-08
TRIAL STUDY 134XCP|PP|A48E4CF0-E6BA-415A-9B09-4A14C81AD7D6|676||ARCMAX|ACCUMULATION RATIO CMAX||||||||NOT DONE||INFRANATANT, PLASMA|||BASELINE|1967-03-05||1973-05-05|1972-07-04|1963-03-04
TRIAL STUDY 134XCP|PP|1FD985ED-A573-4A00-8902-214A7F182F28|677||ARAUCIPD|ACCUM RATIO AUCIFP NORM BY DOSE||||||||NOT DONE||BLOOD|||BLINDED TREATMENT|1963-04-04||1965-08-10|1972-02-02|1969-01-11
TRIAL STUDY 134XCP|PP|A2FD338A-F994-4399-BD02-99CB299F768E|678||AILAMZ|ACCUMULATION INDEX USING LAMBDA Z||||||||NOT DONE||MUSCLE TISSUE|||RUN-IN|1965-06-03||1966-10-03|1970-09-04|1961-02-03
TRIAL STUDY 134XCP|PP|3FE264AB-FCE4-4EEE-8550-1C43B1B1DF4E|679||RCPCIFPB|PCT REC INFINITY PRED NORM BY BMI||||||||NOT DONE||VENOUS CORD BLOOD|||OBSERVATION|1970-11-21||1964-05-15|1965-11-10|1967-07-31
TRIAL STUDY 134XCP|PP|284A96C9-F0ED-4B2C-BEEC-A6D24788912C|680||CMINDW|MIN CONC NORM BY DOSE/WT||||||||NOT DONE||MIXED VENOUS BLOOD|||FOLLOW-UP|1972-03-22||1965-04-17|1969-02-06|1960-06-04
TRIAL STUDY 134XCP|PP|A8821AEE-49EB-4687-BB63-361BC3B8B182|681||CLSTB|LAST NONZERO CONC NORM BY BMI||||||||NOT DONE||VITREOUS HUMOR|||BLINDED TREATMENT|1965-08-25||1970-07-10|1972-12-30|1965-10-13
TRIAL STUDY 134XCP|PP|B2FE7511-A275-4E2E-85C3-5454FA1C02D1|682||AUCALLB|AUC ALL NORM BY BMI||||||||NOT DONE||CIRCULATING TUMOR CELL|||BLINDED TREATMENT|1969-08-26||1960-01-11|1963-07-28|1968-08-30
TRIAL STUDY 134XCP|PP|5F155D7F-6FE9-4AD2-92A2-64A009167BFC|683||VZPB|VZ PRED NORM BY BMI||||||||NOT DONE||PERSPIRATION|||RUN-IN|1966-02-19||1962-03-18|1966-10-25|1968-06-27
TRIAL STUDY 134XCP|PP|33CC5FBC-A2B0-4DA3-8DE7-B2281B98511B|684||AUCIFOW|AUC INFINITY OBS NORM BY WT||||||||NOT DONE||LUNG SURFACTANT|||BLINDED TREATMENT|1966-03-05||1971-06-12|1963-08-30|1973-02-28
TRIAL STUDY 134XCP|PP|E711C534-E58F-4B41-95CC-24E938D89B61|685||RCPCIFOW|PCT REC INFINITY OBS NORM BY WT||||||||NOT DONE||SALIVA|||LONG-TERM FOLLOW-UP|1973-07-09||1960-06-26|1961-10-20|1968-06-13
TRIAL STUDY 134XCP|PP|83938342-C01F-491A-84A7-F85D327F112D|686||RAAUCLST|RATIO AUC TO LAST NONZERO CONC||||||||NOT DONE||ARTERIAL CORD BLOOD|||FOLLOW-UP|1969-04-21||1971-03-08|1971-09-24|1972-08-19
TRIAL STUDY 134XCP|PP|731665AB-4418-4943-BFC5-D78F03C8D423|687||TLST|TIME OF LAST NONZERO CONC||||||||NOT DONE||FLUID|||BLINDED TREATMENT|1963-06-19||1972-04-11|1963-05-05|1966-10-22
TRIAL STUDY 134XCP|PP|3E337B9F-D718-4FE6-83D8-E05BC77CA872|688||CLFPS|TOTAL CL PRED BY F NORM BY SA||||||||NOT DONE||STRIATED MUSCLE TISSUE|||OBSERVATION|1972-11-28||1968-04-23|1969-11-24|1960-07-29
TRIAL STUDY 134XCP|PP|D5243E6E-2521-4331-ABFB-75112D06F771|689||VSSOW|VOL DIST STEADY STATE OBS NORM BY WT||||||||NOT DONE||PLEURAL TISSUE|||OBSERVATION|1966-01-02||1969-12-14|1961-01-26|1964-05-22
TRIAL STUDY 134XCP|PP|AD9332D4-879F-4CD3-BA96-C6FF69CF85AC|690||AURCINTB|AURC FROM T1 TO T2 NORM BY BMI||||||||NOT DONE||SKIN TISSUE|||FOLLOW-UP|1969-01-06||1969-05-20|1966-01-26|1961-05-06
TRIAL STUDY 134XCP|PP|5B3E406E-F2A5-4F25-8271-DC1FABA40138|691||RNCLTAUW|RENAL CL FOR DOSE INT NORM BY WT||||||||NOT DONE||SEMINAL FLUID|||INDUCTION TREATMENT|1968-12-27||1966-02-08|1961-02-04|1971-06-30
TRIAL STUDY 134XCP|PP|D5262627-52D7-42F5-B4BA-D7E6FA243959|692||ERMAXB|MAX EXCRETION RATE NORM BY BMI||||||||NOT DONE||NAIL|||OBSERVATION|1967-08-30||1963-05-31|1966-12-15|1967-08-02
TRIAL STUDY 134XCP|PP|C550278D-F171-42D0-8C34-D60824A3FE98|693||RAMAXMIN|RATIO OF CMAX TO CMIN||||||||NOT DONE||SWABBED MATERIAL|||BLINDED TREATMENT|1969-09-01||1967-11-01|1968-03-11|1963-02-12
TRIAL STUDY 134XCP|PP|5E76262E-FE1E-40C9-B147-3C792F768F48|694||AUMCTAUD|AUMC OVER DOSING INTERVAL NORM BY DOSE||||||||NOT DONE||PLATELET|||BASELINE|1965-12-23||1960-06-17|1963-12-29|1966-08-08
TRIAL STUDY 134XCP|PP|2F21921D-D18C-43EE-A39E-91A93B262B8C|695||AUCIFOD|AUC INFINITY OBS NORM BY DOSE||||||||NOT DONE||SUPERNATANT, CEREBROSPINAL FLUID|||LONG-TERM FOLLOW-UP|1966-05-28||1962-01-18|1960-09-21|1962-11-10
TRIAL STUDY 134XCP|PP|B2AAF3FD-AA9B-4BA9-8DE5-4C4BA12ECEBC|696||CONCW|CONC BY WT||||||||NOT DONE||SMOOTH MUSCLE TISSUE|||OBSERVATION|1964-09-10||1963-02-12|1964-10-17|1972-10-25
TRIAL STUDY 134XCP|PP|55985646-0224-4442-90C5-EFEDF990E88C|697||CAVGD|AVERAGE CONC NORM BY DOSE||||||||NOT DONE||MONOCYTE|||INDUCTION TREATMENT|1972-02-25||1971-01-19|1969-07-04|1967-07-14
TRIAL STUDY 134XCP|PP|86509C90-3C57-4755-A06F-79C620779371|698||AUCIFPW|AUC INFINITY PRED NORM BY WT||||||||NOT DONE||SEMEN|||BLINDED TREATMENT|1968-05-03||1963-08-07|1964-03-30|1970-06-24
TRIAL STUDY 134XCP|PP|8C9966BC-922D-4F74-9057-B2DE1DEF21E3|699||RCAMLST|AMT REC TO LAST NONZERO CONC||||||||NOT DONE||VENOUS PLASMA|||SCREENING|1965-03-21||1967-10-24|1969-03-01|1967-06-20
TRIAL STUDY 134XCP|PP|FDE870DC-5091-4CAE-9E47-88F2F4D95FE1|700||RCPCIFOS|PCT REC INFINITY OBS NORM BY SA||||||||NOT DONE||ARTERIAL CORD BLOOD|||INDUCTION TREATMENT|1961-02-22||1972-11-22|1964-06-20|1968-12-14
TRIAL STUDY 134XCP|PP|0FFBFF7C-7C64-411E-8D07-C959F0886023|701||NRENLCLW|NONRENAL CL NORM BY WT||||||||NOT DONE||GASTRIC FLUID|||BASELINE|1970-12-03||1960-03-29|1968-03-23|1961-12-19
TRIAL STUDY 134XCP|PP|75BC43A6-C796-48F7-9F2B-B24E7D5D5C51|702||RENALCLB|RENAL CL NORM BY BMI||||||||NOT DONE||SPUTUM|||RUN-IN|1962-02-14||1966-11-15|1963-06-07|1965-02-19
TRIAL STUDY 134XCP|PP|5DC5F780-264A-4EB1-BEA5-28209D416FEB|703||ARAUCINT|ACCUMULATION RATIO AUC FROM T1 TO T2||||||||NOT DONE||SKELETAL MUSCLE TISSUE|||CONTINUATION TREATMENT|1965-09-10||1971-02-14|1960-03-01|1967-02-05
TRIAL STUDY 134XCP|PP|DDBCA084-DD05-4FA0-9083-7CD31CECA420|704||TAUHL|HALF-LIFE TAU||||||||NOT DONE||DIALYSIS FLUID, PERITONEAL|||FOLLOW-UP|1972-03-13||1962-12-06|1968-08-21|1969-12-16
TRIAL STUDY 134XCP|PP|65A5AAA6-A817-45F8-9BA8-584E9627AB26|705||RCAMINTW|AMT REC FROM T1 TO T2 NORM BY WT||||||||NOT DONE||CELL PELLET|||CONTINUATION TREATMENT|1965-06-03||1966-04-23|1961-06-28|1961-01-18
TRIAL STUDY 134XCP|PP|854AD9A5-A869-41C7-9AF0-43383CE64B86|706||VZPS|VZ PRED NORM BY SA||||||||NOT DONE||DERMAL TISSUE|||RUN-IN|1961-12-08||1964-05-31|1964-10-15|1960-09-16
TRIAL STUDY 134XCP|PP|008F02C8-B28A-490E-A77A-F32584DA06FA|707||AUCLST|AUC TO LAST NONZERO CONC||||||||NOT DONE||MECONIUM|||LONG-TERM FOLLOW-UP|1972-07-19||1962-05-23|1965-03-16|1965-11-13
TRIAL STUDY 134XCP|PP|7C06549D-596C-4C47-BD0B-119DF6CD67AC|708||CONCS|CONC BY SA||||||||NOT DONE||LYSATE|||INDUCTION TREATMENT|1973-08-14||1970-11-10|1965-01-22|1971-01-13
TRIAL STUDY 134XCP|PP|39A00D93-61B9-44C5-9672-005A1F9A93EB|709||RCAMIFPW|AMT REC INFINITY PRED NORM BY WT||||||||NOT DONE||SUPERNATANT, PLEURAL FLUID|||RUN-IN|1966-11-02||1969-01-03|1960-12-01|1961-10-28
TRIAL STUDY 134XCP|PP|71B78EFA-AE7A-4248-9A59-63885131F1D1|710||ERINT|EXCRET RATE FROM T1 TO T2||||||||NOT DONE||PLEURAL FLUID|||OPEN LABEL TREATMENT|1967-05-15||1971-10-27|1970-11-19|1971-02-20
TRIAL STUDY 134XCP|PP|CE28B885-422E-471D-895C-DE8F41CD9FE9|711||ERINTB|EXCRET RATE FROM T1 TO T2 NORM BY BMI||||||||NOT DONE||BILE|||BASELINE|1960-10-25||1968-07-24|1967-02-01|1972-06-05
TRIAL STUDY 134XCP|PP|FF7391DA-13A3-4548-BFB3-E79A2E9698E5|712||CMAXLN|MAX CONC LN TRANSFORMED||||||||NOT DONE||TUMOR TISSUE|||WASHOUT|1965-05-05||1969-08-21|1966-03-31|1972-03-13
TRIAL STUDY 134XCP|PP|CE23E4F1-2E6F-42A8-964C-E7D3810F3982|713||AUCALLD|AUC ALL NORM BY DOSE||||||||NOT DONE||SPERMATOZOON|||LONG-TERM FOLLOW-UP|1963-02-19||1964-05-06|1963-09-15|1970-07-15
TRIAL STUDY 134XCP|PP|A9F69F2E-28FD-4581-BC39-9BAE2CFAA862|714||CLRPCLEV|RENAL CL AS PCT CL EV||||||||NOT DONE||SUPERNATANT, PLASMA|||FOLLOW-UP|1964-11-12||1961-11-04|1972-05-23|1961-04-06
TRIAL STUDY 134XCP|PP|3AA56307-0D09-4C82-91B6-717A7C503EFE|715||AUMCPEP|AUMC % EXTRAPOLATION PRED||||||||NOT DONE||VENOUS PLASMA|||RUN-IN|1966-03-20||1961-07-29|1964-09-09|1967-09-10
TRIAL STUDY 134XCP|PP|811AE318-625A-4913-8B18-2D318AF04EAC|716||SRAUC|STATIONARITY RATIO AUC||||||||NOT DONE||AMNIOTIC FLUID|||WASHOUT|1962-06-12||1962-11-01|1961-08-20|1968-02-23
TRIAL STUDY 134XCP|PP|E8F0AF72-5DB4-41D5-814E-5E280A027E94|717||RCAMIFPS|AMT REC INFINITY PRED NORM BY SA||||||||NOT DONE||VENOUS CORD BLOOD|||CONTINUATION TREATMENT|1973-05-09||1961-03-09|1969-12-02|1961-01-22
TRIAL STUDY 134XCP|PP|3B726736-01B3-4A69-ABFB-C6255E341E69|718||VZOS|VZ OBS NORM BY SA||||||||NOT DONE||SKIN TISSUE|||INDUCTION TREATMENT|1969-06-07||1969-01-25|1968-02-20|1972-09-17
TRIAL STUDY 134XCP|PP|C96A9C9D-3EFF-4675-8B75-9B38D4D94AF0|719||RARECINT|RATIO AMT REC FROM T1 TO T2||||||||NOT DONE||BONE MARROW MONONUCLEAR CELL|||INDUCTION TREATMENT|1969-05-10||1968-01-26|1964-08-17|1970-04-11
TRIAL STUDY 134XCP|PP|0535EF31-5388-4CC0-8567-44F4C20975EC|720||RNCLTAUB|RENAL CL FOR DOSE INT NORM BY BMI||||||||NOT DONE||SMEGMA|||LONG-TERM FOLLOW-UP|1969-04-28||1967-08-04|1965-01-01|1961-11-27
TRIAL STUDY 134XCP|PP|F149BD98-0802-4C18-8599-426C5258D513|721||RCAMIFPB|AMT REC INFINITY PRED NORM BY BMI||||||||NOT DONE||EMOTIONAL TEAR|||OBSERVATION|1960-12-26||1967-07-02|1969-07-17|1966-09-17
TRIAL STUDY 134XCP|PP|5A31D035-90D2-4BD0-AE08-839862D6E0DF|722||VSSOW|VOL DIST STEADY STATE OBS NORM BY WT||||||||NOT DONE||ADIPOSE TISSUE|||OPEN LABEL TREATMENT|1960-02-04||1969-12-04|1961-02-16|1968-08-18
TRIAL STUDY 134XCP|PP|B337DBF1-53AC-4DA1-B1AE-A023F8189A49|723||RNCLUB|RENAL CL FOR UNBOUND DRUG||||||||NOT DONE||HAIR|||INDUCTION TREATMENT|1973-08-18||1973-07-06|1961-01-15|1965-12-03
TRIAL STUDY 134XCP|PP|A6E5EEA6-957D-40C8-9D9E-99FEB525A355|724||AUCPBEO|AUC %BACK EXTRAPOLATION OBS||||||||NOT DONE||MIXED VENOUS BLOOD|||WASHOUT|1972-04-25||1970-09-29|1970-10-03|1968-12-24
TRIAL STUDY 134XCP|PP|9C9398A4-38BC-40A7-880D-4549A676F69B|725||CAVGINTB|AVERAGE CONC FROM T1 TO T2 NORM BY BMI||||||||NOT DONE||ARTERIAL CORD BLOOD|||RUN-IN|1972-07-30||1973-01-02|1962-08-08|1965-05-27
TRIAL STUDY 134XCP|PP|4FDE7F38-E0DD-40E7-B193-E2BEC4D3B549|726||NRENLCLW|NONRENAL CL NORM BY WT||||||||NOT DONE||LUNG SURFACTANT|||OBSERVATION|1970-11-29||1962-05-24|1970-12-12|1966-04-06
TRIAL STUDY 134XCP|PP|DFFEFBCE-D68C-4BE3-99AA-5866EF7F2824|727||ERINTD|EXCRET RATE FROM T1 TO T2 NORM BY DOSE||||||||NOT DONE||PLASMA ULTRAFILTRATE|||TREATMENT|1972-11-28||1969-04-30|1971-12-22|1966-01-27
TRIAL STUDY 134XCP|PP|1E049F70-8E29-458F-BF37-13450BC9227E|728||CLRPCLEV|RENAL CL AS PCT CL EV||||||||NOT DONE||EXUDATE|||TREATMENT|1970-07-13||1971-10-01|1960-08-09|1972-12-12
TRIAL STUDY 134XCP|PP|7A612F0F-943A-4283-9A11-B8E8E8D68D66|729||VSSPD|VOL DIST STEADY STATE PRED NORM BY DOSE||||||||NOT DONE||EMESIS|||TREATMENT|1960-08-09||1969-08-18|1969-03-16|1972-03-28
TRIAL STUDY 134XCP|PP|DBFC7D83-4E1D-47FA-9DD9-35923025B44B|730||VZFPS|VZ PRED BY F NORM BY SA||||||||NOT DONE||URINE|||SCREENING|1964-10-01||1969-03-01|1964-11-16|1961-09-16
TRIAL STUDY 134XCP|PP|8C86A799-2717-46E8-99C2-76D11AAB54D7|731||AUCPEO|AUC %EXTRAPOLATION OBS||||||||NOT DONE||CIRCULATING TUMOR CELL|||BLINDED TREATMENT|1971-10-30||1964-06-04|1961-11-04|1965-07-01
TRIAL STUDY 134XCP|PP|727807A8-A180-4589-A553-E3C82E1D3CF2|732||ARAUCIOD|ACCUM RATIO AUCIFO NORM BY DOSE||||||||NOT DONE||BILE|||CONTINUATION TREATMENT|1971-04-20||1970-09-06|1968-09-10|1973-02-14
TRIAL STUDY 134XCP|PP|BFFB5321-5FC7-4465-8579-D75865306359|733||MRAUCTAU|METABOLITE RATIO FOR AUC DOSING INTERVAL||||||||NOT DONE||CERVICOVAGINAL SECRETION|||FOLLOW-UP|1968-04-15||1964-09-07|1964-01-20|1973-06-05
TRIAL STUDY 134XCP|PP|12F9A745-F76D-4222-B37E-22AF93981ECE|734||RCPCTAU|PCT REC OVER DOSING INTERVAL||||||||NOT DONE||LEUKOCYTE|||BASELINE|1963-02-16||1961-03-25|1965-09-24|1970-05-26
TRIAL STUDY 134XCP|PP|BA8BF93F-ECC0-4EE9-A5C0-554DC9A0D297|735||AUMCPEO|AUMC % EXTRAPOLATION OBS||||||||NOT DONE||CERUMEN|||OPEN LABEL TREATMENT|1973-07-08||1965-02-24|1967-07-06|1964-10-20
TRIAL STUDY 134XCP|PP|37693A38-D8A0-4313-A4D1-56E282579636|736||VZPS|VZ PRED NORM BY SA||||||||NOT DONE||PLATELET POOR PLASMA|||FOLLOW-UP|1963-10-31||1973-01-08|1967-12-30|1972-02-29
TRIAL STUDY 134XCP|PP|5C48E0BB-FD52-47F5-8759-6126ECB47B80|737||AUCIFOLN|AUC INFINITY OBS LN TRANSFORMED||||||||NOT DONE||BONE MARROW|||WASHOUT|1961-04-06||1965-03-31|1969-04-23|1966-11-26
TRIAL STUDY 134XCP|PP|5B420A5A-DB2C-48D2-8E9B-97639F49F182|738||RENALCL|RENAL CL||||||||NOT DONE||LEUKOCYTE|||CONTINUATION TREATMENT|1960-05-30||1963-04-28|1961-06-12|1970-04-27
TRIAL STUDY 134XCP|PP|F21F3E77-82CF-44D8-AE5A-FAC04EACD019|739||ARCMIN|ACCUMULATION RATIO CMIN||||||||NOT DONE||SERUM OR PLASMA OR BLOOD|||TREATMENT|1962-06-30||1968-03-19|1962-06-01|1969-03-26
TRIAL STUDY 134XCP|PP|6AB33EBF-5C5B-4040-9A18-0AF864BC490F|740||FREL|RELATIVE BIOAVAILABILITY||||||||NOT DONE||SEMINAL FLUID|||FOLLOW-UP|1963-05-12||1972-03-01|1966-07-22|1963-05-10
TRIAL STUDY 134XCP|PP|0D4B685D-9C50-416C-B5B3-A17B7653AAEB|741||RACMIN|RATIO MIN CONC||||||||NOT DONE||INFRANATANT, SERUM|||FOLLOW-UP|1965-04-22||1969-11-08|1966-11-27|1971-12-28
TRIAL STUDY 134XCP|PP|9B95CE9F-E755-463A-92EC-07A55EE8A58F|742||VZOD|VZ OBS NORM BY DOSE||||||||NOT DONE||BONE|||OBSERVATION|1967-02-23||1964-02-14|1960-05-08|1967-01-08
TRIAL STUDY 134XCP|PP|ED388A78-3B06-4529-861A-0174E7F345C2|743||ERLSTW|LAST MEAS EXCRETION RATE NORM BY WT||||||||NOT DONE||INFRANATANT, PLASMA|||WASHOUT|1968-06-02||1972-11-06|1971-12-30|1962-02-08
TRIAL STUDY 134XCP|PP|F73DB6D9-A860-4250-ABF8-017C4E62FCFA|744||AUCINTS|AUC FROM T1 TO T2 NORM BY SA||||||||NOT DONE||ARTERIALIZED CAPILLARY BLOOD|||WASHOUT|1967-06-28||1965-11-27|1965-12-08|1965-12-18
TRIAL STUDY 134XCP|PP|172AB680-362D-488C-9DF1-E1C8E386980D|745||FB|FRACTION BOUND||||||||NOT DONE||MUCUS|||FOLLOW-UP|1962-05-01||1965-09-12|1962-12-02|1970-11-26
TRIAL STUDY 134XCP|PP|833FAF15-E8F8-47C9-AA1A-1454DC00FA78|746||SRAUC|STATIONARITY RATIO AUC||||||||NOT DONE||REFLEX TEAR|||WASHOUT|1971-07-27||1965-12-01|1970-11-28|1971-03-21
TRIAL STUDY 134XCP|PP|8317AFA6-2E45-4B5B-AFE9-31AE86761BAC|747||CTROUGHD|CONC TROUGH BY DOSE||||||||NOT DONE||DERMAL TISSUE|||WASHOUT|1960-03-21||1964-09-18|1971-07-14|1960-02-07
TRIAL STUDY 134XCP|PP|9C06CFC3-5D87-4717-89D0-172EA17ABDAB|748||AUCTAUD|AUC OVER DOSING INTERVAL NORM BY DOSE||||||||NOT DONE||ALVEOLAR AIR|||WASHOUT|1969-07-05||1964-12-27|1960-08-11|1969-12-23
TRIAL STUDY 134XCP|PP|AE7EAB81-A12F-4135-A64A-E89CD55E0AFE|749||RAAUCALL|RATIO AUC ALL||||||||NOT DONE||INFRANATANT, PLEURAL FLUID|||OPEN LABEL TREATMENT|1971-11-19||1961-12-31|1967-02-18|1963-11-17
TRIAL STUDY 134XCP|PP|2DF1D841-0B0E-477D-A73E-BE3F73F0DDA3|750||RCAMINTB|AMT REC FROM T1 TO T2 NORM BY BMI||||||||NOT DONE||VENOUS PLASMA|||INDUCTION TREATMENT|1961-09-15||1971-01-26|1971-02-02|1971-08-13
TRIAL STUDY 134XCP|PP|740D80F1-8BD5-4409-8087-E48F94363362|751||VZFOD|VZ OBS BY F NORM BY DOSE||||||||NOT DONE||SUPERNATANT, PLEURAL FLUID|||FOLLOW-UP|1972-11-09||1962-04-29|1962-10-01|1960-10-03
TRIAL STUDY 134XCP|PP|39FB0A16-25B8-4D51-B9F5-9ADACCEF6A87|752||AUCALLS|AUC ALL NORM BY SA||||||||NOT DONE||NAIL|||INDUCTION TREATMENT|1963-10-09||1963-06-06|1968-05-18|1964-04-05
TRIAL STUDY 134XCP|PP|12AD3838-F986-4A27-8AEE-59C387988B0F|753||CLPS|TOTAL CL PRED NORM BY SA||||||||NOT DONE||CALCULUS|||TREATMENT|1969-06-01||1964-04-09|1973-03-06|1961-09-27
TRIAL STUDY 134XCP|PP|441F1A21-6350-478A-9719-75B053182B78|754||CLSTD|LAST NONZERO CONC NORM BY DOSE||||||||NOT DONE||BONE MARROW MONONUCLEAR CELL|||INDUCTION TREATMENT|1970-02-27||1966-07-22|1963-03-18|1971-03-31
TRIAL STUDY 134XCP|PP|A69520E2-01A5-4CBC-AFC9-00324531779F|755||CMINS|MIN CONC NORM BY SA||||||||NOT DONE||CELL PELLET|||SCREENING|1966-10-08||1963-11-12|1971-07-24|1962-01-30
TRIAL STUDY 134XCP|PP|1BCAEE81-9148-4D99-93E7-8B9CC9C9C1E7|756||AUMCIFOS|AUMC INFINITY OBS NORM BY SA||||||||NOT DONE||INFRANATANT, PLEURAL FLUID|||INDUCTION TREATMENT|1966-09-21||1961-07-29|1972-08-01|1971-01-28
TRIAL STUDY 134XCP|PP|C361B153-4623-4F03-9D81-8316B1046F35|757||ARAUCIPD|ACCUM RATIO AUCIFP NORM BY DOSE||||||||NOT DONE||CEREBROSPINAL FLUID|||INDUCTION TREATMENT|1961-08-30||1970-05-12|1964-05-14|1960-09-21
TRIAL STUDY 134XCP|PP|8FF0A93C-26D1-49E9-853F-B063A958FE1E|758||VSSOS|VOL DIST STEADY STATE OBS NORM BY SA||||||||NOT DONE||CERUMEN|||BLINDED TREATMENT|1961-07-02||1972-07-10|1969-04-18|1966-07-20
TRIAL STUDY 134XCP|PP|31D8814B-5542-4540-B955-24410D42F1EF|759||VZFTAU|VZ FOR DOSE INT BY F||||||||NOT DONE||STOOL|||TREATMENT|1966-07-08||1966-04-06|1973-01-21|1964-01-07
TRIAL STUDY 134XCP|PP|F49BC9E7-45A5-4482-AA39-EC49857B2B6A|760||AUCIFPB|AUC INFINITY PRED NORM BY BMI||||||||NOT DONE||VENOUS CORD BLOOD|||RUN-IN|1973-05-17||1965-04-03|1960-12-15|1963-09-05
TRIAL STUDY 134XCP|PP|A55BBD57-6AD2-4D49-9377-7CD13BFF800C|761||AUCLSTW|AUC TO LAST NONZERO CONC NORM BY WT||||||||NOT DONE||EPITHELIAL CELL|||FOLLOW-UP|1969-08-06||1969-01-14|1968-09-08|1966-07-29
TRIAL STUDY 134XCP|PP|15BFC17A-2F55-441A-AB99-76D270D62367|762||RCPCIFOW|PCT REC INFINITY OBS NORM BY WT||||||||NOT DONE||DISCHARGE|||BLINDED TREATMENT|1971-01-05||1961-09-18|1972-03-04|1968-09-01
TRIAL STUDY 134XCP|PP|CA231D77-1A1F-49F3-8172-06709A1330B7|763||ARCMAX|ACCUMULATION RATIO CMAX||||||||NOT DONE||ALVEOLAR AIR|||WASHOUT|1963-04-27||1963-03-15|1966-10-21|1963-01-06
TRIAL STUDY 134XCP|PP|7A4D6074-E870-40E8-B567-D069BCB7DA9F|764||MRTEVIFP|MRT EXTRAVASC INFINITY PRED||||||||NOT DONE||ARTERIAL BLOOD|||TREATMENT|1960-01-23||1973-08-05|1966-05-11|1961-08-10
TRIAL STUDY 134XCP|PP|3DDD2A7E-B955-424B-B485-54E81D0E0699|765||RENCLTAU|RENAL CL FOR DOSE INT||||||||NOT DONE||LYMPH|||SCREENING|1961-08-20||1973-01-11|1968-11-25|1963-04-28
TRIAL STUDY 134XCP|PP|D6757E79-3104-468E-BADC-8CCB51BFAE87|766||V0S|VOL DIST INITIAL NORM BY SA||||||||NOT DONE||CALCULUS|||LONG-TERM FOLLOW-UP|1967-01-21||1964-03-27|1972-04-18|1970-05-16
TRIAL STUDY 134XCP|PP|1AD25253-DE25-4DB8-A2C6-04763FEEB73E|767||CLPB|TOTAL CL PRED NORM BY BMI||||||||NOT DONE||SYNOVIAL FLUID|||INDUCTION TREATMENT|1967-06-11||1964-07-16|1963-08-19|1971-06-18
TRIAL STUDY 134XCP|PP|FBAA59F4-154C-40CC-B740-A87769BFEC45|768||RCAMIFOB|AMT REC INFINITY OBS NORM BY BMI||||||||NOT DONE||SEBUM|||FOLLOW-UP|1960-06-20||1973-07-25|1972-09-19|1968-06-26
TRIAL STUDY 134XCP|PP|9A9E638B-426B-4F3E-8363-50DC2617FD63|769||C0S|INITIAL CONC NORM BY SA||||||||NOT DONE||VENOUS CORD BLOOD|||INDUCTION TREATMENT|1969-06-21||1966-05-22|1965-07-26|1972-09-17
TRIAL STUDY 134XCP|PP|9995CD08-2650-4711-8F04-E41183E28B21|770||RNCLINTW|RENAL CL FROM T1 TO T2 NORM BY WT||||||||NOT DONE||COLOSTRUM|||LONG-TERM FOLLOW-UP|1972-05-27||1963-08-23|1972-01-06|1962-02-23
TRIAL STUDY 134XCP|PP|B7ED8BAC-7627-43FE-AF13-DB7398A6AF9A|771||CLSTW|LAST NONZERO CONC NORM BY WT||||||||NOT DONE||PLATELET POOR PLASMA|||LONG-TERM FOLLOW-UP|1961-10-17||1963-10-09|1965-02-15|1960-07-21
TRIAL STUDY 134XCP|PP|DE805225-C632-46E6-B673-DA0D864D47F7|772||VZFOD|VZ OBS BY F NORM BY DOSE||||||||NOT DONE||PROSTATIC FLUID|||RUN-IN|1965-11-11||1968-10-13|1965-05-17|1963-01-08
TRIAL STUDY 134XCP|PP|9C921E89-706F-46E8-ADE3-A806289D43A5|773||AUCIFPW|AUC INFINITY PRED NORM BY WT||||||||NOT DONE||DISCHARGE|||LONG-TERM FOLLOW-UP|1962-02-15||1961-11-18|1962-04-10|1966-02-23
TRIAL STUDY 134XCP|PP|9EB82D4E-DE71-49D9-AA9E-C52EC90D64BB|774||AURCLSTS|AURC DOSING TO LAST CONC NORM BY SA||||||||NOT DONE||LYSATE|||CONTINUATION TREATMENT|1972-02-11||1966-08-09|1965-06-24|1966-09-13
TRIAL STUDY 134XCP|PP|17C2A52E-1232-4CBB-A809-9DC2C863366A|775||AUCIFPDW|AUCIFPDW NORM BY DOSE/WT||||||||NOT DONE||SEBUM|||WASHOUT|1960-06-23||1973-03-20|1972-08-29|1967-04-24
TRIAL STUDY 134XCP|PP|32B58BED-E5BF-4E10-8DBB-36DC44F68C26|776||AURCIFPD|AURC INFINITY PRED NORM BY DOSE||||||||NOT DONE||EXPIRED AIR|||BASELINE|1968-02-19||1973-06-21|1965-04-25|1963-08-16
TRIAL STUDY 134XCP|PP|AC14DD26-89BB-4F9D-BAD5-F2C8E62CC93B|777||RCAMIFPS|AMT REC INFINITY PRED NORM BY SA||||||||NOT DONE||VENOUS CORD BLOOD|||LONG-TERM FOLLOW-UP|1967-09-03||1966-11-28|1970-01-31|1973-06-09
TRIAL STUDY 134XCP|PP|93324DA9-7BD9-4CCA-B575-57A81E5F0C33|778||VZFO|VZ OBS BY F||||||||NOT DONE||SKIN TISSUE|||OBSERVATION|1967-03-20||1964-07-22|1963-03-04|1962-06-23
TRIAL STUDY 134XCP|PP|585A17D7-12A3-40C8-811F-339497B9D09C|779||AUCTAU|AUC OVER DOSING INTERVAL||||||||NOT DONE||BLOOD|||CONTINUATION TREATMENT|1972-01-07||1967-07-24|1970-06-18|1970-07-15
TRIAL STUDY 134XCP|PP|D777661E-DF03-4221-88CC-34EB805EF5DB|780||FABS|ABSOLUTE BIOAVAILABILITY||||||||NOT DONE||BLOOD|||FOLLOW-UP|1973-01-10||1973-03-19|1971-09-09|1961-10-23
TRIAL STUDY 134XCP|PP|67828FC5-94DE-4A68-83DE-F86AA8F86D72|781||CLST|LAST NONZERO CONC||||||||NOT DONE||MENSTRUAL BLOOD|||INDUCTION TREATMENT|1961-02-26||1968-12-20|1972-10-22|1962-01-02
TRIAL STUDY 134XCP|PP|A0DEC4FD-123D-41A0-8357-81496BB5B2DC|782||AUCLSTB|AUC TO LAST NONZERO CONC NORM BY BMI||||||||NOT DONE||PLASMA|||TREATMENT|1961-07-26||1961-09-02|1962-01-15|1965-08-27
TRIAL STUDY 134XCP|PP|650E5DFA-08CC-413C-B43D-070E61353E6E|783||VZPW|VZ PRED NORM BY WT||||||||NOT DONE||SERUM OR PLASMA|||CONTINUATION TREATMENT|1967-01-19||1973-08-31|1966-01-21|1967-12-21
TRIAL STUDY 134XCP|PP|71716F05-3ABE-4A2A-B9DD-2201A63087ED|784||VZTAUB|VZ FOR DOSE INT NORM BY BMI||||||||NOT DONE||SEBUM|||SCREENING|1966-04-03||1969-08-30|1963-06-23|1964-03-31
TRIAL STUDY 134XCP|PP|EF9208B0-4DF0-4029-AB67-8F87662D3E90|785||MRAUCLST|METABOLITE RATIO AUC LAST NONZERO CONC||||||||NOT DONE||INTERSTITIAL FLUID|||SCREENING|1962-09-10||1961-10-17|1962-12-10|1968-03-03
TRIAL STUDY 134XCP|PP|6A9F1495-1ECD-44FA-BAEE-29C96EF238E5|786||FU|FRACTION UNBOUND||||||||NOT DONE||SUPERNATANT, SERUM OR PLASMA|||CONTINUATION TREATMENT|1967-03-02||1961-05-21|1972-11-04|1966-04-24
TRIAL STUDY 134XCP|PP|25580765-CB09-4BE3-8DED-C0068C69E9C4|787||AURCALLD|AURC ALL NORM BY DOSE||||||||NOT DONE||GASTRIC CONTENTS|||BASELINE|1968-11-08||1964-07-26|1964-07-14|1969-12-08
TRIAL STUDY 134XCP|PP|98A99811-9439-4BC7-BDE8-CCF6DD7DF4A3|788||CLOB|TOTAL CL OBS NORM BY BMI||||||||NOT DONE||VENOUS PLASMA|||BLINDED TREATMENT|1962-01-10||1971-09-08|1970-08-11|1970-07-08
TRIAL STUDY 134XCP|PP|A902F087-3BF4-4387-80F9-DDCDDCE1813E|789||VZTAUD|VZ FOR DOSE INT NORM BY DOSE||||||||NOT DONE||SYNOVIAL FLUID|||CONTINUATION TREATMENT|1964-11-20||1964-03-20|1961-07-03|1964-08-22
TRIAL STUDY 134XCP|PP|BC88F32F-FEB6-46D0-8B45-4A30BA4625E9|790||RACONC|RATIO CONCENTRATION||||||||NOT DONE||SEMINAL FLUID|||BASELINE|1960-07-06||1962-07-17|1963-11-24|1961-12-19
TRIAL STUDY 134XCP|PP|415F9206-A793-437C-B227-BD245DBF40AB|791||TMAX|TIME OF CMAX||||||||NOT DONE||SWABBED MATERIAL|||BASELINE|1965-01-21||1964-02-17|1972-06-09|1969-10-01
TRIAL STUDY 134XCP|PP|C580BA02-D031-4875-AC02-347AA65C4C6C|792||FREL|RELATIVE BIOAVAILABILITY||||||||NOT DONE||LOCHIA|||BLINDED TREATMENT|1964-07-07||1970-07-25|1968-05-12|1964-08-11
TRIAL STUDY 134XCP|PP|4DD6944D-662E-4C9A-A663-601B657BCF5E|793||AILAMZ|ACCUMULATION INDEX USING LAMBDA Z||||||||NOT DONE||SPERMATOZOON|||OPEN LABEL TREATMENT|1968-01-02||1966-02-20|1967-09-26|1967-05-21
TRIAL STUDY 134XCP|PP|24DD8893-87F9-44E9-8F9D-3E8CCD5EA2AB|794||RENCLTAU|RENAL CL FOR DOSE INT||||||||NOT DONE||EMESIS|||TREATMENT|1961-07-19||1973-05-24|1968-07-07|1965-12-03
TRIAL STUDY 134XCP|PP|69A130F1-44A1-4091-BF0C-FF8087CC9940|795||ERINTW|EXCRET RATE FROM T1 TO T2 NORM BY WT||||||||NOT DONE||LEUKOCYTE|||WASHOUT|1962-03-09||1961-03-06|1965-08-14|1969-10-14
TRIAL STUDY 134XCP|PP|EAEBBD6C-E86D-4865-AE17-82BF5F3823DF|796||HDCL|HEMODIALYSIS CLEARANCE||||||||NOT DONE||CERUMEN|||BLINDED TREATMENT|1964-08-02||1964-03-16|1962-03-05|1964-11-29
TRIAL STUDY 134XCP|PP|96C60715-2EDE-40FD-B41C-ECD1E5065C81|797||AURCALLW|AURC ALL NORM BY WT||||||||NOT DONE||SEBUM|||CONTINUATION TREATMENT|1972-01-24||1966-05-23|1971-07-27|1968-10-15
TRIAL STUDY 134XCP|PP|61C29FFE-8EA1-47B9-A060-37D70EDCB88D|798||VSSOD|VOL DIST STEADY STATE OBS NORM BY DOSE||||||||NOT DONE||SERUM OR PLASMA|||OPEN LABEL TREATMENT|1960-02-06||1967-04-23|1968-12-14|1970-02-07
TRIAL STUDY 134XCP|PP|8452DD7A-4DC9-4BDF-B670-AE5B49292805|799||CMAXUB|MAX CONC, UNBOUND DRUG||||||||NOT DONE||LEUKOCYTE|||OPEN LABEL TREATMENT|1966-02-01||1967-05-02|1962-11-07|1961-02-22
TRIAL STUDY 134XCP|PP|F955EF3A-FE2C-4F03-9384-9FBCF637DB0E|800||V0|VOL DIST INITIAL||||||||NOT DONE||INFRANATANT, PLEURAL FLUID|||OBSERVATION|1960-05-03||1960-06-23|1964-10-26|1960-02-19
TRIAL STUDY 134XCP|PP|30108497-140B-499E-8924-8BFCDC57457A|801||AUCIFOS|AUC INFINITY OBS NORM BY SA||||||||NOT DONE||PERIPHERAL BLOOD MONONUCLEAR CELL|||OPEN LABEL TREATMENT|1963-09-09||1970-12-16|1961-05-06|1963-01-21
TRIAL STUDY 134XCP|PP|5FFEF358-5014-497F-A091-6EF27A1BCF7D|802||RCAMIFPB|AMT REC INFINITY PRED NORM BY BMI||||||||NOT DONE||DIALYSIS FLUID|||INDUCTION TREATMENT|1965-01-13||1972-11-10|1962-12-02|1968-01-16
TRIAL STUDY 134XCP|PP|9DFBE459-22E4-4BA7-A993-AC06D6644562|803||CLFPS|TOTAL CL PRED BY F NORM BY SA||||||||NOT DONE||SEMINAL FLUID|||OPEN LABEL TREATMENT|1963-09-20||1964-05-15|1972-12-03|1963-12-25
TRIAL STUDY 134XCP|PP|850B35FA-69C7-44AD-A471-964C59C4CFD8|804||TROUGHPR|TROUGH PEAK RATIO||||||||NOT DONE||CERUMEN|||RUN-IN|1965-06-20||1969-06-28|1962-01-19|1970-05-30
TRIAL STUDY 134XCP|PP|981B890E-1257-4F04-A974-6006401F78CC|805||AUMCIFOW|AUMC INFINITY OBS NORM BY WT||||||||NOT DONE||SKELETAL MUSCLE TISSUE|||OBSERVATION|1960-12-12||1970-10-08|1962-08-10|1962-01-31
TRIAL STUDY 134XCP|PP|52FF8D96-64AD-498D-8B28-3DDD015796E3|806||AUCPBEO|AUC %BACK EXTRAPOLATION OBS||||||||NOT DONE||LYMPH|||TREATMENT|1969-09-18||1964-11-14|1960-10-31|1969-04-06
TRIAL STUDY 134XCP|PP|B017565E-4AF2-4B01-B65A-2A9FB3B96F40|807||AUCLSTW|AUC TO LAST NONZERO CONC NORM BY WT||||||||NOT DONE||PLASMA|||RUN-IN|1960-12-14||1965-09-12|1968-03-26|1967-08-05
TRIAL STUDY 134XCP|PP|7DC0EC29-9F24-4851-A953-1EC6490D8ACD|808||AUCIFO|AUC INFINITY OBS||||||||NOT DONE||PERITONEAL FLUID|||WASHOUT|1968-08-28||1969-09-30|1973-02-19|1968-04-07
TRIAL STUDY 134XCP|PP|CD65CBB8-D056-4738-93A8-FF465534961B|809||AUCTAU|AUC OVER DOSING INTERVAL||||||||NOT DONE||FLUID|||RUN-IN|1961-12-29||1964-11-26|1962-04-02|1961-12-08
TRIAL STUDY 134XCP|PP|7F014394-ABE2-45F8-891F-2DE808762532|810||VZTAU|VZ FOR DOSE INT||||||||NOT DONE||NAIL|||SCREENING|1963-06-28||1970-11-13|1963-01-14|1971-04-20
TRIAL STUDY 134XCP|PP|523E40AD-3C19-46E6-B839-0BF83AFB5EF4|811||CAVINTDW|CAVGINT NORM BY DOSE/WT||||||||NOT DONE||EMESIS|||SCREENING|1962-10-10||1961-07-04|1966-12-22|1971-10-29
TRIAL STUDY 134XCP|PP|FB781158-BB8A-4A75-BD55-00D6A5C72720|812||CLRPCLIV|RENAL CL AS PCT CL IV||||||||NOT DONE||URINE SEDIMENT|||TREATMENT|1961-01-08||1964-09-26|1969-08-01|1969-06-21
TRIAL STUDY 134XCP|PP|F9A4A196-CB1F-48A3-9CA7-F1F3483062F0|813||ARAUCIOD|ACCUM RATIO AUCIFO NORM BY DOSE||||||||NOT DONE||SERUM|||BLINDED TREATMENT|1964-01-28||1971-04-20|1963-03-22|1963-07-22
TRIAL STUDY 134XCP|PP|90D79875-49B9-4EE2-A23D-5DBC7AA489FA|814||AURCLSTW|AURC DOSING TO LAST CONC NORM BY WT||||||||NOT DONE||SOFT TISSUE|||OPEN LABEL TREATMENT|1973-03-15||1965-01-30|1969-06-05|1960-10-25
TRIAL STUDY 134XCP|PP|505A1BB6-135A-4839-BB9E-6DD37F49DC45|815||ARCTROUD|ACCUM RATIO CTROUGH NORM BY DOSE||||||||NOT DONE||BASAL TEAR|||OBSERVATION|1970-12-18||1963-08-08|1964-01-31|1965-03-06
TRIAL STUDY 134XCP|PP|E0889B7B-923D-4AFF-ACB7-952B7BAF912F|816||RNCLTAUS|RENAL CL FOR DOSE INT NORM BY SA||||||||NOT DONE||TUMOR TISSUE|||TREATMENT|1962-04-04||1970-07-08|1967-07-28|1972-06-11
TRIAL STUDY 134XCP|PP|16F375DC-DC27-461B-969E-1269DC53F4D9|817||AUCLSTB|AUC TO LAST NONZERO CONC NORM BY BMI||||||||NOT DONE||RETICULOCYTES|||OBSERVATION|1969-01-23||1964-04-16|1970-04-24|1970-08-18
TRIAL STUDY 134XCP|PP|17BF9A68-265F-4FCC-A499-615A1B71A8D6|818||LAMZUL|LAMBDA Z UPPER LIMIT||||||||NOT DONE||LEUKOCYTE|||WASHOUT|1968-03-01||1965-12-27|1965-10-22|1967-09-23
TRIAL STUDY 134XCP|PP|327E38A8-FEAD-4868-AA3B-3DF2225E7CDF|819||CLFO|TOTAL CL OBS BY F||||||||NOT DONE||SUPERNATANT, SERUM|||RUN-IN|1962-09-25||1961-02-18|1973-01-20|1973-02-21
TRIAL STUDY 134XCP|PP|B842981B-AD7A-4A03-8E84-D5FC887BAD60|820||VZPB|VZ PRED NORM BY BMI||||||||NOT DONE||PLASMA ULTRAFILTRATE|||RUN-IN|1966-07-16||1972-02-19|1973-07-06|1963-03-17
TRIAL STUDY 134XCP|PP|07F7C4E7-7722-4916-AB89-46EF540E2BD7|821||CLPUB|TOTAL CL PRED FOR UNBOUND DRUG||||||||NOT DONE||LAVAGE FLUID|||INDUCTION TREATMENT|1965-03-21||1968-01-23|1964-09-08|1971-11-02
TRIAL STUDY 134XCP|PP|58661394-906E-43F3-8935-150DF240A04C|822||RENCLTAU|RENAL CL FOR DOSE INT||||||||NOT DONE||PERSPIRATION|||OBSERVATION|1966-11-28||1970-09-24|1964-09-23|1964-05-23
TRIAL STUDY 134XCP|PP|B70F3694-B764-4B39-BFB9-B1281ED091B8|823||RCPCTAUB|PCT REC OVER DOSING INTERVAL NORM BY BMI||||||||NOT DONE||VENOUS PLASMA|||FOLLOW-UP|1969-08-20||1962-01-31|1966-12-13|1967-10-30
TRIAL STUDY 134XCP|PP|5B2471DB-807A-44F8-9529-D2319CCFE017|824||ERLST|LAST MEAS EXCRETION RATE||||||||NOT DONE||SUPERNATANT, CEREBROSPINAL FLUID|||RUN-IN|1964-04-10||1968-12-24|1961-04-04|1961-11-26
TRIAL STUDY 134XCP|PP|14D63A01-8418-4F72-ABE4-6E5DE30AE4C2|825||RCPCIFO|PCT REC INFINITY OBS||||||||NOT DONE||CEREBROSPINAL FLUID|||BLINDED TREATMENT|1962-11-02||1966-07-31|1970-05-05|1966-06-19
TRIAL STUDY 134XCP|PP|A6E00A2C-7DBC-4577-8873-C780F5A6B400|826||ARCMIN|ACCUMULATION RATIO CMIN||||||||NOT DONE||DISCHARGE|||WASHOUT|1962-01-14||1964-11-10|1962-10-17|1972-06-14
TRIAL STUDY 134XCP|PP|06611015-E99C-466B-B0B3-EBE10EA9E627|827||MRAUCIFP|METABOLITE RATIO FOR AUC INFINITY PRED||||||||NOT DONE||GASTRIC CONTENTS|||BLINDED TREATMENT|1970-07-05||1961-08-04|1963-05-02|1971-12-18
TRIAL STUDY 134XCP|PP|5AF91C46-87FC-4714-B956-A4ECFC87C30A|828||RCPCTAUB|PCT REC OVER DOSING INTERVAL NORM BY BMI||||||||NOT DONE||PROSTATIC FLUID|||TREATMENT|1970-05-08||1969-05-29|1970-06-13|1970-08-16
TRIAL STUDY 134XCP|PP|3DEA7E00-77B9-4710-A37E-577F925BFBD8|829||CAVGINTW|AVERAGE CONC FROM T1 TO T2 NORM BY WT||||||||NOT DONE||LAVAGE FLUID|||TREATMENT|1968-04-04||1965-07-04|1965-06-09|1964-02-05
TRIAL STUDY 134XCP|PP|DC79E350-1B89-4518-8B42-5858F5270928|830||CLFP|TOTAL CL PRED BY F||||||||NOT DONE||SEBUM|||SCREENING|1968-05-24||1964-05-22|1962-02-09|1971-07-30
TRIAL STUDY 134XCP|PP|9B8B6DCE-AF08-40AC-90BB-87CCC5592726|831||AURCINTB|AURC FROM T1 TO T2 NORM BY BMI||||||||NOT DONE||BASAL TEAR|||FOLLOW-UP|1963-04-22||1972-02-02|1970-10-19|1968-07-12
TRIAL STUDY 134XCP|PP|7F51014D-D2B5-4956-9DD6-52676EB66ED7|832||ARCMAX|ACCUMULATION RATIO CMAX||||||||NOT DONE||STOOL|||INDUCTION TREATMENT|1969-12-11||1962-07-20|1970-10-21|1966-02-28
TRIAL STUDY 134XCP|PP|0568B2DD-3184-472D-89C6-66A5CE8AE00F|833||AUMCTAUD|AUMC OVER DOSING INTERVAL NORM BY DOSE||||||||NOT DONE||PLATELET|||WASHOUT|1969-06-03||1969-11-07|1962-10-29|1962-02-13
TRIAL STUDY 134XCP|PP|275DC6A6-598C-4997-A442-4A3916AC42BD|834||VSSPUB|VOL DIST STEADY STATE PRED BY UB||||||||NOT DONE||EXPIRED AIR|||OBSERVATION|1973-05-02||1967-03-08|1968-07-18|1963-07-19
TRIAL STUDY 134XCP|PP|B949F90F-524D-4494-A63C-A05F56421EA1|835||RNCLINTW|RENAL CL FROM T1 TO T2 NORM BY WT||||||||NOT DONE||SKIN TISSUE|||OBSERVATION|1968-08-05||1972-01-21|1963-08-26|1973-07-18
TRIAL STUDY 134XCP|PP|152411EA-E7DA-4230-A8A6-163C8A8C0A58|836||CLO|TOTAL CL OBS||||||||NOT DONE||PLEURAL FLUID|||OPEN LABEL TREATMENT|1961-11-16||1961-08-06|1969-02-11|1962-05-13
TRIAL STUDY 134XCP|PP|AB78662C-F90A-4193-9AC7-5621B497A18F|837||RNCLINTB|RENAL CL FROM T1 TO T2 NORM BY BMI||||||||NOT DONE||SMEGMA|||SCREENING|1972-12-21||1960-05-06|1963-07-16|1963-12-28
TRIAL STUDY 134XCP|PP|84CD31FD-BCB9-4439-84F7-11C63D578108|838||AURCINTW|AURC FROM T1 TO T2 NORM BY WT||||||||NOT DONE||PLEURAL TISSUE|||INDUCTION TREATMENT|1964-06-01||1971-08-09|1972-07-02|1966-12-31
TRIAL STUDY 134XCP|PP|BB9A976D-48AC-4618-9BA1-683D97240F2B|839||MRTIVLST|MRT INTRAVASC TO LAST NONZERO CONC||||||||NOT DONE||PLASMA|||OPEN LABEL TREATMENT|1965-04-23||1973-05-19|1964-03-24|1963-06-05
TRIAL STUDY 134XCP|PP|FA440C9B-0D7A-4656-BF17-D46289567FB0|840||CLFTAUW|TOTAL CL BY F FOR DOSE INT NORM BY WT||||||||NOT DONE||VENOUS CORD BLOOD|||OPEN LABEL TREATMENT|1962-07-12||1967-11-04|1967-08-13|1963-04-08
TRIAL STUDY 134XCP|PP|1706BA4E-D2AB-4877-974A-17BDBD834FFF|841||ERLSTD|LAST MEAS EXCRETION RATE NORM BY DOSE||||||||NOT DONE||VENOUS CORD BLOOD|||LONG-TERM FOLLOW-UP|1963-03-25||1967-10-09|1968-02-08|1972-12-29
TRIAL STUDY 134XCP|PP|15E3DD06-7F28-499B-9CF5-6EE5875095B5|842||VZFPB|VZ PRED BY F NORM BY BMI||||||||NOT DONE||ARTERIALIZED CAPILLARY BLOOD|||OBSERVATION|1962-11-05||1972-05-16|1960-02-13|1971-02-20
TRIAL STUDY 134XCP|PP|D6201F20-A9DD-4F72-9FB2-9F238819A0BD|843||CLOUB|TOTAL CL OBS FOR UNBOUND DRUG||||||||NOT DONE||ARTERIAL CORD BLOOD|||CONTINUATION TREATMENT|1961-08-11||1968-09-12|1972-02-10|1967-07-24
TRIAL STUDY 134XCP|PP|787ADEF3-A20C-4977-A06E-1A4BE008C3AB|844||AUCINTW|AUC FROM T1 TO T2 NORM BY WT||||||||NOT DONE||ARTERIALIZED CAPILLARY BLOOD|||INDUCTION TREATMENT|1972-12-25||1964-08-03|1961-11-07|1969-05-28
TRIAL STUDY 134XCP|PP|87ED1C08-AF47-4827-A897-E8FC24A69ECC|845||CHTMAX|CONCENTRATION AT HALF TMAX||||||||NOT DONE||BONE|||OPEN LABEL TREATMENT|1961-07-06||1964-02-08|1972-08-31|1960-08-26
TRIAL STUDY 134XCP|PP|47389FD4-FB17-4BD9-9B08-0F2C6FF60D9A|846||AUCPEO|AUC %EXTRAPOLATION OBS||||||||NOT DONE||EPIDERMAL TISSUE|||TREATMENT|1970-07-31||1971-11-01|1970-01-14|1960-04-10
TRIAL STUDY 134XCP|PP|719A3C37-C9C2-4A84-BEC2-CE3033AB5D2F|847||MRAUCIFO|METABOLITE RATIO FOR AUC INFINITY OBS||||||||NOT DONE||SPUTUM|||SCREENING|1967-12-20||1966-02-28|1969-07-02|1968-02-13
TRIAL STUDY 134XCP|PP|C817A043-1331-47AB-A627-D85893F9D61A|848||AURCLSTW|AURC DOSING TO LAST CONC NORM BY WT||||||||NOT DONE||PLEURAL FLUID|||OBSERVATION|1961-08-13||1969-06-24|1971-02-02|1960-02-11
TRIAL STUDY 134XCP|PP|DDD6F5D1-AE97-412C-A161-869C4178223A|849||C0D|INITIAL CONC NORM BY DOSE||||||||NOT DONE||SUPERNATANT, CEREBROSPINAL FLUID|||RUN-IN|1967-01-16||1962-02-24|1967-11-01|1962-05-23
TRIAL STUDY 134XCP|PP|D41D9F0A-56BF-46E5-A936-3B4AD5210C18|850||CAVGINTS|AVERAGE CONC FROM T1 TO T2 NORM BY SA||||||||NOT DONE||ENDOTRACHEAL FLUID|||CONTINUATION TREATMENT|1961-05-19||1964-05-16|1966-01-20|1973-06-15
TRIAL STUDY 134XCP|PP|25FB07EA-3CB8-430D-B775-CA0E9918C069|851||RARECIFO|RATIO AMT REC INFINITY OBS||||||||NOT DONE||NAIL|||RUN-IN|1960-04-11||1972-08-14|1964-03-28|1963-09-21
TRIAL STUDY 134XCP|PP|21F6CB0B-3483-4BFF-AEC7-FCF14873077A|852||MRAUCTAU|METABOLITE RATIO FOR AUC DOSING INTERVAL||||||||NOT DONE||PLEURAL TISSUE|||WASHOUT|1966-12-26||1968-11-06|1972-12-28|1964-11-09
TRIAL STUDY 134XCP|PP|B49B9695-9815-4B7B-9F96-4EE6A4432062|853||VSSOBD|VOL DIST STEADY STATE OBS BY B||||||||NOT DONE||AMNIOTIC FLUID|||BASELINE|1971-12-14||1964-08-20|1973-08-09|1967-09-28
TRIAL STUDY 134XCP|PP|E1A56CAC-35A4-4EC1-8F3C-8E117E667D44|854||RNCLTAUS|RENAL CL FOR DOSE INT NORM BY SA||||||||NOT DONE||SYNOVIAL FLUID|||SCREENING|1970-09-29||1972-07-18|1965-03-08|1963-04-25
TRIAL STUDY 134XCP|PP|BCA460B7-5102-41F9-BCA7-B7BC0A4A9A53|855||AURCALLS|AURC ALL NORM BY SA||||||||NOT DONE||EMESIS|||INDUCTION TREATMENT|1967-07-03||1964-12-22|1971-11-07|1969-01-30
TRIAL STUDY 134XCP|PP|5FFAB7D3-39FC-4429-9DBA-B1A1B972708B|856||AUCIFPUB|AUC INFINITY PRED, UNBOUND DRUG||||||||NOT DONE||WHITE MATTER TISSUE|||BLINDED TREATMENT|1968-12-20||1960-06-18|1972-08-19|1970-12-30
TRIAL STUDY 134XCP|PP|07A934C8-0237-4B37-9FDD-503B8BF94357|857||VZTAUD|VZ FOR DOSE INT NORM BY DOSE||||||||NOT DONE||EPITHELIAL CELL|||SCREENING|1966-03-29||1968-09-10|1973-09-03|1970-10-08
TRIAL STUDY 134XCP|PP|DB1EA2BE-FBA7-4E37-8F23-3156A349D8FF|858||TAU|DOSING INTERVAL||||||||NOT DONE||URINE SEDIMENT|||CONTINUATION TREATMENT|1967-07-31||1962-10-21|1967-10-17|1962-04-18
TRIAL STUDY 134XCP|PP|10E1249E-10AC-45E8-9896-84C7B0F548BC|859||AURCIFO|AURC INFINITY OBS||||||||NOT DONE||SALIVA|||CONTINUATION TREATMENT|1972-12-11||1969-04-25|1967-10-16|1966-02-19
TRIAL STUDY 134XCP|PP|6CA97CE0-D120-4E14-A82F-4799D2699110|860||VSSPB|VOL DIST STEADY STATE PRED NORM BY BMI||||||||NOT DONE||EPITHELIAL CELL|||SCREENING|1965-01-02||1972-09-05|1960-01-16|1960-10-02
TRIAL STUDY 134XCP|PP|D807C3F6-0955-4742-A29B-815682559530|861||AURCIFPB|AURC INFINITY PRED NORM BY BMI||||||||NOT DONE||LUNG SURFACTANT|||CONTINUATION TREATMENT|1972-08-25||1971-10-18|1970-09-23|1964-06-06
TRIAL STUDY 134XCP|PP|EA95AD62-1630-43A0-ABA5-ADD7C2F31F75|862||RNCLINTW|RENAL CL FROM T1 TO T2 NORM BY WT||||||||NOT DONE||BASAL TEAR|||WASHOUT|1970-11-23||1970-06-15|1964-01-02|1972-07-02
TRIAL STUDY 134XCP|PP|38C36B22-EC60-4D40-A1B6-71B17F8C8625|863||RCPCINTS|PCT REC FROM T1 TO T2 NORM BY SA||||||||NOT DONE||MIXED VENOUS BLOOD|||BASELINE|1969-12-03||1971-02-04|1968-03-29|1965-02-16
TRIAL STUDY 134XCP|PP|E2F4144C-543D-4F55-A94E-58F244FB21D1|864||LAMZNTAU|NUMBER OF POINTS FOR LAMBDA Z TAU||||||||NOT DONE||DISCHARGE|||LONG-TERM FOLLOW-UP|1968-10-25||1960-08-18|1963-08-16|1968-10-15
TRIAL STUDY 134XCP|PP|CA59C4CD-E3E7-46C8-8B88-3D00E448B1D8|865||AURCIFOS|AURC INFINITY OBS NORM BY SA||||||||NOT DONE||KERATINOCYTE|||OPEN LABEL TREATMENT|1960-11-06||1966-07-11|1964-11-18|1965-09-21
TRIAL STUDY 134XCP|PP|49B857CF-22F2-406F-A269-54944B23C236|866||LAMZHL|HALF-LIFE LAMBDA Z||||||||NOT DONE||COLOSTRUM|||OPEN LABEL TREATMENT|1962-05-06||1972-05-04|1969-03-13|1971-03-04
TRIAL STUDY 134XCP|PP|E09B394B-9E48-4132-B430-991DF1953A81|867||ERLSTW|LAST MEAS EXCRETION RATE NORM BY WT||||||||NOT DONE||MUSCLE TISSUE|||SCREENING|1962-02-10||1973-03-27|1962-12-04|1968-04-02
TRIAL STUDY 134XCP|PP|5FB65CB2-DB12-4D00-818E-C51992DC7273|868||CMIND|MIN CONC NORM BY DOSE||||||||NOT DONE||COLOSTRUM|||WASHOUT|1965-01-19||1969-01-25|1971-08-22|1970-12-23
TRIAL STUDY 134XCP|PP|ADACD31B-F89B-4920-9E0C-7C58FA00DEF6|869||VZFOD|VZ OBS BY F NORM BY DOSE||||||||NOT DONE||BILE|||CONTINUATION TREATMENT|1971-06-11||1964-01-19|1962-04-02|1968-02-01
TRIAL STUDY 134XCP|PP|CB6A1101-1EF8-476D-BD15-B60EF323D740|870||CAVGS|AVERAGE CONC NORM BY SA||||||||NOT DONE||INFRANATANT, PLEURAL FLUID|||OBSERVATION|1963-05-04||1966-03-18|1971-03-09|1961-04-20
TRIAL STUDY 134XCP|PP|3AED1654-6D9A-40EE-A560-99F51C469D63|871||RCAMTAUW|AMT REC OVER DOSING INTERVAL NORM BY WT||||||||NOT DONE||SERUM|||WASHOUT|1964-06-05||1967-08-27|1971-08-03|1964-08-30
TRIAL STUDY 134XCP|PP|4C13FD80-8950-4194-B76C-F46B643BED82|872||RNCLTAUD|RENAL CL FOR DOSE INT NORM BY DOSE||||||||NOT DONE||ERYTHROCYTES|||TREATMENT|1966-01-03||1967-11-19|1970-07-04|1963-03-05
TRIAL STUDY 134XCP|PP|AE059FB8-BE8F-4F4A-88A0-4EF300F692D2|873||RCAMTAUS|AMT REC OVER DOSING INTERVAL NORM BY SA||||||||NOT DONE||INFRANATANT, PLASMA|||TREATMENT|1967-02-04||1969-03-02|1966-07-07|1971-01-09
TRIAL STUDY 134XCP|PP|2A3D5CAE-6BC2-4B96-A36C-67C885C519D2|874||TAUHL|HALF-LIFE TAU||||||||NOT DONE||EPITHELIAL CELL|||RUN-IN|1960-11-05||1970-04-15|1973-02-02|1968-12-30
TRIAL STUDY 134XCP|PP|CFFA0003-098B-486E-82DB-30838F6541DD|875||LAMZNTAU|NUMBER OF POINTS FOR LAMBDA Z TAU||||||||NOT DONE||EMESIS|||BASELINE|1970-08-12||1962-03-13|1969-03-29|1960-01-16
TRIAL STUDY 134XCP|PP|C5505069-530E-44CE-BD90-D0F7B0CF9C2D|876||RCAMLST|AMT REC TO LAST NONZERO CONC||||||||NOT DONE||SERUM OR PLASMA OR BLOOD|||SCREENING|1963-04-20||1971-10-28|1971-04-26|1962-10-30
TRIAL STUDY 134XCP|PP|3F29184F-1963-4EC7-881A-61C9DEF95D2D|877||RCAMTAUB|AMT REC OVER DOSING INTERVAL NORM BY BMI||||||||NOT DONE||AQUEOUS HUMOR|||BASELINE|1970-02-27||1961-03-19|1970-10-06|1964-09-25
TRIAL STUDY 134XCP|PP|A962AE4A-1E74-4CC7-8201-A8DF9A1AA8D3|878||LAMZLL|LAMBDA Z LOWER LIMIT||||||||NOT DONE||SEBUM|||BASELINE|1964-05-06||1967-12-28|1967-08-29|1969-04-04
TRIAL STUDY 134XCP|PP|D9C32CF1-51C7-412D-A030-682B2860F89D|879||AUMCTAUW|AUMC OVER DOSING INTERVAL NORM BY WT||||||||NOT DONE||EXPIRED AIR|||RUN-IN|1960-07-30||1962-01-26|1966-11-26|1965-07-27
TRIAL STUDY 134XCP|PP|102F6B51-5A86-497B-A36D-13FB77928C39|880||RCAMIFPS|AMT REC INFINITY PRED NORM BY SA||||||||NOT DONE||LUNG SURFACTANT|||SCREENING|1962-07-19||1969-08-24|1973-01-09|1965-05-10
TRIAL STUDY 134XCP|PP|C123D04C-1AA4-418D-B68C-EC9D410376F0|881||ERLSTW|LAST MEAS EXCRETION RATE NORM BY WT||||||||NOT DONE||DISCHARGE|||CONTINUATION TREATMENT|1961-12-10||1967-12-28|1970-06-29|1969-08-21
TRIAL STUDY 134XCP|PP|30352D31-4A96-4B1C-9BE8-BA4E0DC5A4C6|882||RCAMIFO|AMT REC INFINITY OBS||||||||NOT DONE||SUPERNATANT, SERUM OR PLASMA|||CONTINUATION TREATMENT|1961-12-08||1963-09-24|1967-06-28|1966-08-02
TRIAL STUDY 134XCP|PP|079A46B1-EEB3-4524-AC5F-60E2A9E16DB4|883||CTROUGHW|CONC TROUGH BY WT||||||||NOT DONE||DIALYSIS FLUID|||CONTINUATION TREATMENT|1971-11-09||1965-03-12|1969-06-08|1971-10-26
TRIAL STUDY 134XCP|PP|82BB0613-BBBB-4EA2-90F8-EDCA19A637A5|884||RENALCLB|RENAL CL NORM BY BMI||||||||NOT DONE||INFRANATANT, PLASMA|||INDUCTION TREATMENT|1969-05-15||1972-02-11|1961-05-27|1963-02-15
TRIAL STUDY 134XCP|PP|5F368FD6-5F04-490E-9720-5BE0FE34C1FC|885||AUMCLSTD|AUMC TO LAST NONZERO CONC NORM BY DOSE||||||||NOT DONE||VENOUS PLASMA|||OPEN LABEL TREATMENT|1964-01-11||1968-12-03|1972-03-24|1963-08-06
TRIAL STUDY 134XCP|PP|E3310689-5727-4970-A675-A58931E406FA|886||ARCMIND|ACCUM RATIO CMIN NORM BY DOSE||||||||NOT DONE||PLATELET POOR PLASMA|||FOLLOW-UP|1962-03-19||1966-09-17|1961-07-10|1965-03-17
TRIAL STUDY 134XCP|PP|D5359BBA-960E-4392-996A-BCDD8637894A|887||RCPCIFOB|PCT REC INFINITY OBS NORM BY BMI||||||||NOT DONE||PLEURAL FLUID|||TREATMENT|1963-11-06||1967-09-23|1964-02-16|1960-04-26
TRIAL STUDY 134XCP|PP|C3022BA6-BC2B-4553-A02A-C2FB6B3CBFF5|888||CMINB|MIN CONC NORM BY BMI||||||||NOT DONE||SMEGMA|||SCREENING|1964-03-21||1968-04-08|1967-07-08|1961-12-30
TRIAL STUDY 134XCP|PP|EED3F55E-892E-46C6-8B0A-30D2E1112072|889||AURCIFOW|AURC INFINITY OBS NORM BY WT||||||||NOT DONE||SERUM|||CONTINUATION TREATMENT|1968-12-09||1961-03-04|1963-07-26|1965-04-16
TRIAL STUDY 134XCP|PP|1CE2AE1C-B0E4-4303-AAE5-F877A133D9CF|890||ARAUCIND|ACCUM RATIO AUC T1 TO T2 NORM BY DOSE||||||||NOT DONE||SUPERNATANT, SERUM OR PLASMA|||TREATMENT|1967-12-30||1971-02-27|1962-01-15|1970-05-30
TRIAL STUDY 134XCP|PP|B865DADD-9A4E-4521-A2E8-104D709F4144|891||RCPCINTW|PCT REC FROM T1 TO T2 NORM BY WT||||||||NOT DONE||TUMOR TISSUE|||RUN-IN|1964-11-09||1966-11-25|1968-09-13|1963-04-13
TRIAL STUDY 134XCP|PP|D8C78860-7893-4239-8F29-A0EE98C90310|892||VZFTAUD|VZ FOR DOSE INT BY F NORM BY DOSE||||||||NOT DONE||BREAST MILK|||FOLLOW-UP|1970-03-17||1962-08-14|1971-05-29|1973-02-27
TRIAL STUDY 134XCP|PP|841D0118-C3F9-4169-B43E-D88CEB2795BA|893||CLSTD|LAST NONZERO CONC NORM BY DOSE||||||||NOT DONE||MUCUS|||TREATMENT|1960-05-08||1961-03-08|1962-10-20|1970-01-02
TRIAL STUDY 134XCP|PP|9C3C0334-F7A4-4530-A6D3-574C039979E7|894||AUMCTAUW|AUMC OVER DOSING INTERVAL NORM BY WT||||||||NOT DONE||LUNG SURFACTANT|||INDUCTION TREATMENT|1964-05-10||1969-05-13|1967-08-24|1961-12-12
TRIAL STUDY 134XCP|PP|FE955CB9-9992-4521-8788-7597AF40F214|895||AUCINTS|AUC FROM T1 TO T2 NORM BY SA||||||||NOT DONE||LYMPH|||FOLLOW-UP|1963-12-15||1964-01-15|1966-08-16|1968-03-15
TRIAL STUDY 134XCP|PP|C4C89E29-ADFC-4883-87BA-FA0BDD37AB4D|896||NRENLCLB|NONRENAL CL NORM BY BMI||||||||NOT DONE||SUPERNATANT, SERUM OR PLASMA|||SCREENING|1962-02-09||1960-04-23|1966-05-23|1973-01-02
TRIAL STUDY 134XCP|PP|FF087F6A-E9C7-4A01-B6CD-A95FF609F13E|897||CMIN|MIN CONC||||||||NOT DONE||PLATELET|||OBSERVATION|1964-09-01||1969-04-02|1960-11-10|1968-01-16
TRIAL STUDY 134XCP|PP|28B6CF51-A007-4CED-8247-37BD468F41C5|898||RCAMIFO|AMT REC INFINITY OBS||||||||NOT DONE||VITREOUS HUMOR|||SCREENING|1973-05-11||1969-11-02|1970-11-06|1964-06-10
TRIAL STUDY 134XCP|PP|4E600C41-1B27-4042-B48E-B60489701D2D|899||VZOS|VZ OBS NORM BY SA||||||||NOT DONE||BASAL TEAR|||INDUCTION TREATMENT|1964-04-14||1970-12-01|1965-10-05|1966-04-14
TRIAL STUDY 134XCP|PP|1E162E13-C5F0-4892-BE7E-A2E6A2191DAD|900||CLPS|TOTAL CL PRED NORM BY SA||||||||NOT DONE||INTERSTITIAL FLUID|||SCREENING|1964-08-05||1962-04-24|1967-04-16|1967-02-01
TRIAL STUDY 134XCP|PP|00D760E7-DC21-41A8-AD28-FF48A5C21E83|901||RCAMIFOB|AMT REC INFINITY OBS NORM BY BMI||||||||NOT DONE||SUPERNATANT, SERUM|||OPEN LABEL TREATMENT|1969-08-09||1971-07-18|1968-03-07|1968-05-16
TRIAL STUDY 134XCP|PP|946ABDE0-2C2B-48BB-8003-1BAEE37264F3|902||AURCPEO|AURC % EXTRAPOLATION OBS||||||||NOT DONE||AMNIOTIC FLUID|||CONTINUATION TREATMENT|1966-03-28||1970-04-15|1967-11-29|1970-06-06
TRIAL STUDY 134XCP|PP|4EC25C9E-F259-405B-8B7D-3C9640FB9748|903||CLP|TOTAL CL PRED||||||||NOT DONE||BONE MARROW MONONUCLEAR CELL|||WASHOUT|1962-11-19||1969-01-13|1963-02-21|1960-02-20
TRIAL STUDY 134XCP|PP|FF1CC617-040D-42E9-AD31-32E7B8DAED24|904||VZOD|VZ OBS NORM BY DOSE||||||||NOT DONE||EXUDATE|||CONTINUATION TREATMENT|1960-09-18||1963-05-25|1963-09-10|1970-09-11
TRIAL STUDY 134XCP|PP|F8A4AF92-256A-4ECF-9C87-036FA7E5BF53|905||VZOW|VZ OBS NORM BY WT||||||||NOT DONE||BUFFY COAT|||BASELINE|1967-01-15||1964-08-02|1963-10-23|1962-06-10
TRIAL STUDY 134XCP|PP|BD3E97D8-A24F-49AA-8C3D-23C708A1B62F|906||RNCLINTW|RENAL CL FROM T1 TO T2 NORM BY WT||||||||NOT DONE||CIRCULATING TUMOR CELL|||INDUCTION TREATMENT|1963-05-21||1963-12-16|1972-11-08|1964-02-13
TRIAL STUDY 134XCP|PP|BFA83769-F31F-49AE-8C43-49046C719D69|907||TMIN|TIME OF CMIN OBSERVATION||||||||NOT DONE||EPITHELIAL CELL|||WASHOUT|1963-05-17||1972-06-02|1965-02-22|1966-01-02
TRIAL STUDY 134XCP|PP|6D52A8E1-CC3D-4D85-AAEC-264743FDA85E|908||CAVGINTB|AVERAGE CONC FROM T1 TO T2 NORM BY BMI||||||||NOT DONE||EPIDERMAL TISSUE|||WASHOUT|1962-08-24||1970-06-22|1963-05-10|1969-01-19
TRIAL STUDY 134XCP|PP|91838668-D463-4728-A581-2E1987592885|909||RCPCIFP|PCT REC INFINITY PRED||||||||NOT DONE||URINE SEDIMENT|||BLINDED TREATMENT|1964-01-12||1961-10-09|1962-04-03|1961-10-14
TRIAL STUDY 134XCP|PP|DE440A90-82D5-4269-A48B-47E2F5495440|910||LAMZLL|LAMBDA Z LOWER LIMIT||||||||NOT DONE||HAIR|||WASHOUT|1963-06-03||1966-11-22|1969-08-04|1963-07-24
TRIAL STUDY 134XCP|PP|74CA3A61-3179-43F1-8721-2582F50C44EF|911||ERLST|LAST MEAS EXCRETION RATE||||||||NOT DONE||SOFT TISSUE|||SCREENING|1969-10-26||1965-08-18|1961-12-07|1964-01-03
TRIAL STUDY 134XCP|PP|B16F2A3D-7DA3-4E50-AC6D-CA9F209A86CE|912||ERLST|LAST MEAS EXCRETION RATE||||||||NOT DONE||SPUTUM|||RUN-IN|1966-11-05||1960-12-07|1963-03-04|1966-11-10
TRIAL STUDY 134XCP|PP|AE1FC2A0-5A47-4AB3-B1A5-0E5D033598BE|913||CMIN|MIN CONC||||||||NOT DONE||REFLEX TEAR|||SCREENING|1972-09-13||1970-04-25|1962-06-21|1967-09-07
TRIAL STUDY 134XCP|PP|3F3D60F6-E32A-46FA-9A55-396F9A19AD27|914||AUCTAUDW|AUCTAU NORM BY DOSE/WT||||||||NOT DONE||EXUDATE|||FOLLOW-UP|1968-01-19||1970-01-03|1968-11-26|1966-11-04
TRIAL STUDY 134XCP|PP|7EDE94C5-F4F6-41A0-B0A8-89F5E13ACE86|915||CLTAUS|TOTAL CL FOR DOSE INT NORM BY SA||||||||NOT DONE||PERSPIRATION|||INDUCTION TREATMENT|1962-11-18||1972-01-20|1970-02-17|1968-12-30
TRIAL STUDY 134XCP|PP|70ECA05B-727E-4B2B-A9DF-7F60C40FCEE2|916||AUMCIFP|AUMC INFINITY PRED||||||||NOT DONE||CERVICOVAGINAL SECRETION|||LONG-TERM FOLLOW-UP|1963-10-09||1964-01-04|1965-08-04|1965-11-13
TRIAL STUDY 134XCP|PP|C34E6498-9F9C-4F9A-82AE-6B7331AD8EE9|917||LAMZNTAU|NUMBER OF POINTS FOR LAMBDA Z TAU||||||||NOT DONE||SERUM OR PLASMA OR BLOOD|||FOLLOW-UP|1973-08-26||1972-10-30|1971-05-14|1961-02-25
TRIAL STUDY 134XCP|PP|687E56D1-7E45-4598-819A-A0D8D770F406|918||RCPCINTW|PCT REC FROM T1 TO T2 NORM BY WT||||||||NOT DONE||BUFFY COAT|||LONG-TERM FOLLOW-UP|1972-12-06||1965-04-19|1971-12-16|1972-11-25
TRIAL STUDY 134XCP|PP|FA25647C-7E2D-4FD8-9A76-83B8CF8AB849|919||AUCIFPS|AUC INFINITY PRED NORM BY SA||||||||NOT DONE||SALIVA|||TREATMENT|1965-11-30||1962-07-10|1973-05-06|1965-04-19
TRIAL STUDY 134XCP|PP|F536FDD9-881B-41AD-B863-FE8AB14062A1|920||VZTAUB|VZ FOR DOSE INT NORM BY BMI||||||||NOT DONE||SMEGMA|||SCREENING|1968-09-23||1965-05-17|1968-12-04|1964-02-23
TRIAL STUDY 134XCP|PP|CB726766-A812-45B3-95CA-D1AD8F697FD3|921||ERMAXW|MAX EXCRETION RATE NORM BY WT||||||||NOT DONE||SEMEN|||RUN-IN|1962-02-19||1960-04-01|1963-04-02|1965-01-17
TRIAL STUDY 134XCP|PP|1CC00AA0-6D99-4C72-B211-A2DD3F36D830|922||RCPCIFPW|PCT REC INFINITY PRED NORM BY WT||||||||NOT DONE||GASTRIC FLUID|||TREATMENT|1971-06-29||1972-01-02|1961-10-17|1973-06-25
TRIAL STUDY 134XCP|PP|20DC654F-595C-410D-A340-465A23434D42|923||AURCIFOD|AURC INFINITY OBS NORM BY DOSE||||||||NOT DONE||PLASMA ULTRAFILTRATE|||CONTINUATION TREATMENT|1962-05-05||1964-04-04|1968-07-24|1968-01-13
TRIAL STUDY 134XCP|PP|3AFCED00-B717-49B6-ADA0-5E321C97D0A1|924||CORRXY|CORRELATION BETWEEN TIMEX AND LOG CONCY||||||||NOT DONE||ARTERIAL CORD BLOOD|||CONTINUATION TREATMENT|1972-06-07||1961-04-11|1963-06-18|1966-02-18
TRIAL STUDY 134XCP|PP|4EA8DC88-09C8-4954-A469-D8E12F01CB56|925||RAAUCALL|RATIO AUC ALL||||||||NOT DONE||ENDOMETRIAL TISSUE|||TREATMENT|1962-06-11||1973-01-21|1964-05-16|1965-12-21
TRIAL STUDY 134XCP|PP|4D4868E9-3CAA-4BF1-A3BE-1BE3664DE6B7|926||RAMAXMIN|RATIO OF CMAX TO CMIN||||||||NOT DONE||PERSPIRATION|||WASHOUT|1970-05-14||1970-02-24|1973-01-15|1962-07-15
TRIAL STUDY 134XCP|PP|521B1614-9092-4F89-A47F-728C66E01B23|927||CMAXUB|MAX CONC, UNBOUND DRUG||||||||NOT DONE||PUS|||CONTINUATION TREATMENT|1965-05-25||1960-07-27|1967-08-19|1965-04-21
TRIAL STUDY 134XCP|PP|3DB9B1C5-47C4-4684-96B6-334C9C33CD0D|928||AUCINT|AUC FROM T1 TO T2||||||||NOT DONE||LYSATE|||BLINDED TREATMENT|1972-08-20||1966-03-31|1970-09-07|1964-06-23
TRIAL STUDY 134XCP|PP|FF6B8B49-3C82-459D-A35D-61136FC594D2|929||AUMCIFP|AUMC INFINITY PRED||||||||NOT DONE||PLATELET RICH PLASMA|||LONG-TERM FOLLOW-UP|1970-11-29||1961-05-21|1967-01-22|1965-10-05
TRIAL STUDY 134XCP|PP|2196D9F4-937A-4662-B24B-AC9D472E0393|930||CONCB|CONC BY BMI||||||||NOT DONE||EPIDERMAL TISSUE|||RUN-IN|1967-10-06||1964-08-17|1969-02-16|1966-03-10
TRIAL STUDY 134XCP|PP|F192452A-4088-46AA-9DD1-8D14809E18F6|931||LAMZTAU|LAMBDA Z TAU||||||||NOT DONE||EXHALED BREATH CONDENSATE|||INDUCTION TREATMENT|1966-06-16||1968-05-14|1969-10-13|1970-10-28
TRIAL STUDY 134XCP|PP|02FCAF7E-984A-4EF7-95C1-EF545DDFD2C5|932||CLTAU|TOTAL CL FOR DOSE INT||||||||NOT DONE||SYNOVIAL FLUID|||LONG-TERM FOLLOW-UP|1968-05-15||1967-11-18|1971-08-11|1968-12-13
TRIAL STUDY 134XCP|PP|0D51A87E-2597-4B2D-A7B5-E533790E917D|933||VZOW|VZ OBS NORM BY WT||||||||NOT DONE||PROSTATIC FLUID|||BLINDED TREATMENT|1965-11-13||1962-02-13|1969-12-10|1961-06-19
TRIAL STUDY 134XCP|PP|3CD8C9A3-A0A4-4BE5-8DA9-6FDA02FC85D4|934||AUMCTAUB|AUMC OVER DOSING INTERVAL NORM BY BMI||||||||NOT DONE||ENDOMETRIAL TISSUE|||BASELINE|1963-03-27||1961-12-23|1968-09-16|1964-12-22
TRIAL STUDY 134XCP|PP|16075684-F04D-4CB8-970A-0819378790EB|935||VSSOF|VOL DIST STEADY STATE OBS BY F||||||||NOT DONE||SOFT TISSUE|||LONG-TERM FOLLOW-UP|1972-02-14||1968-11-23|1961-11-01|1960-08-14
TRIAL STUDY 134XCP|PP|3527E844-D4D5-480A-B6D6-04C5DC0A3380|936||RAAUCALL|RATIO AUC ALL||||||||NOT DONE||INTERSTITIAL FLUID|||BASELINE|1966-02-25||1961-11-21|1963-11-25|1961-12-26
TRIAL STUDY 134XCP|PP|DFB0DF52-4D95-4A26-B28F-071774D78426|937||AUCLSTS|AUC TO LAST NONZERO CONC NORM BY SA||||||||NOT DONE||ERYTHROCYTES|||OPEN LABEL TREATMENT|1960-09-12||1964-05-09|1972-12-03|1968-12-12
TRIAL STUDY 134XCP|PP|7F7EFCD6-CFE3-4C15-B25B-0843C02CB439|938||AURCIFPB|AURC INFINITY PRED NORM BY BMI||||||||NOT DONE||EPITHELIAL CELL|||RUN-IN|1960-04-05||1960-12-05|1964-02-13|1966-02-06
TRIAL STUDY 134XCP|PP|CFF20837-0091-467E-ABDE-72645BAFC849|939||CLFPW|TOTAL CL PRED BY F NORM BY WT||||||||NOT DONE||CORD BLOOD|||TREATMENT|1973-07-04||1960-08-09|1962-10-11|1968-09-12
TRIAL STUDY 134XCP|PP|C79756C8-8601-4770-8BC2-7A530428BA82|940||CLSTD|LAST NONZERO CONC NORM BY DOSE||||||||NOT DONE||KERATINOCYTE|||CONTINUATION TREATMENT|1965-04-11||1967-04-06|1969-12-30|1961-09-19
TRIAL STUDY 134XCP|PP|5533A669-828B-4CA3-BEC3-849CE7384167|941||ERMAXB|MAX EXCRETION RATE NORM BY BMI||||||||NOT DONE||MUCUS|||CONTINUATION TREATMENT|1971-05-19||1971-02-18|1969-12-08|1964-06-20
TRIAL STUDY 134XCP|PP|C711ADD3-F398-4161-BE13-B75BEDF91402|942||TMAX|TIME OF CMAX||||||||NOT DONE||LAVAGE FLUID|||OPEN LABEL TREATMENT|1967-11-10||1963-09-05|1971-05-14|1971-08-24
TRIAL STUDY 134XCP|PP|2CD70FFA-5977-4718-961B-6D67368F99B8|943||FREL|RELATIVE BIOAVAILABILITY||||||||NOT DONE||INTERSTITIAL FLUID|||BLINDED TREATMENT|1968-07-07||1969-05-15|1967-05-03|1969-06-25
TRIAL STUDY 134XCP|PP|F01FF884-E12B-4C43-BB7B-5E8918B19A4A|944||CHTMAX|CONCENTRATION AT HALF TMAX||||||||NOT DONE||MENSTRUAL BLOOD|||INDUCTION TREATMENT|1964-07-01||1972-01-23|1961-06-15|1962-02-21
TRIAL STUDY 134XCP|PP|F82601ED-4E74-4349-8F01-2F0DA9AE4BD7|945||VSSPB|VOL DIST STEADY STATE PRED NORM BY BMI||||||||NOT DONE||ABSCESS FLUID|||BASELINE|1973-07-07||1960-11-20|1968-02-25|1961-03-05
TRIAL STUDY 134XCP|PP|43E00B7D-684F-4BAC-A135-E65C22B191AD|946||ARAUCIOD|ACCUM RATIO AUCIFO NORM BY DOSE||||||||NOT DONE||ARTERIALIZED CAPILLARY BLOOD|||BASELINE|1967-01-09||1969-05-05|1966-08-02|1966-07-27
TRIAL STUDY 134XCP|PP|25680BE0-7CE5-4B76-A48E-2D977A07E749|947||LAMZLL|LAMBDA Z LOWER LIMIT||||||||NOT DONE||PERSPIRATION|||LONG-TERM FOLLOW-UP|1961-10-16||1971-05-24|1973-07-08|1972-10-28
TRIAL STUDY 134XCP|PP|67CA2619-351F-493E-93B2-5CDC9AF99C8B|948||VZOW|VZ OBS NORM BY WT||||||||NOT DONE||BILE|||BLINDED TREATMENT|1971-10-26||1964-02-12|1964-08-22|1964-12-07
TRIAL STUDY 134XCP|PP|A4E6FC7C-719C-4891-8C08-E5907F07A4EA|949||AUMCIFPD|AUMC INFINITY PRED NORM BY DOSE||||||||NOT DONE||CIRCULATING TUMOR CELL|||OBSERVATION|1964-11-01||1963-05-01|1963-02-28|1965-10-12
TRIAL STUDY 134XCP|PP|890AFEEA-4AC7-4F32-B18F-2FBD860F7B86|950||AUCIFOUB|AUC INFINITY OBS, UNBOUND DRUG||||||||NOT DONE||CORD SERUM|||WASHOUT|1963-11-28||1961-11-05|1968-11-10|1972-06-16
TRIAL STUDY 134XCP|PP|51B01BE3-230D-4AE0-A229-81EF519EA932|951||VZFTAUB|VZ FOR DOSE INT BY F NORM BY BMI||||||||NOT DONE||DIALYSIS FLUID, PERITONEAL|||CONTINUATION TREATMENT|1961-07-03||1969-10-24|1966-03-30|1963-12-22
TRIAL STUDY 134XCP|PP|5665DA4F-6C20-46F3-A00B-E9688DCBF4DE|952||VZFTAUS|VZ FOR DOSE INT BY F NORM BY SA||||||||NOT DONE||ADIPOSE TISSUE|||WASHOUT|1967-04-09||1965-02-17|1960-04-27|1971-09-29
TRIAL STUDY 134XCP|PP|01FD66DA-C67B-48A7-9320-F29C6C226155|953||VZFPUB|VZ PRED BY F FOR UB||||||||NOT DONE||BILE|||WASHOUT|1969-06-26||1971-12-29|1972-05-05|1962-04-23
TRIAL STUDY 134XCP|PP|DCBA9A22-BC7B-4EA1-9441-AD40D064233C|954||AUCLSTD|AUC TO LAST NONZERO CONC NORM BY DOSE||||||||NOT DONE||SUPERNATANT, CEREBROSPINAL FLUID|||FOLLOW-UP|1971-04-24||1961-01-07|1961-06-01|1966-06-16
TRIAL STUDY 134XCP|PP|5D7626F9-604F-4D8B-8D39-1ACD1363CFE2|955||AUCIFOW|AUC INFINITY OBS NORM BY WT||||||||NOT DONE||ENDOMETRIAL TISSUE|||BASELINE|1971-11-06||1972-05-10|1967-03-09|1970-09-18
TRIAL STUDY 134XCP|PP|81E3641F-6145-4B3C-9E26-8DEC1200509D|956||CONCDW|CONCENTRATION NORM BY DOSE/WT||||||||NOT DONE||SKIN TISSUE|||INDUCTION TREATMENT|1965-03-15||1972-03-18|1960-07-05|1966-05-26
TRIAL STUDY 134XCP|PP|8F3D0A71-FD09-4E43-BC54-0562AF99306E|957||VZO|VZ OBS||||||||NOT DONE||VENOUS CORD BLOOD|||FOLLOW-UP|1966-04-01||1973-06-18|1965-01-18|1960-05-19
TRIAL STUDY 134XCP|PP|BE750F04-5992-42B5-A084-A33D6FBBFD2E|958||RNCLTAUW|RENAL CL FOR DOSE INT NORM BY WT||||||||NOT DONE||ARTERIAL CORD BLOOD|||SCREENING|1962-09-29||1967-11-10|1967-10-21|1972-01-14
TRIAL STUDY 134XCP|PP|4926DCA5-2DA6-4A16-8CDB-A92ABDB66B89|959||DISTHL|HALF-LIFE DISTRIBUTION||||||||NOT DONE||SOFT TISSUE|||LONG-TERM FOLLOW-UP|1962-09-06||1963-08-01|1966-03-21|1973-03-22
TRIAL STUDY 134XCP|PP|8417B146-336C-4777-A566-C1D086F39430|960||ARCTROUD|ACCUM RATIO CTROUGH NORM BY DOSE||||||||NOT DONE||SYNOVIAL FLUID|||WASHOUT|1972-07-31||1961-05-31|1965-11-25|1962-06-14
TRIAL STUDY 134XCP|PP|FB8D36FD-B57F-4D93-AA64-2BFD130B39C7|961||CMAXLN|MAX CONC LN TRANSFORMED||||||||NOT DONE||CAPILLARY BLOOD|||TREATMENT|1965-12-24||1971-01-09|1964-11-09|1973-08-07
TRIAL STUDY 134XCP|PP|1B82113D-E76E-45BC-8CC8-EBE3D5FB10EE|962||AURCALLB|AURC ALL NORM BY BMI||||||||NOT DONE||SEMINAL FLUID|||BLINDED TREATMENT|1966-01-15||1960-08-27|1971-05-15|1967-01-01
TRIAL STUDY 134XCP|PP|7F6F9ECF-978B-49D7-ADD2-8403D813DFEB|963||RACMIN|RATIO MIN CONC||||||||NOT DONE||SMOOTH MUSCLE TISSUE|||RUN-IN|1971-11-02||1960-11-19|1969-04-17|1973-08-17
TRIAL STUDY 134XCP|PP|2926D795-9C17-4440-8411-68525E93E78D|964||CONC|CONCENTRATION||||||||NOT DONE||SUPERNATANT, SERUM|||OBSERVATION|1960-08-10||1962-07-18|1963-06-23|1963-02-17
TRIAL STUDY 134XCP|PP|BA3378F3-C308-469F-9818-9AD811086548|965||ARAUCD|ACCUM RATIO AUCTAU NORM BY DOSE||||||||NOT DONE||MUCUS|||OPEN LABEL TREATMENT|1970-09-25||1967-05-27|1963-05-29|1967-11-27
TRIAL STUDY 134XCP|PP|D9CABD49-D3C9-4792-8110-3D48D0D11DBA|966||RENALCLD|RENAL CL NORM BY DOSE||||||||NOT DONE||SKIN TISSUE|||WASHOUT|1972-10-13||1960-01-24|1972-02-06|1972-11-20
TRIAL STUDY 134XCP|PP|C9F6564B-D41D-406B-ABD3-5F453B66F1C6|967||CAVGW|AVERAGE CONC NORM BY WT||||||||NOT DONE||MUSCLE TISSUE|||TREATMENT|1972-10-02||1969-11-26|1962-01-12|1970-11-01
TRIAL STUDY 134XCP|PP|02AE6CFC-BC7C-49D1-8B5C-E57147B147B7|968||AUCINTD|AUC FROM T1 TO T2 NORM BY DOSE||||||||NOT DONE||PLASMA ULTRAFILTRATE|||LONG-TERM FOLLOW-UP|1967-12-24||1968-01-06|1965-10-19|1961-09-27
TRIAL STUDY 134XCP|PP|15594D4E-1DAE-449F-AA52-9B0A926D9985|969||CAVGINTD|AVERAGE CONC FROM T1 TO T2 NORM BY DOSE||||||||NOT DONE||CARDIAC MUSCLE TISSUE|||OPEN LABEL TREATMENT|1961-07-06||1973-06-19|1971-02-23|1968-11-08
TRIAL STUDY 134XCP|PP|079DEA7B-A617-4787-9872-025F4248ABFF|970||VZO|VZ OBS||||||||NOT DONE||COLOSTRUM|||BASELINE|1969-07-23||1967-11-14|1969-08-19|1962-10-11
TRIAL STUDY 134XCP|PP|3178AE30-9653-4470-84E4-FB0E4587DF6B|971||AURCIFPW|AURC INFINITY PRED NORM BY WT||||||||NOT DONE||WHITE MATTER TISSUE|||BLINDED TREATMENT|1971-05-24||1968-05-06|1968-02-15|1970-06-23
TRIAL STUDY 134XCP|PP|921EE2AA-D4FB-49E1-A3CD-05B064D0E83A|972||V0W|VOL DIST INITIAL NORM BY WT||||||||NOT DONE||LAVAGE FLUID|||WASHOUT|1963-02-23||1961-12-15|1966-07-02|1961-11-05
TRIAL STUDY 134XCP|PP|D274C760-A607-4DA8-ACD3-346EF6E191D2|973||ERLSTB|LAST MEAS EXCRETION RATE NORM BY BMI||||||||NOT DONE||AMNIOTIC FLUID|||RUN-IN|1963-05-02||1965-11-04|1961-02-16|1964-01-31
TRIAL STUDY 134XCP|PP|F5B7E82D-49AD-422E-9C38-5681105094AA|974||TAUHL|HALF-LIFE TAU||||||||NOT DONE||AMNIOTIC FLUID|||BLINDED TREATMENT|1963-02-05||1961-08-16|1962-01-24|1972-04-20
TRIAL STUDY 134XCP|PP|AF8D32B4-B2CC-4EE3-A612-179814C691B8|975||AUCTAUS|AUC OVER DOSING INTERVAL NORM BY SA||||||||NOT DONE||CEREBROSPINAL FLUID|||FOLLOW-UP|1967-10-01||1969-10-17|1962-07-06|1969-06-20
TRIAL STUDY 134XCP|PP|64153B43-9DDC-473D-97E1-0E2E8C3E8116|976||RNCLTAUW|RENAL CL FOR DOSE INT NORM BY WT||||||||NOT DONE||TRANSUDATE|||OBSERVATION|1969-01-24||1968-01-06|1960-06-29|1969-01-15
TRIAL STUDY 134XCP|PP|0F5775AD-1D20-4B59-8558-8A41C12E03D0|977||RNCLINTS|RENAL CL FROM T1 TO T2 NORM BY SA||||||||NOT DONE||PERSPIRATION|||LONG-TERM FOLLOW-UP|1965-02-02||1960-10-02|1965-02-14|1967-12-28
TRIAL STUDY 134XCP|PP|DF533087-690C-489A-9163-9D4503B7BCC9|978||RNCLTAUS|RENAL CL FOR DOSE INT NORM BY SA||||||||NOT DONE||EXUDATE|||OPEN LABEL TREATMENT|1970-02-19||1971-04-15|1960-06-28|1971-02-17
TRIAL STUDY 134XCP|PP|D4FE3C52-9E91-47D4-89B2-E9458C6F5919|979||ERTMAX|MIDPOINT OF INTERVAL OF MAXIMUM ER||||||||NOT DONE||SWABBED MATERIAL|||OPEN LABEL TREATMENT|1964-02-12||1961-06-20|1969-05-04|1964-08-09
TRIAL STUDY 134XCP|PP|D4D4EEF1-9188-4969-A704-4EB2DAF625B5|980||VSSP|VOL DIST STEADY STATE PRED||||||||NOT DONE||PUS|||RUN-IN|1960-07-25||1961-12-11|1971-01-17|1968-01-19
TRIAL STUDY 134XCP|PP|0456B11C-D064-4E92-AA2D-12DA09F3FAF4|981||AURCIFP|AURC INFINITY PRED||||||||NOT DONE||URINE SEDIMENT|||BLINDED TREATMENT|1972-03-17||1960-04-10|1968-07-16|1972-08-16
TRIAL STUDY 134XCP|PP|D0C56E07-2ECA-4990-B7AB-6B06E5616C9F|982||V0W|VOL DIST INITIAL NORM BY WT||||||||NOT DONE||DIALYSIS FLUID|||OBSERVATION|1967-06-11||1964-10-21|1967-05-15|1965-01-23
TRIAL STUDY 134XCP|PP|BCAF5E7C-8A2E-43E6-9292-95021AFDAB1E|983||AUCINT|AUC FROM T1 TO T2||||||||NOT DONE||TISSUE|||WASHOUT|1966-01-12||1962-12-23|1965-02-24|1964-10-24
TRIAL STUDY 134XCP|PP|219A70B2-48A6-407C-B901-9847583DB5F4|984||CMIN|MIN CONC||||||||NOT DONE||MUCUS|||BLINDED TREATMENT|1967-12-15||1963-11-21|1968-01-13|1971-12-16
TRIAL STUDY 134XCP|PP|CF3AC42D-DFBA-448E-A688-46A87D6264EB|985||VZFTAU|VZ FOR DOSE INT BY F||||||||NOT DONE||STOOL|||LONG-TERM FOLLOW-UP|1971-07-13||1964-08-31|1967-10-04|1962-02-13
TRIAL STUDY 134XCP|PP|0FB5E37C-B78E-4EE2-A55E-9E850D680BB4|986||AURCIFPS|AURC INFINITY PRED NORM BY SA||||||||NOT DONE||SMOOTH MUSCLE TISSUE|||BLINDED TREATMENT|1967-09-16||1962-05-07|1964-03-03|1971-01-31
TRIAL STUDY 134XCP|PP|D19D43A5-DFE6-415D-86B7-6A767A357BC9|987||CMAXW|MAX CONC NORM BY WT||||||||NOT DONE||BONE MARROW|||FOLLOW-UP|1962-10-13||1969-01-19|1961-07-31|1964-06-29
TRIAL STUDY 134XCP|PP|B9DDBCB0-91F7-4C06-B1E7-5577928C799F|988||AURCIFPW|AURC INFINITY PRED NORM BY WT||||||||NOT DONE||CERVICOVAGINAL SECRETION|||INDUCTION TREATMENT|1968-02-11||1962-01-29|1963-06-24|1969-10-06
TRIAL STUDY 134XCP|PP|7D307F63-4A25-4E7D-9980-16764AE5C4A4|989||V0D|VOL DIST INITIAL NORM BY DOSE||||||||NOT DONE||ENDOTRACHEAL FLUID|||TREATMENT|1968-03-25||1968-09-03|1960-01-08|1963-11-18
TRIAL STUDY 134XCP|PP|C651B2EE-281E-4CC6-ACC6-E91B19138A7D|990||AURCINTW|AURC FROM T1 TO T2 NORM BY WT||||||||NOT DONE||SEMEN|||CONTINUATION TREATMENT|1967-10-12||1972-12-17|1970-01-29|1967-04-23
TRIAL STUDY 134XCP|PP|F4718E0D-4DD9-442E-8907-076551C83AEE|991||AUCIFOW|AUC INFINITY OBS NORM BY WT||||||||NOT DONE||INFRANATANT, PLEURAL FLUID|||BASELINE|1972-01-07||1969-06-02|1963-10-23|1961-10-04
TRIAL STUDY 134XCP|PP|AC095369-9EEF-47F5-938C-DAF5D4FAF7C9|992||RACONC|RATIO CONCENTRATION||||||||NOT DONE||SKELETAL MUSCLE TISSUE|||CONTINUATION TREATMENT|1961-07-27||1972-10-04|1960-05-14|1972-04-01
TRIAL STUDY 134XCP|PP|E86F996D-3A96-4C36-82B2-1AC4B4906F49|993||RCPCINTW|PCT REC FROM T1 TO T2 NORM BY WT||||||||NOT DONE||CORD BLOOD|||SCREENING|1970-09-15||1960-12-03|1964-09-06|1964-09-20
TRIAL STUDY 134XCP|PP|10DEC5CB-7A18-4A1D-9138-4F2C83A7737C|994||ARAUCD|ACCUM RATIO AUCTAU NORM BY DOSE||||||||NOT DONE||ISOLATE|||FOLLOW-UP|1969-09-18||1960-02-15|1970-02-12|1962-04-19
TRIAL STUDY 134XCP|PP|5E3C9256-B0B9-4221-B5B6-FB2B76DA9BEF|995||AUCIFPS|AUC INFINITY PRED NORM BY SA||||||||NOT DONE||CORD SERUM|||WASHOUT|1961-07-20||1972-12-15|1964-07-06|1968-05-09
TRIAL STUDY 134XCP|PP|28E9B15E-4757-42F5-8AE7-2C868904F88B|996||AUCALL|AUC ALL||||||||NOT DONE||SERUM|||TREATMENT|1961-12-23||1971-11-18|1972-02-27|1966-03-01
TRIAL STUDY 134XCP|PP|1547C5B8-C63D-4A54-8FCF-8BC022E0A52B|997||ARCTROUD|ACCUM RATIO CTROUGH NORM BY DOSE||||||||NOT DONE||SUPERNATANT, PLASMA|||LONG-TERM FOLLOW-UP|1970-10-01||1962-10-31|1965-03-18|1968-03-16
TRIAL STUDY 134XCP|PP|2E1011F1-A091-4E7E-B661-477A1F6DD39A|998||CAVGB|AVERAGE CONC NORM BY BMI||||||||NOT DONE||CELL PELLET|||BASELINE|1970-12-10||1969-01-21|1963-11-10|1961-09-16
TRIAL STUDY 134XCP|PP|7227F990-6CFE-49BD-BB46-5B2DDAD9CB49|999||ERLSTB|LAST MEAS EXCRETION RATE NORM BY BMI||||||||NOT DONE||SPERMATOZOON|||OBSERVATION|1960-05-07||1966-01-20|1964-03-30|1963-01-06
TRIAL STUDY 134XCP|PP|176B6882-0C9E-435E-9842-FF8714BC9CAF|1000||LAMZUTAU|LAMBDA Z UPPER LIMIT TAU||||||||NOT DONE||SALIVA|||FOLLOW-UP|1961-03-12||1968-04-23|1966-05-24|1967-08-06
